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Abstract
The central carbon metabolism is the driving force of cellular processes as it covers the
essential generation of energy and biomass from extracellular substrates. Understand-
ing its capacity and regulation provides an enormous potential to the design of efficient
biotechnological processes as well as to remedy metabolic diseases. Unfortunately, the
complexity and versatility of metabolism conceals the interplay of different regulatory
layers and leaves the field of metabolic research with numerous, partially competing
hypotheses, which calls for an integrated analysis.
This work aims at unraveling the interplay of regulation mechanisms in the central
carbon metabolism of adherent Madin-Darby canine kidney (MDCK) cells for a broad
range of growth conditions and relies on the development of mathematical models for
the quantitative description of experimental measurements.
With the objective to find an initial concept for an integrated modeling approach, this
work characterizes in a first step the growth and metabolism of MDCK cells cultivated
in two different media. Surprisingly, this analysis reveals an identical growth behavior
as well as comparable dynamics in intracellular metabolite concentrations. The data,
thus, implicitly suggests that extracellular substrate levels may have a minor influence
on the metabolic activity. Also the hypothesis of an energy homeostasis is rendered as
less relevant for describing the MDCK cell metabolism. It rather seems that substrate
uptake rates, which change with culture duration, and key enzyme metabolite interac-
tions constitute salient features of intracellular metabolite dynamics.
To fully account for cell growth and uptake of substrates, this work develops in a second
step a segregated model that describes the proliferation of adherent cells in number and
volume by taking into account the mean cell diameter. The process of growth involves
that cells pass through different diameter classes, while consuming substrates and re-
leasing byproducts. In addition to the substrate availability, growth is also limited by
the cell density on the attachment surface. The derived model is simply structured, easy
to compute and recapitulates the data of three independent experiments using a single
parameter set. Apart from evaluating and predicting cell cultivations, the model also
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provides macroscopic functions for complex cellular processes such as substrate uptake,
biosynthesis and change in cell size and is, thus, particularly suited for a growth-related
analysis of the cellular metabolism.
Coupling the segregated cell growth model to simple, biologically relevant descriptions
of the central carbon metabolism supports the analysis of metabolite dynamics for a
variety of growth conditions and time scales. The derived model covers central parts of
glycolysis and glutaminolysis, accounts for links to associated metabolic pathways and
takes into account in vitro measurements of enzyme activities. Based on an advanced
simulation scheme and sequential model fitting, the approach suggests that metabolic
activity is mainly driven by a growth-dependent substrate transport while the distribu-
tion of fluxes to biosynthesis and energy generation is determined by the properties of
the involved enzymes. In case substrates are limiting, the metabolic activity reduces
and enzyme-metabolite-interactions enable the supply of the central carbon metabolism
with intracellular amino acids and biomass precursor, which guarantees a minimum ac-
tivity. Therefore, the shift in metabolic control is an essential property of the cellular
metabolism that consistently describes metabolite dynamics of three cell cultivations,
two substrate limitation experiments and one substrate pulse experiment. Furthermore,
the approach considers the preculture of cells, which explains variations among repli-
cate experiments. Based on the model’s performance in describing the data, its simple
structure and its power to predict the metabolic activity, the model enables a reliable
evaluation of strategies that aim at a faster or more efficient metabolism.
Overall, the modeling approach realizes a combined analysis of growth and metabolism
of MDCK cells that contributes to the field of metabolic research. By placing relevant
hypotheses on the metabolic regulation into the context of various experimental condi-
tions, this work delivers conclusive insights into the mechanisms of metabolic pathways
and illuminates the turnover of metabolites as well as the supply of the cell with energy
and biomass precursors.
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Kurzfassung
Der zentrale Kohlenstoffwechsel einer Zelle wandelt extrazellula¨re Substrate zu Ener-
gie und Biomasse um und ist damit die Triebkraft zellula¨rer Prozesse. Ein umfassendes
Versta¨ndnis von Kapazita¨t und Regulation des Stoffwechsels besitzt daher ein enormes
Potential sowohl fu¨r die Auslegung effizienter biotechnologischer Prozesse als auch fu¨r die
Behandlung metabolischer Erkrankungen. Bedauerlicherweise verdecken seine Komple-
xita¨t und Vielseitigkeit das Zusammenspiel der verschiedenen regulatorischen Ebenen,
was der Metabolismusforschung unza¨hlige, zum Teil konkurrierende Hypothesen ein-
brachte und nach einer ganzheitlichen Analyse verlangt.
Diese Arbeit zielt darauf ab, das Zusammenspiel von Regulationsmechanismen im Zen-
tralstoffwechsel der adha¨renten Madin-Darby canine kidney (MDCK) Zelle u¨ber einen
weiten Bereich von Wachstumsbedingungen aufzukla¨ren und stu¨tzt sich dabei auf die
Entwicklung mathematischer Modelle zur quantitativen Beschreibung experimenteller
Messungen.
Mit dem Ziel, ein initiales Konzept fu¨r den ganzheitlichen Modellierungsansatz zu finden,
werden im ersten Schritt dieser Arbeit Wachstum und Stoffwechsel der MDCK Zelle fu¨r
zwei unterschiedlichen Kultivierungsmedien charakterisiert. U¨berraschenderweise zeigen
sich u¨bereinstimmende Wachstumsphasen und vergleichbare Dynamiken in den intrazel-
lula¨ren Metabolitkonzentrationen. Die Daten legen damit implizit nahe, dass der Ein-
fluss der Substrate auf die Stoffwechselaktivita¨t begrenzt ist. Auch die Hypothese einer
Energie-Homeostase ist minder relevant fu¨r die Beschreibung des MDCK Zellstoffwech-
sels. Vielmehr scheinen die Substrataufnahmeraten, welche sich mit der Kultivierungs-
dauer a¨ndern, im Zusammenspiel mit entscheidende Enzym-Metabolit-Interaktionen be-
reits wesentliche Dynamiken in den intrazellula¨ren Metaboliten auszumachen.
Um Wachstum und Substratbedarf der Zellen vollsta¨ndig nach zu bilden, wird ein se-
gregiertes Modell entworfen, welches das adha¨rente Wachstum in Zahl und Volumen
durch die Beru¨cksichtigung des mittleren Durchmessers beschreibt. Der Wachstumspro-
zess beinhaltet das Durchlaufen verschiedener Zelldurchmesser-Klassen, was Substrate
verbraucht und Nebenprodukte freisetzt. Zusa¨tzlich zur Substratverfu¨gbarkeit ist das
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Wachstum auch durch die Zelldichte auf der Anheftungsoberfla¨che begrenzt. Dabei be-
sitzt das Modell eine relativ einfache Struktur, ist schnell zu berechnen und gibt die
Daten von drei unabha¨ngigen Experimenten unter Verwendung eines einzigen Parame-
tersatzes wieder. Neben dem Evaluieren und Vorhersagen von Zellkultivierungen kann
das Modell komplexe zellula¨re Prozesse wie Substrataufnahme, Biosynthese und Zell-
gro¨ßena¨nderung durch einfache, makroskopische Funktionen abbilden und ist damit ide-
al fu¨r wachstumsabha¨ngige Analysen des Zellstoffwechsels geeignet.
Die anschließende Kopplung des segregierten Zellwachstumsmodells mit einer einfachen,
biologisch relevanten Beschreibung des Zentralstoffwechsels erlaubt es, Dynamiken in den
Metabolitkonzentrationen u¨ber verschiedene Kultivierungsbedingungen und Zeitskalen
hinweg aufzukla¨ren. Hierbei werden zentrale Bestandteile von Glykolyse und Glutamino-
lyse als auch deren Verbindung zu assoziierten metabolischen Wegen beru¨cksichtigt und
in vitro Messungen von Enzymaktivita¨ten einbezogen. Basierend auf einem erweiter-
ten Simulationsschema und sequentieller Modellanpassung legt der angewandte Ansatz
nahe, dass die Aktivita¨ten des Stoffwechselnetzwerkes im Wesentlichen durch wachs-
tumsabha¨ngige Substrattransporte bestimmt sind. Die exakte Verteilung der Stoffflu¨sse
zu Biosynthese oder Energiegenerierung ha¨ngt hingegen von den Eigenschaften der invol-
vierten Enzyme ab. Im Falle einer Substratlimitierung verringert sich die metabolische
Aktivita¨t wobei Enzym-Metabolit-Interaktionen eine minimale Versorgung der Stoff-
wechselwege mit intrazellula¨ren Aminosa¨uren und Biomassevorla¨ufern ermo¨glichen. Die
Verlagerung der metabolischen Kontrolle ist somit eine essentielle Eigenschaft des zel-
lula¨ren Stoffwechsels, welche Metabolitdynamiken fu¨r drei Zellkultivierungen, zwei Sub-
stratlimitierungen und einem Substratpuls Experiment konsistent beschreibt. Weiterhin
beru¨cksichtigt der Ansatz die Vorkultur der Zelle, was experiment-spezifische Unterschie-
de erkla¨rt. Basierend auf der Leistungsfa¨higkeit im Beschreiben der Daten, der einfachen
Modellstruktur und der erzielten Vorhersagekraft fu¨r Kultivierungen ist das entwickelte
Modell auch geeignet, Strategien die auf einen schnelleren oder effizienteren Stoffwechsel
abzielen verla¨sslich zu evaluieren.
Zusammengefasst realisiert der hier vorgestellte Modellierungsansatz eine kombinierte
Analyse von Wachstum und Metabolismus der MDCK Zelle und tra¨gt zur Erforschung
des Zellstoffwechsels bei. Relevante Hypothesen zur Stoffwechselregulation werden in
den Kontext verschiedenster Kultivierungsbedingungen gesetzt, was Aufschluss u¨ber die
Kontrolle der metabolischen Netzwerke gibt und die Metabolitumsetzung als auch die
Versorgung der Zelle mit Energie und Biomassevorla¨ufern beleuchtet.
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1ChapterIntroduction
Cell culture processes represent an advanced technology platform for developing and pro-
ducing diagnostic and therapeutic biologicals that improve human and animal health.
Fundamental to any cell culture-based process is the robust and efficient growth of cells
in an artificial environment to produce, for example, insulin with E. coli [1], antibodies
with CHO or hybridoma cells [2, 3] and viral vaccines with BHK or MDCK cells [4, 5].
To enable growth, division and response to stress, the cell requires a steady supply with
energy and biomass precursors from metabolism to fuel numerous biosynthetic reactions
and physiological functions [6]. Therefore, the metabolic conversion of nutrients is the
driving force of cellular life and organized in cellular reaction pathways. These reaction
pathways consist of enzymes that catalyze the conversion of one metabolic intermediate
to another [7, pp. 90-119] and compose a metabolic network that is supplied by uptake of
substrates via facilitated transports across cellular membranes. Based on the individual
properties of the involved enzymes, the resulting production rates for cellular energy and
biomass precursors are determined by the network properties and adjusted to cellular
needs by sophisticated regulation mechanisms, which together enable biosynthesis in a
changing environment.
The in vitro properties of single enzymes were investigated by biochemists since many
years to unravel the network architecture and regulation mechanisms of metabolic path-
ways. These studies delivered a detailed description of substrate and cofactor use of
enzymatic reactions, while regulation mechanisms and overall dynamics of the in vivo
metabolism remained largely hypothetical [8–10]. Firstly, because in vitro measurements
barely reflect the in vivo behavior [11] and, secondly, many of the identified cofactors
and allosteric effects may not act as regulators of metabolism [12]. In parallel, biotech-
nologists analyzed in empiric studies the cellular need for extracellular nutrients under
various cultivation conditions and achieve appreciable cell growth rates and product
titers [13, 14]. Combined with knowledge of biochemical reaction pathways, the analysis
of substrate uptake and byproduct release rates provides insights into metabolic pathway
activities under (pseudo) steady state conditions and facilitates the design of cell feeding
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strategies [15, 16]. During standard cultivations, however, cells easily adapt their growth
and substrate uptake rates to environmental conditions, e.g. switch from growth to in-
termediary to stationary phase, with a concomitant adjustment of the metabolic activity
through multiple regulatory mechanisms. For instance, the genomic, translational and
proteomic level influences the abundance of enzymes and transporter as well as their
degree of phosphorylation which, in addition to metabolite, cofactors and allosteric ef-
fector levels, determine the conversion rate within the reaction pathways. Since the
pools and fluxes of the metabolic network represent the functional endpoints through
all these regulatory layers, their quantification is key for a comprehensive systems level
analysis of the cellular metabolism [17, 18]. Together with the measurement of enzyme
activities, such data can illuminate many facets of metabolism and can indirectly unravel
regulatory principles. However, it involves the acquisition of large data sets from differ-
ent analytical methods and for a variety of experiments, which often impedes conclusive
insights unless integrated into a systematic data analysis framework.
Mathematical models can organize information in a comprehensive system description
and offer a predictive rationalization for bioprocesses [19]. Current metabolic models
(e.g. [20]) elegantly explain general phenomenological aspects such as metabolic steady
states, the response of metabolism to substrate, enzyme and effector level perturbations
or the connection between transcriptome and metabolome. These models were largely
developed for yeast or bacteria and deliver conclusive insights into regulatory principles
of the central carbon metabolism. However, for mammalian cells only very few data-
driven models are available and explanations for the metabolic regulation in a broader
physiological context, where cells undergo changes in growth and substrate uptake rates,
are rare. Whilst the correlation between specific growth rate and metabolic activity is
widely accepted, the question of what actually regulates the metabolic activity is still
difficult to answer [21].
Over the past decade, the BPE group from the Max Planck Institute for Dynamics of
Complex Technical Systems in Magdeburg collected a profound data set for adherently
growing MDCK cells that covers enzyme activities [22], metabolite pools [23] and intra-
cellular fluxes [16] for a variety of growth conditions. Although MDCK cells are only
sparsely considered in metabolic research, their adherent nature provides an ideal op-
portunity to study the metabolic activity in dependence of the cellular growth status.
In contrast to suspension cells such as CHO, the growth status of adherent cultures can
exclusively depend on the available attachment surface if well defined media are used,
which ultimately allows to distinguish the influence of growth and extracellular substrate
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levels on metabolism. It is the aim of this work to develop a mathematical model that
incorporates the available data for adherent MDCK cells and that unravels the interplay
of regulatory principles of the cellular metabolism. Provided that the model is capable to
predict the metabolic behavior of MDCK cells, this work also seeks to evaluate strategies
for a faster or more efficient cell growth. The initial step towards these objectives is the
pre-analysis of cell cultivations in GMEM-Z and EpiSerf medium to strengthen or reject
hypotheses on the regulation of metabolism. Based on these observations, the second
step is to develop and evaluate a simple kinetic model for the central carbon metabolism
that explains metabolite pools upon substrate limitations and substrate pulses with the
regulation of single enzymes. In a third step, cell growth dynamics are coupled to the
kinetic model of metabolism to evaluate whether the derived mechanisms of enzyme
regulation also explain metabolite pool dynamics during cell cultivation or if additional,
hierarchical influences need to be considered.
The following theoretical part explains the physiology and metabolism of MDCK
cells and provides an overview on systems biological approaches to cell growth and
metabolism (Chapter 2). Afterwards, the structure of the established mathematical
models, the applied simulation strategies and the required theoretical methods are spec-
ified (Chapter 3). The modeling as well as its implications to the MDCK cell metabolism
start with observations for MDCK cell cultivations and proceed with the analysis of cell
growth, glycolysis and glutaminolysis (Chapter 4). Each part of Chapter 4 is provided
with a separate discussion and summary while the contribution of this work to the field
of metabolic research and the opportunities for future studies are addressed in Chapter 5
and 6, respectively.
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2ChapterTheory
2.1. Madin Darby canine kidney cells
In 1958, Madin and Darby described a method to obtain continuously growing cells from
domestic animal tissues [24]. The renal tubular cell analyzed in this work is derived from
a cocker spaniel kidney, wherefore it is referenced as MDCK cell, and grows adherently
(Fig. 2.1 A, B). Based on its fast and robust proliferation under standardized conditions
and its high susceptibility for virus infections, the MDCK cell evolved as a host system
for biotechnological virus production processes (see next section). Apart from its role as
host system for virus production, the MDCK cell also finds attention as model system
for studying a variety of biological phenomena such as the drug transport across the
epithelial barrier [25], the regulation of cell-cell adhesion [26], the development of the
cell surface polarity [27] or the localization of sugar transporter ([28], Fig. 2.1C).
A B C 
Figure 2.1.: Madin Darby canine kidney cells (MDCK) attached to a growth sur-
face. (A) MDCK cell cultivation in 6-well plates (picture from BPE group). (B) Magnification
of cell monolayer (picture from BPE group, scale bar: 40 µm). (C) MDCK cells (nucleus in
green) co-transfected with glucose transporter GLUT1 (in green at basolateral membrane) and
GLUT5 (in red at the apical membrane) are shown in d1 while d2 is the same picture as X-Z
slice image, both taken from Takata et al. [28] (scale bar: 10 µm).
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2.1.1. Biotechnological application of MDCK cells
The production of recombinant proteins, such as erythropoetin, insulin and antibodies,
by cultivated mammalian cells is of great medical and industrial relevance as the ex-
traction from animals is less efficient, less stable or simply not possible [29]. A second,
equally important field of application is the production of viral vaccines that prevent
the body from infections by pathogens where causal cures are not yet available. From a
biotechnological point of view, the use of the MDCK cell is almost completely located
and widely recognized in the field of influenza virus production [30] and is licensed for
human vaccine production since 2001 [31]. Any production process relies upon cell culti-
vation in which the cells undergo several growth phases (see section 2.1.2) with changing
substrate uptake and byproduct release rates. Typically, serum-containing (e.g. GMEM
+ fetal calf serum) or serum-free (e.g. EpiSerf) media are used to supply the cells with
nutrients. To better understand the variations of the cultivation process, to optimize cell
growth or the conditions for virus production and to establish new cultivation strate-
gies, a deeper understanding of the growth-related metabolism is of key importance.
Apart from the routine monitoring of the cultivation conditions and the growth status
of the cells, measurements of intracellular metabolites, which are intermediates in the
breakdown of, e.g., glucose in glycolysis or of glutamine in glutaminolysis (see section
2.2), provide an additional dimension for the identification of rate limiting intracellular
reaction steps [32] or of mechanisms important for adaptation of cells to new cultivation
media [33]. For MDCK and other cell lines, the bioprocess engineering group at the Max
Planck Institute in Magdeburg developed an assay platform to gather data on cultiva-
tion conditions, growth status [14], intracellular metabolite levels [34–36] and enzyme
activities [22, 37] to support a systems-level analysis of the MDCK cell metabolism.
2.1.2. Growth phases during cell cultivation
Cultivation processes start with inoculating cells in a bioreactor (e.g 6-well plate,
T-Flask, roller bottle, stirred tank reactor). The subsequent growth of cells can be
divided into the following characteristic phases:
Lag phase: Cultivation of cells starts with a lag phase in which adaption to the
environment occurs prior to the initiation of biomass increase. In case of adherent cells
in non-stirred bioreactors, the lag phase involves sedimentation to a surface, followed by
an active attachment and flatening [38]. Afterwards, cells increase in biomass well before
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the actual division [39, 40], which is already accompanied by an increased demand for
substrates [41]. Since the cell only divides after a certain size is reached, the cell number
is in many cases a delayed indicator for cell growth ([42], Fig. 2.2).
lag phase 
growth  
phase 
intermediate 
growth phase 
stationary 
growth phase 
cell number biomass 
time 
re
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Figure 2.2.: Schematic representation of growth phases during cell cultivation.
Growth phase: The increase in biomass with a concomitant increase in cell volume
[43] and protein content [44] marks the beginning of the growth phase. When reaching
a certain cell-specific volume, a mother cell divides into two daughter cells, which start
growing again. It is further observed that the relative number of cells in the S-phase of
the cell cycle is increased [45]. On a population level, the amount of biomass increases
in an exponential manner, which is close to the maximum growth rate. On the level of
a single cell, however, the growth process unravels an unexpected degree of complexity.
The cell-specific volume increase in the different cell cycle phases is far different from
being monotonic [46]. Furthermore, larger cells have higher biomass growth rates than
smaller cells which in consequence changes the distribution of the population with each
generation [47]. Since cells still remain in a certain size range, mechanisms exist that
limit the size variations [48]. However, the exponential growth of cells lasts until either
substrates or byproduct levels become limiting. In case of adherent cells, growth can
also be limited by the availability of free growth surface, which is formally defined as
cell density-dependent growth inhibition [49].
Intermediate growth phase: Independent of which resource is limiting, when the
growth rate decreases the cell passes into an intermediate growth phase that is charac-
terized by a decreasing mean cell diameter and protein content [22, 25]. For example, a
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significant reduction in the growth of mammalian cells is typically observed if the main
substrates glucose and glutamine become limiting [50], which is, at least for hybridoma
cells, expected to be at about 0.2 mmol/L [51]. Alternatively, growth inhibition can
occur due to accumulation of byproducts from the breakdown of glucose and glutamine
[52]. The incomplete oxidation of glucose yields lactate, which reduces the pH and im-
pairs cell growth [51]. Also, ammonia, which is either released by thermal decomposition
of glutamine [53] or by uptake and enzymatic conversion of glutamine, can reduce cell
growth in the range of 2.3 – 7 mmol/L [41, 54] as it shifts the amino acid transport across
cell membranes towards unfavorable conditions [55].
Stationary growth and decline phase: Under full growth inhibition, cells remain
in a stationary growth phase which is characterized by maintenance metabolism with
a minimum substrate consumption. A decline phase may follow if main substrates are
depleted or byproducts reach toxic levels and cells start to lyse.
2.2. Metabolism of continuously growing cells
The growth of cells in the environment of both biotechnological processes and living
organisms depends on the ability to convert substrates in a rapid and economic fashion
into cellular energy and biomass precursors. Therefore, the study of cell growth implies
the characterization of metabolism regarding its capacity and regulation. In case of con-
tinuously growing cells, which are cells with a permanent drive for growth, decades of
research delivered deep insights into the enormously complex and versatile metabolism.
The most prominent among these finding was made ninety years ago by Warburg et al.
[56] and fits to most fast proliferating cells. It describes tumor cells, which also possess a
permanent drive for growth, to secrete larger amounts of lactate under aerobic glycolysis
than normal cells and is today exploited to mark cancers in surgery [57]. Since then,
many facets of metabolism have been reported that contribute to an overflow metabolism
and reduced mitochondrial respiration but a consistent explanation for these phenom-
ena that fits to all continuously growing cells is still lacking, which could be due to
genomic differences [58]. Perhaps, the efforts of studying metabolism suffer from the
fact that characteristics change with the cell type [59], with the physiological status at
time of measurement [21] and with the cultivation conditions [60]. Even after decades
of research, the link between cell growth and metabolism remains an exciting area of
research [61] with many important questions to be answered. The following sections
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give an overview on how cell growth, cultivation conditions and metabolism influence
each other (Fig. 2.3) and introduce hypotheses on how the central metabolic pathways
glycolysis and glutaminolysis, which convert the largest portion of the overall substrate
uptake [15, 62], are regulated. Particular emphasis is placed on hypotheses that cover
hierarchical aspects, the direct influence of extracellular substrates, transport processes,
supply and demand scenarios and intrinsic pathway properties. As data for the MDCK
cell metabolism is sparse, the following summary relies upon findings for other, preferen-
tially continuously growing cells such as AGE1, BHK, CHO and hybridomas. However,
plausible observations for cancer cells are also taken into account and we refer to normal
cells or even yeast cells if very general observations were made that possibly also apply
to MDCK cells.
Figure 2.3.: Mutual influence of cell growth, metabolism and environment. Well-
known cellular processes/mechanisms that interact with the metabolic activity are placed next
to the arrows (gray, see text for further explanations).
2.2.1. Hierarchical control
A long standing question is whether cell growth controls metabolism or whether the
activity of metabolism modulates the biosynthesis machinery (Fig. 2.3), which Suarez
and Moyes described as ”cart and horse” phenomenon as both influence each other
[21]. In principle, mammalian cells possess sophisticated mechanisms to act on the level
of genomes, transcripts [63, 64], proteins [13], and by enzyme phosphorylation [65] on
the activity of metabolic pathways, which are often recognized as hierarchical control
mechanisms. Several reviews comprehensively discuss, for example, the Mth1 enzyme
to enable the amplification of the glucose transporter (GLUT) in yeast [57]. Also, the
transcription factor HIF-1, oncogenes (myc family), and the PI3K/Akt/mTOR signaling
pathway are involved in the activation of several enzymes and the GLUT in mammalian
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cells [66–68]. In an antagonistic way tumor suppressor genes, such as p53, can be involved
in switching the metabolic activity of cancer cells [69] towards, for example, higher GLUT
expression levels [70]. Some of these factors integrate extracellular stimuli such as Akt
signaling in hepatoma cells, which responds to insulin [71], or HIF-1, which responds
to growth factors and low oxygen levels [67]. Another example is the ERK signaling
cascade, which is involved in cell proliferation and stimulated by glucose sensing through
the glucose transporter (GLUT, [72]). Accordingly, hierarchical mechanisms integrate
different sources of information like a hub and, in response, influence the metabolic
activity to better suit the conditions for cell proliferation. In contrast to such hierarchical
influences, it is suggested that the control over metabolism lies within the properties of
the network itself (see section 2.2.4 and 2.2.5), e.g. a control shared by several enzymes
[73] or a control exerted by mechanisms for flux sensing [74]. In particular, enzymes
are suggested to switch in activity with changing energy and precursors levels ([75],
see section 2.2.6) and also metabolite levels may report back to the transcriptomic and
proteomic level, as reviewed by Gru¨ning et al. [76]. So both, hierarchical mechanisms
as well as intrinsic pathway properties, are discussed to control metabolic activity as
well as biosynthesis (Fig. 2.3). Although the mutual influence is not yet fully resolved,
a correlation between metabolic activity and cell growth seems evident and calls for a
growth-related analysis of metabolism [77], which is a central element of this work.
2.2.2. Extracellular substrates
Glucose and glutamine are main substrates for continuously growing cells and their pres-
ence is fundamental to a normal metabolic activity. Glucose is suggested to provide most
of the cellular energy through the breakdown to pyruvate in the glycolysis pathway [78]
while glutamine is expected to provide essential building blocks for biosynthesis [50],
e.g. as protein and peptide constituent and as nitrogen carrier [79]. However, substrate
labeling experiments of continuously growing cells revealed that glutamine, which is me-
tabolized by glutaminolysis and subsequently by the citric acid cycle, not only supports
protein and nucleotide synthesis but can replace the energy production of glycolysis
such that glucose is solely used for the synthesis of biosynthetic precursors [80], e.g.
macromolecule and lipid synthesis [81]. Other studies reported that glutamine is the
major ATP source [82, 83], which however depends on the assumed ATP yield from
glutamine [84]. Furthermore, the abundance of glutamine can stimulate the uptake of
glucose [85, 86]. The opposite, i.e. an activation of glutamine uptake by increasing
glucose levels, is not observed and minimal glutamine levels are essential to stimulate
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cell growth [87, 88]. In conclusion, both substrates contribute to the cellular energy and
precursor generation and are to a certain degree complementary but cannot necessarily
replace each other [89]. Besides glutamine, a wide range of essential and non-essential
amino acids are metabolized by MDCK cells [15].
Mammalian cells are not only flexible in the use of substrate sources but also in the
efficiency to catabolize glucose. It is shown for many continuous cell lines that the
glucose-specific lactate yield is influenced by the media composition [90, 91], e.g. by
ammonium [85] and pyruvate [14]. Under limiting glucose concentrations, much lower
relative lactate release rates [87, 92] and higher glutamine uptake rates were found [93].
It seems that high glucose levels impair the full oxidation of glucose for ATP produc-
tion [78], which is described as Crabtree effect [94]. Renner et al. [95] concluded that a
high glycolytic flux easily saturates the synthetic and oxidative pathways, which utilize
glucose-derived pyruvate, and, hence, increases the glucose-specific lactate yield. How-
ever, also the depletion of substrates, which may induce a rewiring of metabolic routes
and a reduction in metabolic activity, is an example for the influence of extracellular
substrate levels on the mammalian cell metabolism.
2.2.3. Transport processes
Transport of molecules across membranes is a prerequisite of living cells and is facili-
tated by entire protein families. The hexose transporters of kidney cells that predomi-
nantly transfers glucose and fructose between the medium and the cytosol are GLUT1,
GLUT2 and GLUT5 [96]. In principle, the cell can modulate the influx by changing
the transporter’s affinity for its substrate, translocate GLUT to the plasma membrane
and activate preexisting GLUT [97, 98]. For fibroblasts it is described that modulation
of the influx mainly depends on changes in the maximum activity of GLUT [99], for
example by hierarchical regulation through the transcription factor HIF-1, oncogenes or
extracellular stimuli, while for HEK cells the GLUT1 activity is influenced by the ATP
level [100]. For fibroblasts it was also shown that overexpression of ras or src drives the
glucose uptake [101]. Independent of which mechanisms modulate the influx, the trans-
port of glucose is a potential target for the design of bioprocess and is an often overseen
element that exhibits significant control over glycolysis in well studied systems, such as
yeast, as shown by Reijenga et al. [102] and by Galazzo and Bailey [103]. Even in cases
where the transport may not be rate limiting for the glucose metabolism (e.g. in BHK,
CHO or hybridoma cells [86, 92, 104]), reducing the high glucose uptake rates through
molecular biological tools [105] or by chemical inhibition [106] may yield a more eco-
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nomic breakdown of glucose with lower lactate secretion rates as it potentially interferes
with the Crabtree effect. In cancer cells, it is commonly perceived that the GLUT has
substantial control over glycolysis [107, 108] and is, therefore, studied as potential target
for therapy [109–111]. For example, Matsushita and coworkers inhibited GLUT1 with
3-bromopyruvate acid and found significantly suppressed proliferation rates for tumor
cells with high GLUT1 expression levels [112]. In turn, an increase in GLUT1 expression
levels yields a faster increase in tumor size [113]. Also, cells from the immune system
show higher fluxes in upper glycolysis and the pentose phosphate pathway (PPP) after
activation of GLUT with concanavalin A [114]. In turn, genetic deletion of GLUT1 yields
reduced glucose uptake with concomitantly reduced growth rates and ATP levels [115].
Taken together, the fields of bioprocess, cancer and diabetes research [116] describe the
GLUT as a central element in understanding a highly active metabolism.
In contrast to glucose, there is no mammalian cell transporter that is specific to glu-
tamine [117]. Furthermore, incorporation of glutamine into cellular building blocks is
difficult to track, which complicates direct measurements. Normal kidney cells realize
the glutamine uptake through the B0AT transporter, which has a wide specificity as it
transports also hydrophobic and aromatic neutral amino acids, and through the SNAT3
transporter, which is electrogenic and ion-dependent. For tumor cells, it is reported that
glutamine uptake is facilitated by the ASCT2 transporter [117], and the expression of
ASCT2 transporter is stimulated by oncogenes (myc family) to maintain cellular via-
bility and citric acid cycle anaplerosis1 [117, 118]. For cultured HeLa and hybridoma
cells, it is assumed that glutamine transport is the rate limiting step for glutaminolysis
[82, 104]. Finally, the uptake of glutamate is an electroneutral (ion-dependent) transport
in kidney cells and suggested to be rate-limiting in analogy to the glutamine transport
[119].
2.2.4. Glucose metabolism
The breakdown of intracellular glucose (GLC) to pyruvate (PYR) through several in-
termediate metabolites with the concomitant production of ATP and precursors for
anabolic processes is a well studied metabolic conversion route and denoted as glycol-
ysis (Fig. 2.4). A high activity in glycolysis supports the growth of cells [120] and is,
therefore, often found in cancer or transformed cells but also in cells of the body, e.g.
enterocytes [121] and lymphocytes [114], that show high rates of proliferation. On the
one hand an increase in glycolytic activity readily outpaces the capacity for oxidative
1anaplerosis: reactions that supply the citric acid cycle with precursor.
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Figure 2.4.: Simplified reaction network of the central carbon metabolism of
MDCK cells (modified from Wahl et al. [15]). Square symbols represent metabolites
and are illustrated in green if quantified by Ritter [23]. Oval symbols represent enzymes and
are illustrated in blue if measured by Janke et al. [22]. Lines represent reactions and thickness
of lines indicates the relative enzyme activity measured in vitro for cultivation in GMEM-Z
medium. Reactions with asterisks are not further specified but are part of the model. Abbre-
viations are explained in the text.
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phosphorylation or of low flux branches [67] but on the other hand enables a robust
and steady supply with biomass precursors [122]. Curi et al. [123] described the influx
into the citric acid cycle to compete with a highly active lactate dehydrogenase (LDH).
Thus, cytosolic PYR is not accumulating but rather secreted as lactate into the medium
(LACx). It is discussed that the high activity of glycolysis is enabled by overexpression of
enzymes [124, 125] or expression of certain isoenzymes [126, 127] and seems to correlate
with the malignancy of tumor cells [128]. In contrast to these findings, it is hypothesized
that cells rather modulate the specific activity of enzymes than their abundance [129].
For example, an overexpression of single enzymes by molecular biological tools may not
enhance the metabolic activity simply because they have diminishing flux control [130],
which is defined as follows: each pathway consists of a reaction cascade where enzymes
and intermediates interact. The conversion rate of intermediates is determined by the
properties of the involved enzymes. Thus, enzymes exert a certain control over the sub-
strate abundance [131]. On a higher level, some of these substrates also participate in
other reactions or act as allosteric modifier of enzymes such that the control spreads
over several reactions (example given in [122]). Another example are rate limiting steps
that dictate the conversion speed of follow up reactions and can, thus, control the activ-
ity of entire pathways. The more the control is located at a single enzymatic step the
less control have the remaining reactions. In the following, we describe the metabolic
network of upper and lower glycolysis as well as of closely related metabolic pathways
and illuminate whether the involved enzyme-mediated reactions are expected to be flux
controlling.
Upper glycolysis: In the first step of upper glycolysis, hexokinase (HK) phosphory-
lates GLC to glucose 6-phosphate (G6P, Fig. 2.4) and preferentially relies on mitochon-
drial ATP [132]. Depending on the cell, the HK is highly active such that any GLC
is rapidly converted [91, 95] and trapped intracellularly, which would indirectly point
towards the GLUT as rate-limiting step. However, with changing cell growth conditions
the control can shift between the GLUT and HK, for example in rat heart cells [60],
and it is difficult to distinguish the influence of both reactions on the metabolic activity,
as reviewed by Rodr´ıguez-Enr´ıquez et al. [133] and by Mar´ın-Herna´ndez et al. [108]. In
BHK and hybridoma cells, for example, the maximum activity of HK was observed to be
close to the flux through glycolysis and, therefore, assumed to be rate-limiting [86, 104].
With the subsequent phosphoglucose isomerase (GPI) mediated conversion to fructose
6-phosphate (F6P), the hexose can continue to follow the glycolytic pathway where it
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serves as a substrate for the phosphofructokinase (PFK). The PFK catalyzes an essen-
tially irreversible reaction of F6P and ATP to fructose 1,6-bisphosphate (F16BP) and
ADP. It consists of three subunits [134] and is regulated in many ways. Among others,
by adenosine-based nucleotides, fatty acids, citrate and fructose 2,6-bisphosphate [135].
The latter is reversibly generated from F6P and the most potent activator of the PFK
[136]. Although the PFK is observed to be rate limiting in normal cells, as reviewed
by Dunaway [137], it seems that glycolysis of continuously growing cells is not limited
by the PFK activity [86, 104]. Rate limiting or not, an inhibition by, e.g. citrate, can
increase metabolite pools of upper glycolysis and yield higher fluxes into the PPP, which
is shown for endothelial cells by Wu et al. [138], and indicates a certain flux control.
Lower glycolysis: In the lower part of glycolysis, the hexose F16BP is split into 3-
carbon sugars, or trioses, while their subsequent degradation is mostly reversible and
exerts only a minor control over the glycolytic activity in AS-30D [108] and HeLa cells
[139]. In particular, the products of the aldolase (ALD) mediated reaction are di-
hydroxyacetone phosphate (DAP) and glyceraldehyde 3-phosphate (GAP), which can
be interconverted by the triosephosphate isomerase (TPI). GAP is further degraded
by glyceraldehyde phosphate dehydrogenase (GAPDH) to 1,3-bisphosphoglyceric acid
(13DGP), which concomitantly oxidizes NAD to NADH. Afterwards, phosphoglycerate
kinase (PGK) converts 13DGP to 3-phosphoglycerate (3PG) and an equimolar amount
of ADP to ATP. It seems that rapidly growing tumor cells keep 3PG at low levels by
a highly active phosphoglycerate mutase (PGM) as it inhibits the PPP and the serine
production [140]. The PGM reversibly converts 3PG into 2-phosphoglycerate (2PG)
and targeting the PGM with inhibitors arrests cancer cell proliferation [141]. The in-
termediate 2PG is a substrate to enolase (ENO), which produces phosphoenolpyruvate
(PEP). The subsequent conversion of PEP to PYR is mediated by the pyruvate kinase
(PK) and phosphorylates ADP to ATP. It is assumed that fast proliferating cells keep
the PK at low activities to increase upstream metabolite concentrations, which then
fuel nucleic acid synthesis with precursor [120]. The decrease in activity can be achieved
by changing from a tetrameric to a dimeric form of the embryonic PK type M2 [142],
which is assumed to be induced by low F16BP levels [143]. In MDCK cells, PYR is
mainly metabolized to lactate (LAC) by the LDH, which is the natural end product of
glycolysis [144]. Only minor amounts of PYR enter the citric acid cycle by conversion to
citrate (CIT) or oxaloacetate (OAA) [16, 22]. The activity of the LDH converts NADH
to NAD and supports the cell in maintaining a proper redox balance. A high LDH
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activity is often indirectly observed as high lactate secretion rate, e.g. for MDCK [145]
or hybridoma [104] cells. Apart from glycolysis, mammalian cells are also capable to
perform gluconeogensis, which is the synthesis of hexoses from PYR and an important
feature of liver cells [146]. However, gluconeogenesis is not engaged by rhenal epithelial
cells when brought to tissue culture [147] and also not by tumor cells [148].
Pathways fueled by glycolysis: Possible metabolic branches for the glycolytic inter-
mediate G6P are glycogenesis for a possible glycogen storage or the PPP for nucleotide,
nucleic acid and macromolecule synthesis as well as NADPH generation. Glycogen lev-
els are low in kidney cells [149] and glycogenesis is initiated by an isomerization of
G6P to glucose 1-phosphate followed by a reaction with uridine triphosphate (UTP)
to uridine diphosphate glucose (UGLC). Afterwards glycogen is produced and serves
as glucose storage. The first reactions of the PPP are mediated by the glucose 6-
phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGDH)
yielding ribulose 5-phosphate (Rul5P) with its isomers ribose 5-phosphate (R5P) and
xylulose 5-phosphate (X5P). Both enzymes constitute the oxidative entry point into
the PPP and especially 6PGDH is inhibited by glycolytic intermediates such as F16BP
and 3PG [140]. The metabolites F6P and 3PG are also part of the PPP such that
glycolysis and the PPP overlap to a certain degree. The interconversion of metabo-
lites in the PPP is mediated by the transaldolase and transketolase (TATK) reactions
yielding erythrose 4-phosphate (E4P) and seduheptulose 7-phosphate (S7P). The influx
into the PPP ranges from 4 % to 40 % of the glycolytic flux [150–152] for most con-
tinuously growing cells and even higher contributions are estimated for CHO cells by
metabolic flux analysis [2, 153]. A large fraction of the glucose-derived pentose phos-
phate metabolites are found in nucleic acids and adenosine-based nucleotides and, thus,
their contribution to lactate production is diminishing [13, 82]. In transformed mam-
malian cell lines, the generated NADPH covers 30 – 50 % of the total cellular production
and is predominantly used for lipid synthesis [154]. The glycolytic intermediate F6P
is in addition used for generation of UDP N-acetylhexosamines denoted as hexosamine
biosynthesis pathway [85]. In particular, F6P is used for ammination with intracellular
ammonium (NH4) and linked to UTP under consumption of glutamine (GLN) such that
UDP N-acetylglucosamine (UDPGlcNAc) and its isomer UDP N-acetylgalactosamine
(UDPGalNAc) are derived. Both metabolites are important for oxygen-linked protein
glycosylation and play a role in signal transduction [155] as well as sensor mechanisms
[156]. It is, for example, suggested that hexosamines influence growth factor signalling
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and, thus, indirectly couple glucose with glutamine metabolism [157]. In CHO cell-based
anti-body production processes, it is observed that the glycosylation of products depends
on the UDP N-acetylhexosamine levels, which in turn correlate with extracellular glu-
tamine (GLNx) levels and the glycolytic flux [158]. However, also a dependence of UDP
N-acetylhexosamines on NH4 is described [78]. Finally, lower glycolysis fuels the serine
and glycine production, which is enhanced in tumor cells to support biosynthesis [159]
as well as the ability to reduce osmotic [160] and oxidative stress [154].
2.2.5. Glutamine metabolism
It is frequently observed in mammalian cell cultures that the secreted lactate exceeds
the theoretical maximum of two molecules per molecule of consumed glucose [104, 124].
Although puzzling at first glance, it indicates that cells produce lactate from sources
other than glucose [13]. One reason lies in their permanent drive for growth that builds
upon an alternative use of the citric acid cycle, which comes along with a supply differ-
ent from glycolysis. The role of the citric acid cycle changes in fast proliferating cells
from a highly efficient energy production system (fueled from glucose) towards a hub
that ubiquitously supplies biosynthesis [67]. Thus, intermediates of the citric acid cycle
are only partly used for oxidation in mitochondria and the concomitant reduction in
respiratory activity is misinterpreted as defect [56], which has become a central dogma
of tumor cell research [58]. Neither elevated mitophagy2 nor reduced enzyme activi-
ties, which are perceived as causal explanation, are evidenced [161, 162]. Furthermore,
Barnabe´ and Butler [78] could show that continuously growing cells engage in respira-
tion and derive most of the cellular energy from the citric acid cycle when glycolysis
is limited in substrates. So, the citric acid cycle can engage in energy production and
replace glycolysis as main energy generating pathway depending on the cell and the
culture conditions, as summarized by Moreno-Sanchez et al. [58]. However, the con-
stant eﬄux of intermediates for biosynthetic purposes, which is called cataplerosis [67],
is refilled with the uptake and degradation of glutamine, a preferred substrate of cancer
cells [163], and also supported by the uptake of other amino acids [13, 164]. Therefore,
glutamine is one of the largest contributor to biosynthesis in mammalian cell culture
and minimal levels are required to enable cell proliferation [78]. In analogy to glycoly-
sis, glutamine is only partially oxidized and yields PYR as end product, which can be
converted to LAC [121, 150]. Motivated by these observations, McKeehan [89] denoted
the path from glutamine to pyruvate as ”glutaminolysis”. The incomplete oxidation in
2mitophagy: degradation of mitochondria
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the citric acid cycle is described as ”truncation” although the capability for oxidative
phosphorylation is still given [165]. Within this definition, glutaminolysis consists not
of a single reaction sequence but of a network with at least four active routes in kidney
cells ([166], out of eight possible routes [84]) and resides partly in the cytosol and partly
in the mitochondrium. Therefore, the description that follows is condensed to central
reactions.
Glutaminolysis: In the first part of glutaminolysis, glutamate (GLU) is generated
from GLN and serves as a source for the second part known as citric acid cycle. The
transport of both intermediates across the mitochondrial membrane is found to work
near equilibrium and, thus, seems to have almost no flux control [167]. The conversion
of GLN to GLU is mediated by glutaminase (GLNase) and releases NH4. Afterwards,
GLU is converted to α-ketoglutarate (αKG) either by a second release of NH4 through
the glutamate dehydrogenase (GDH) yielding NADH or by transferring the amino group
to PYR or OAA under the production of alanine (ALA) or aspartate (ASP), respectively
[124]. Such a transfer of amino groups is facilitated by transaminases3, which are located
in the cytosol and the mitochondrium. In principle, ALA is a nitrogen acceptor that is
secreted by cancer cells [148] as well as by CHO [32], AGE1.HN [168] and MDCK cells
[15] while ASP is used for biosynthesis. It is reported for tumor cells that glutamate is
mainly degraded by transamination and not by the dehydrogenase route [169]. In line
with these observations, MDCK cells were found to have high transaminases activity
[22, 170]. Therefore, release of NH4 results largely from the conversion of glutamine
and not from glutamate [171], which could be due to the negative inhibition of GDH
by guanosine triphosphate (GTP, [172]). Since extracellular ammonium (NHx4) impairs
cell growth, cultivation of cells with a sole supply by extracellular glutamate (GLUx) is
suggested as an alternative worth testing [173] but requires the synthesis of GLN via an
active glutamine synthase (GS, a premise that is given for MDCK cells [22]) to continue
purine, pyrimidine [154] and UDP N-acetylhexosamine synthesis.
Lower citric acid cycle and oxidative phosphorylation: Since the use of the citric
acid cycle is changed in continuously growing cells, the descriptions often follows the
reaction paths starting with αKG. In principle, glutamine-derived αKG either takes
the energy producing path in the lower citric acid cycle or the lipid synthesis path
in the upper citric acid cycle [174] and constitutes 50 – 90 % of the metabolite pools
3transaminases: alanine transaminase (AlaTA), aspartate transaminase (AspTA)
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[148]. The other part of the metabolite pools is generated from non-essential amino
acids [13]. However, the lipid generating route is often denoted as reversed citric acid
cycle flux and exhibits a reductive carboxlyation of GLN, which is not found in normal
cells. This route is expected to rely on a reverse functioning of the NADPH-dependent
isocitrate dehydrogenase (ICDH, [175, 176]). In normal cells of the body, the ICDH
converts isocitrate to αKG using either NAD or NADP to produce NADH or NADPH.
However, Yan and coworkers discovered that more than 70 % of gliomas (tumor cells)
harbor a mutation in genes encoding for the ICDH [177]. On the contrary, Moreno-
Sa´nchez et al. [68] describes the reversibly working ICDH to be thermodynamically
infeasible and casts doubt on this reaction. They propose that an alternative reaction
exists that facilitates a reductive carboxylation of glutamine which is not yet discovered.
However, the degradation of αKG in the lower part of the citric acid cycle is initiated
by the α-ketoglutarate dehydrogenase (KDH) and yields succinyl-CoA (SUCCoA) while
transforming NAD to NADH. Apart from the influence of substrates and products on the
KDH activity [178], ions and adenosine-based nucleotides are also reported to influence
the conversion of αKG by the KDH [179]. In the following reaction steps, SUCCoA
is reversibly converted to succinate (SUC), oxidized to fumarate (FUM) and hydrated
to malate (MAL), and involves, amongst others, the enzymes succinyl-CoA synthase,
succinate dehydrogenase (SDH), fumarase (FMA) and malate dehydrogenase (MDH),
which is in detail described by Nelson and Cox [180, pp. 571-579]. The released energy
from these reactions is stored in GTP (or ATP) as well as NADH and FADH2, which
both drive the oxidative phosphorlyation under mitochondrial respiration [181] using
oxygen. Thus, oxidative phosphorylation links ATP with NADH (1 NADH = 2.5 ATP,
1 FADH2 = 1.5 ATP [6]) and the respiratory chain can exert significant flux control over
the citric acid cycle under physiological conditions [182, 183] by controlling both the
NADH to NAD ratio and the ATP to ADP ratio. Studies for cancer therapy recognized
the oxidative phosphorylation as a potential target to impair cell proliferation [184].
Furthermore, it is hypothesized that alterations in enzymes such as SDH contribute to
the emergance of cancer [185]. However, the control in the citric acid cycle not only
resides in the oxidative phosphorylation but also in metabolites that act allosterically
on enzymes [167, 186]. The end product of the lower citric acid cycle, MAL, is either
converted to mitochondrial OAA or PYR (which are required for AspTA or AlaTA
activity in glutaminolysis) or to cytosolic PYR with synthesis of NADPH, which supports
lipid synthesis.
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Upper citric acid cycle: The upper part of the citric acid cycle involves the reversible
turnover of CIT to isocitrate (ICIT) by aconitase with cis-aconitate (CAC) as an inter-
mediate product. Interestingly, CIT interacts with several branch points of metabolism
(extensively reviewed by [187]) and is produced by the citrate synthase (CS) using OAA
and acetyl-CoA (ACCoA), which is derived from PYR through the pyruvate dehydroge-
nase (PDH). Alternatively, ICIT can be produced from a reductive flux from αKG. It is
shown for melanoma cells that appreciable amounts of CIT are derived from αKG and
used to produce cytosolic acetyl-CoA to support lipid synthesis [148]. The production
of cytosolic acetyl-CoA involves an active transport of CIT into the cytosol [188] and a
subsequent conversion by citrate lyase (CL) under the use of ATP and the formation of
ADP. Disruption of the CL in tumor cells suppresses proliferation [189]. In CHO cells,
Dean and Reddy discovered that 30 % of the CIT is derived from GLN and ASP while
PYR is a negligble source [13]. Icard et al. [187] even anticipate that cytosolic CIT is
converted to PYR, which again enters the citric acid cycle forming a so called vicious
cycle to support cytosolic NADPH synthesis [187]. However, the contribution of PYR to
the citric acid cycle is low and either explained with an impaired mitochondrial uptake
[190] or an inhibition of PDH, for example by HIF-1 induced phosphorylation [191] or
by NADH, ATP and ACCoA [172].
2.2.6. Nucleotide metabolism
Fast proliferating cells need to generate certain levels of energy carriers to fuel biosyn-
thetic reactions and physiological functions. The most famous carriers are the adenosine-
based nucleotides, adenosine triphosphate (ATP), adenosine diphosphate (ADP) and
adenosine monophosphate (AMP), which are partly interconverted by the adenylate ki-
nase (ADK, [192]). Similarly, the cell uses guanosine-based nucleotides (GTP, GDP,
GMP) as energy carriers, which also belong to the purines, and AMP as well as GMP
are generated from the same precursor, i.e. inosine monophosphate (IMP), by the purine
salvage pathway (PSP). Both purines are main energy acceptors during the conversion
of glycolytic as well as citric acid cycle metabolites and the abundance of ATP relative
to ADP is thought to be involved in the regulation of metabolic processes [94]. Simi-
larly, Hofmeyr and Cornish-Bowden [193] describe a supply-demand scenario where the
rate of ATP syntheses is controlled by the demand reactions (biosynthesis) and where
ATP in turn controls the synthesis pathway such that the demand is compensated by
the supply. Atkinson and coworkers even anticipate for rat liver cells that the energy
charge (EC), which is a ratio between ATP, ADP and AMP (see Eq. (2.2.1)), changes
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enzyme activities in favor of energy generation or biosynthesis depending on what is
most required (control by energy charge, [194, 195]).
EC =
[ATP ] + [ADP ]/2
[ATP ] + [ADP ] + [AMP ]
(2.2.1)
In hybridoma and CHO cells the EC and especially the ATP level was found to mainly
depend on the extracellular glucose (GLCx) level [13, 78]. Interestingly, the EC is usually
kept between 0.8 and 1 by vital cells [196], although environmental perturbations can
induce considerable changes in the nucleotide levels. Walther and colleagues unraveled
for yeast cells that large amounts of AMP are transferred to the PSP to maintain a
proper nucleotide balance [197]. For cancer cells, it is further hypothesized that ATP
is never limiting but that the ATP production rate dictates the biosynthesis activity
[61, 198], which is also found for yeast cells [199]. Also, for rat liver cells, it is suggested
that the rate of glycolysis determines the level of ATP and not vice versa [200]. So the
question whether the metabolic activity is mostly independent of the ATP level or fully
determined by the energy status is not yet resolved (addressed later in this work) and
the answer may depend on the cell type [59]. Another group of high energy molecules are
the pyrimidines consisting of uridine-based nucleotides (UTP, UDP, UMP) and cytidine-
based nucleotides (CTP, CDP, CMP). Although their role as energy carriers is limited
compared to the purines, their contribution to biosynthesis is equally important.
2.3. Systems biology approach to cell growth and metabolism
Understanding intrinsically complex biological systems, which typically arise from a
large number of functionally diverse elements that interact symbiotically [201], requires
the integration of experimental and computational approaches in a multidisciplinary
environment. In this regard, systems biology complements molecular biosciences and
addresses the missing link between molecules and physiology with mathematical mod-
els [202]. Such models express hypotheses through the choice and parameterization of
relationships and reach their ultimate sophistication by successfully predicting the bio-
logical process. The actual experience is an iterative cycle of model development and
hypothesis testing that requires multiple rounds of data generation and model adjust-
ment until the predictive power reaches an acceptable agreement with experimental data
[203]. However, succeeding in the development of such models opens up the avenue for a
rational, systematic and efficient design of bioprocesses [204] or of medication strategies
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[205]. In case of dynamic phenomena that involve a sufficiently high number of species
molecules, such models can be composed of ordinary differential equations (ODEs) to
integrate experimental data and structural information of the network. The application
of dynamic mathematical models spans from the analysis of heterogeneous cell popu-
lations (segregated models, cf. [206]) to the investigation of intracellular components
(structured models) and may touch multiple scales (multi-scale model). In the follow-
ing sections, standard models on cell growth and metabolism are introduced regarding
their complexity and field of application. Afterwards, examples for the mathematical
description of enzyme kinetics and methods for the analysis of ODE-based models are
introduced.
2.3.1. Cell growth models
For the understanding of yeast, bacteria or mammalian cell growth, models are desired
that precisely recapitulate the growth process, metabolite consumption and byproduct
release over the course of cultivation. The structure of cell growth models has a mainly
empirical form where the biological system is viewed as a catalyst for the conversion of
substrates into products [19, 207]. This conversion of substrates is directly linked to an
increase and maintenance of cell numbers or biomass.
Cell number-based models: In biotechnology, cell growth models often consist of a
growth function for the cell number that is linked to substrate uptake and byproduct
release rates in order to reflect changes in the culture and to evaluate yield coefficients
[51]. Due to their simple structure and the wide accessibility of data, such models find
application in many studies and were developed for various cells and growth inhibiting
aspects [208–210]. For adherent cells, cell number-based models can reflect the growth
in bioreactors [211] and can take into account the cell number distribution on microcar-
riers [212]. Such models are also used to study growth on flat surfaces [213] and are —
besides ODE-based approaches — also available as stochastic [214] and cell automata
models [215]. The lag phase in cell number growth (see section 2.1.2) is typically real-
ized by implementing delay functions [211] (to account for cell settling, attachment or
size increase until division). Delay functions, however, can fail in rendering the uptake
and release of metabolites experimentally identified during the initial phase of culti-
vation where biomass growth precedes cell division. Towards the end of cultivations,
cell density-dependent growth inhibition can occur and cells enter a stationary growth
phase. If cell density-dependent growth inhibition is calculated on the basis of cell num-
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bers, a distorted view on growth phases may result, as cell numbers can increase while
the biomass remains constant [216]. Furthermore, higher cell concentrations can be
achieved if cells have smaller mean cell diameters [44] and, thus, final cell numbers can
differ among replicate cultivations (e.g. [211]). Therefore, cell number-based models can
explain several aspects of cultivations but only in a very restrictive way.
Biomass-based models: Some of the above-mentioned problems are solved by using
biomass-based models, e.g. by Baltes et al. [217] to support the experimental design of
yeast cultivations or by Dhir et al. [3] as well as Frame and Hu [39] to study hybridoma
cell growth. However, these models can hardly distinguish between cell-specific mass
changes and the cell number increase. Since parameters of intracellular biochemical
processes can correlate with the cell mass (e.g. protein synthesis, membrane composition,
metabolite concentrations) as well as with the cell number (e.g. activities located in
the nucleus, signaling pathways), pure biomass-based models have a limited field of
application when it comes to the analysis of intracellular phenomena. Nevertheless,
cell number-based and biomass-based models are simple and, have without question, a
certain power in analyzing cultivations of mammalian cells.
Cell mass models: Population balance equations are an elegant way to comprehen-
sively characterize the growth in cultivation processes described in section 2.1.2 regarding
the time course of cell mass and cell number changes [218, 219]. Many different ”cell mass
models” for microbial populations in culture have been developed [220–223] and numeri-
cal methods have been established to reduce the computational effort involved [224, 225].
Nevertheless, the validation of the underlying model functions, namely the growth rate
function, the cell division probability function and the partitioning probability function
is still challenging, mainly due to the lack of experimental data. Furthermore, the influ-
ence of substrate depletion, inhibitor accumulation or growth surface limitation on the
respective functions remains to be characterized. Nielsen et al. [42] therefore suggest
for yeast cells a middle course that links the cell number to the biomass using a delay
function to induce an artificial diameter increase.
2.3.2. Dynamic models of metabolism
One of the first computational attempts to simulate the metabolism of tumor cells was
made in 1959 by Chance et al. [226]. Since then, dynamic models for metabolism have
been developed for many pathways and organisms. In the following, we introduce a
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selection of the most insightful models for the cellular metabolism.
Glycolysis models: Since the first computational attempt by Chance et al. [226],
glycolysis became the most intensively modeled metabolic pathway. For erythrocytes,
which have a relatively stable cell composition, a first core model of glycolysis was devel-
oped by Rapoport and colleagues [227] in 1974 and was gradually extended by including
detailed aspects of enzyme kinetics [228, 229] as well as the energy metabolism and ion
transport [230–232]. The last versions integrate also the PPP and steady state metabo-
lite data and are used to predict the impact of enzyme deficiencies [233, 234]. More
recent models of mammalian cell glycolysis where developed for liver cells to analyze the
blood glucose homeostasis [71, 146] and for skeletal muscle cells to illuminate glycogenol-
ysis [235]. However, the largest part of glycolytic models were developed for yeast and
E. coli, perhaps because of the large amount of available data, the ease of experiments
and the wide options for genetic modifications, and cover a broad field of phenomena.
The most advanced models on metabolism describe the response to glucose pulse ex-
periments [20, 236, 237], the link between transcriptome and metabolism [238, 239] or
the emergence of an oscillatory activity under glucose starvation [240, 241]. One of the
best validated models for yeast glycolysis is proposed by Teusink et al. [242] and van
Eunen et al. [20] and considers enzyme kinetics, which were measured under in vivo-like
conditions [11]. It largely agrees with steady state flux and metabolite data, which were
derived from labeling experiments. Although in many of the above cases the existent
experimental data sets do not allow for a full validation of the complex kinetics used
(especially not for a broader physiological context), their benefit lies in the integration
of complex regulatory mechanisms and their explanation for general phenomenological
aspects that are typically found in the respective cell type. However, an apparently
complex metabolic behavior must not result from complex regulatory mechanisms [243].
In case of glycolysis, it seems that few regulatory mechanisms dominate the dynamics
of intracellular pools and readily explain salient features of experimental measurements
[12]. Furthermore, with an increasing number of powerful assays, e.g. to determine
intracellular metabolite concentrations or to measure enzyme activities in yeast and an-
imal cells, changes in glycolytic activity during cell growth or substrate perturbations
can be monitored at an unprecedented level. Integrating such data under considera-
tion of extracellular metabolite changes as well as cell growth dynamics may support
mathematical modeling in the systematic analysis of metabolic pathways under various
cultivation conditions.
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Citric acid cycle models: In a pioneering work, Garfinkel [244] proposed a computer
model for the Krebs cycle and the closely related metabolism. The intention was to
illuminate the control exerted by the different compounds with the use of steady state
metabolite pool data. In the following studies performed with rat heart cells, the kinetic
descriptions of the citric acid cycle were preferentially used to evaluate pathway fluxes
from labeling experiments [245, 246]. Since then, the models were more and more refined
by more detailed enzyme kinetics [167], extended by aspects of electrophysiology [247]
and volume dynamics [248], and transferred to cells other than rat heart and muscle
[249]. The most recent model proposed by Bazil and coworkers [248] incorporates an
impressively large data set that covers in vitro enzyme activities, flux data as well as
metabolite and ion concentrations, which are mostly derived from isolated mitochon-
dria from rat heart and other cells to calibrate the involved kinetics comprising about
400 parameters. However, considerable differences in structure and parameterization of
enzyme kinetics can be observed when using in vitro and in vivo data for model calibra-
tion, as described by Mauch et al. [250, pp. 571-579] and van Eunen et al. [11]. Since
such models are usually too complex for validation with in vivo data, Nazaret et al.
[251] proposed a simplified model for the citric acid cycle and its link to the oxidative
phosphorylation that successfully renders the observed metabolic steady states. It shows
that simple models can also explain salient features of experimental measurements for
the citric acid cycle.
Central carbon metabolism models: With a model for the citric acid cycle at hand,
a connection to glycolysis models seems intuitively attractive since both pathways are
central to the generation of cellular energy and biomass. For E. coli, such models are
validated with knockout mutants [252] and used to evaluate strategies that aim at re-
designing metabolic routes [253], which was similarly done for yeast [237] and relies
on metabolite pool data after a glucose pulse. Although detailed kinetic models of
the central carbon metabolism also exist for CHO cells [254], macroscopic (sometimes
unstructured) descriptions are already sufficient to study process strategies that aim at
higher growth and antibody production rates for hybridoma cells [255, 256].
2.3.3. Model construction and analysis
Kinetics of enzyme-catalyzed reactions: The detailed in vitro characterization of
glycolytic enzymes, such as HK [10], PFK [8] and PK [9], with respect to their catalytic
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properties in the presence of substrates, products and allosteric effectors4 represents an
important step towards a kinetic description of metabolic phenomena of cells. However,
the most simple description for the conversion of substrates into products is provided
by the law of mass action. Depending on the molecule number of reactants involved,
the reactions have a certain order. For enzyme-mediated conversions the different steps,
e.g. substrate binding, change in conformation and product release, can be individually
represented by mass-action kinetics, which, unfortunately, yields large sets of differential
equations and parameters. Under a few simplifying assumptions, Michaelis and Menten
derived a rate-law that links the product formation with the substrate conversion. Cle-
land [257–259] extended that approach by introducing a nomenclature with full steady-
state rate equations for arbitrary complex reactions by taking into account the number
of reactants and products (e.g. uni-uni, bi-uni,...), the reaction sequence (ordered or
random), the isomerization of the enzyme (iso, ping-pong) and the reversibility. The
laborious mathematical derivation of these kinetics motivated King and Altman [260]
to develop a relatively simple, graph-based method which mostly relies on the chemical
reaction scheme. However, cooperative5 as well as allosteric effects are an important
regulatory function of cells and not adequately covered by this approach. In 1910, Hill
[261] discovered that the aggregation of hemoglobin yields sigmoid binding curves for
oxygen. Motivated by this observation the authors proposed the Hill kinetic, which takes
into account cooperativity and is an important discovery that contributes to the charac-
terization of glycolytic enzymes such as the PK and the PFK. Since glycolytic enzymes
are additionally regulated by many allosteric effectors, Monod et al. [262] proposed the
Monod-Wyman-Changeaux model where the affinity for a substrate is a function of all
the above highlighted influences. Taken together, the conversion of a substrate S into
a product P can be expressed with an arbitrary complexity in corresponding kinetics
depending on which effects are considered as relevant. An example of translating a
reversible reaction into a simple enzyme kinetic is given here:
chemical reaction: S
re−⇀↽− P
rate equation: re = K
max
e
(
[S]− [P ]
keqe
kmeS + [S] +
P
keqe
)
(2.3.1)
4allosteric effector: molecule that binds to the enzyme at an allosteric center, which changes the
catalytic activity without a direct influence on ligands
5cooperative effect: aggregation of single units leading to a modification of the catalytic activity
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The basic equation for the rate equation re of enzyme e stems from the simple Michaelis-
Menten kinetic with a maximum cell-volume-specific activity Kmaxe and an affinity con-
stant for the substrate kmeS. Since the back reaction S ↼ P cannot be neglected (in
contrast to a standard Michaelis-Menten kinetic), the difference between S and P influ-
ences the velocity of the reaction and whether re has a positive or negative sign. Due to
the Haldane relationship, the equilibrium constant keqe between S and P is defined as
keqe =
kmeP
kmeS
=
[P ss]
[Sss]
(ss = steady state). (2.3.2)
Such a kinetic is, among others, used in the structured model of this work. An overview
for more detailed kinetics of enzyme mediated reactions is given in the book of Biss-
wanger [263].
Estimation and identifiability of model parameter: The sparsity of experimental
data in combination with the complex nature of biological observations imposes great
challenges for modeling and analysis of biochemical networks [203]. Models, which by
definition are an abstraction of reality, have a great chance to fail in explaining ob-
servations at first simulation either because experimentally measured parameters were
derived under experiment conditions different than required for the simulation scenario
or are simply not available (which is mostly the case). The gap between observation
and model simulation leads to the parameter estimation problem, as for instance de-
scribed by Bellman and A˚stro¨m [264]. The estimation of parameters typically requires
non-linear optimization methods where the objective is to find a parameter set that min-
imizes a function quantifying the goodness of fit, usually a least squares function [204].
A large number of algorithms for solving optimization problems are currently available,
either of deterministic or stochastic nature, and designed to find local or even global
minima in the parameter space [265]. However, the ability to estimate parameters is not
only a question of the optimization method but also of the underlying model structure
and the data available for the analysis, which is further known as identifiability prob-
lem [266]. In particular, two formally distinct but functionally redundant mechanism
of a model, which can replace each other in generating a certain response, may impose
”structural” identifiability problems if both mechanisms cannot be distinguished with
the available data (independent of the data quality, [267]). In consequence, the algo-
rithms yield non-unique parameter solutions with strong correlations for the parameter
estimation problem. In contrast, ”practical” identifiability problems result from low
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quality data that leaves parameters with large uncertainties. Practical identifiability
problems can be identified by analyzing the change in model fit upon infinitesimal pa-
rameter perturbations and solved by acquiring data of higher quality. Note that Sontag
[268] once stated that 2r + 1 of highly informative data points are enough to identify
r unknown parameters. However, since a reliable parameter identification is of utmost
importance for the inference of biological meanings as well as for the quality of model
predictions, uncertainty estimates should always be provided together with the param-
eter values [269]. A simple way of obtaining these uncertainty estimates is the Fisher
Information Matrix (FIM) derived from the parameter sensitivities and the measurement
error of the observables. The FIM can be used to support the design of most informa-
tive experiments [270]. However, the inverse of the FIM only yields a lower bound on
the variance of the parameter, which is known as the Cramer Rao bound. More reli-
able parameter confidence intervals are obtained from bootstrap methods, as described
by Efron and Tibshirani [271], the parameter likelihood-function [272] or by using the
Bayesian approach to parameter identification and identifiability analysis [273]. Since
these methods also unravel parameter correlations, model reduction can be facilitated
such that more precise parameter confidence intervals are achieved. Counterintuitively,
also sloppy parameter estimates6 can enable tight quantitative predictions (since highly
sensitive parameters are also fragile sites [203]) and, thus, are not necessarily optional
or removable degrees of freedom, as shown by the work of Brown et al. [274]. As long
as the understanding of the system is tentative and incomplete, the focus should be on
the predictive power of the model rather than on its parameter values [269]. It should
be born in mind that sloppy parameter estimates may be a central feature of biological
systems to achieve robustness against fluctuations in components or the environment,
which is primarily achieved by functionally redundant or insensitive mechanisms [275].
6sloppy parameter estimates: the simulation result is mostly insensitive to changes in the corre-
sponding parameter
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3.1. Model definitions
3.1.1. Segregated cell growth model
The segregated cell growth model established in the scope of this work simulates data
that is obtained with automated cell counting devices, including cell diameters, and
comprises parameters that are typically used for cell number-based models. It describes
cell populations with growth and maintenance metabolism based on a set of ordinary
differential equations.
Cell growth: To account for differences in cell diameter, several classes of cells Xi are
introduced,
dX1
dt
= rtrans(−X1f + 2XNc), (3.1.1)
dX2
dt
= rtrans(X1f −X2), (3.1.2)
dXi
dt
= rtrans(Xi−1 −Xi), for i = 3, . . . , N c, (3.1.3)
f :=
{
0 if V C > V C∗
f(V C) if V C ≤ V C∗
. (3.1.4)
The factor f accounts for the cell volume-dependent (V C-dependent) growth inhibition,
which we will discuss in the next paragraph. V C∗ is the approximate cell volume for
larger times (t ≈ 200 h). The cells pass with a transition rate rtrans through the classes
X1, ..., XNc with linearly increasing diameter until a critical diameter dc is reached and
the cells divide. The transition rate itself is based on Monod‘s equation [276] where
the specific growth rate µ is a function of the maximum specific growth rate µmax, of
the Monod constant kmGLCx and of the GLC
x concentration. Alternative growth kinetics
might be appropriate for other cell lines [210], but were not required for fitting of our
experimental data. Multiplication with α transforms the commonly used specific growth
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rate µ into rtrans,
rtrans = µα =
µmax[GLC
x]
kmGLCx + [GLC
x]
1
21/Nc − 1, (3.1.5)
to obtain a cell growth model that is asymptotic in cell growth to x˙ = µx (provided by
D. Flockerzi, see Rehberg et al. [216] for mathematical explanation). Note that µmax is
an effective growth rate that considers the loss of cells due to death [277].
Growth inhibition as a function of cell volume: The transition between the ex-
ponential and the stationary growth phase of adherent MDCK cells can depend on
the availability of free surface. Accordingly, cells will grow with µmax as long as all
essential substrates are available in sufficient amounts and surface is not limiting [211–
213, 278, 279]. In this work, the inhibition is assumed to be a function of the cell volume.
Note that biomass and cell volume are linearly correlated as long as changes in the den-
sity due to osmolality effects can be excluded [42]. The cell volume can be calculated
on the basis of the cell numbers and the cell diameters. The cell number, which is the
sum of cells in all classes Xi corresponds to
Xtot =
Nc∑
i=1
Xi (3.1.6)
and is monotonically increasing over time. Assuming that the class-specific diameters
are equidistant between the minimum diameter dm and the critical diameter dc, the
mean diameter d¯ of all cells can be calculated with
d¯ =
Nc∑
i=1
(dm +
dc − dm
N c − 1 (i− 1))
Xi
Xtot
. (3.1.7)
Note that dm and dc may vary with every experiment. The cell volume V
C
model now follows
with summation of all class-specific volumes V Ci , given by V
C
model =
∑Nc
i=1 V
C
i . However,
measurement of cells may only yield mean cell diameters and hence only allows to observe
an ’experimental’ cell volume (e.g. Niklas et al. [164]). Therefore, V C is introduced as
an estimator for V Cmodel and defined as
V C = pi
d¯3
6
Xtot10
−9, (3.1.8)
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with the unit µL. Note that Eq. (3.1.8) underestimates the true cell volume, V C < V Cmodel
(Jensen‘s inequality) but allows a larger applicability in the field of biotechnology where
diameter distributions are not available. In cultivation processes monitored using coulter
counters, e.g. for the data published by Frame and Hu [43], a deviation of up to 13 %
can result. However, this is here within the error bars provided for the data of V C . The
cell-specific volume V Cs (unit: L) follows with:
V Cs =
V C
Xtot
10−6 (3.1.9)
To describe an inhibition by cell density, Frame and Hu [278] proposed a nonlinear term,
which is dependent on the cell number concentration. Here, a transformation based on
V C is used on [0, V C∗ ] to derive a cell volume-dependent growth inhibition factor f :
f = f(V C) = 1− exp
(
(−s)V
C
∗ − V C
V C
)
. (3.1.10)
The adjustable parameter s is cell line-dependent and shapes the sensitivity of the (in
silico) cell to extracellular limitations. Furthermore, we assume that growth inhibition
only affects the initiation of cell proliferation at the first transition X1 → X2 (Eq. (3.1.1)
and (3.1.2)). Hence, cells that are already in the division process have passed the early
checkpoint of cell growth and continue to increase in size.
Metabolic uptake and release rates: Cells consume substrates to sustain or increase
their biomass. Thus, the substrate uptake rates are commonly linked to the cell number
concentration or its increase [211, 212]. Nielsen et al. [42] hypothesized that cells with
larger biomass consume and release more metabolites. Accordingly, we link the medium-
volume-specific uptake rates for maintenance (rm/S) to V
C , leading to
rm/S = mSV
CΘ([S])λ with S out of {GLCx, GLNx, NHx4 }, (3.1.11)
where mS is the cell-volume-specific uptake rate of substrate S for maintenance
metabolism, where S stands for GLCx, extracellular glutamine (GLNx) or NHx4. Θ
is a unit step function, which is one for [S] > 0 and zero otherwise. Each reaction
is scaled by λ to account for water evaporation (see Eq. (3.1.21)). Furthermore, the
medium-volume-specific uptake rate (rX/S) of substrate S is linked to the number of
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growing cells (as discussed later) by
rX/S = µ
(
X1f +
Nc∑
i=2
Xi
)
YX/Sλ, (3.1.12)
where YX/S is the cell-growth-specific yield coefficient for S. Apart from these com-
monly used definitions, the uptake of extracellular glutamate (GLUx) seems to be best
represented by
rGLT = KGLT [GLU
x](1− f), (3.1.13)
according to the results of Maria Wetzel [280], and can be interpreted as a GLUx trans-
porter (GLT) that is inhibited as long as the cell proliferates. Note that rGLT is a
cell-volume-specific rate and, thus, different to rm/S or rX/S. The specific activity KGLT
is further explained in section 3.1.3. The change in extracellular metabolite concentra-
tions is thus given with
d[GLCx]
dt
= −rX/GLCx − rm/GLCx + Fevap[GLC
x]
V M
, (3.1.14)
d[GLNx]
dt
= −rX/GLNx − rm/GLNx − rdGLNx + Fevap[GLN
x]
V M
, (3.1.15)
d[GLUx]
dt
= −rGLT V
C
s Xtot
V M
+
Fevap[GLU
x]
V M
, (3.1.16)
d[LACx]
dt
= (rX/GLCx + rm/GLCx)YLACx/GLCx +
Fevap[LAC
x]
V M
, (3.1.17)
d[NHx4 ]
dt
= 2(rX/GLNx + rm/GLNx) + rdGLNx − rX/NHx4 − rm/NHx4 +
Fevap[NH
x
4 ]
V M
.
(3.1.18)
Here, Fevap represents the measured water evaporation in 6-well plates (data not shown)
and V M stands for the medium volume during cultivation, defined by
dV M
dt
= −Fevap, (3.1.19)
and thus by
⇒ V M(t) = V M(0)− Fevapt
!
> 0. (3.1.20)
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Note that V M(0) corresponds to the well volume V W , which allows to define λ with:
λ =
V W
V M
(3.1.21)
According to Ozturk and Palsson [53], glutamine decomposition can occur and was
explicitly taken into account with
rdGLNx = kdGLNx [GLN
x], (3.1.22)
where kdGLNx is the specific decomposition rate, estimated for GMEM-Z at 37
◦C by
Bock et al. [212]. YLACx/GLCx is the glucose-specific lactate yield. Note that the accu-
mulation of NHx4 depends on a maximum stoichiometric production from GLN
x and its
incorporation into biomass during cell growth and maintenance. A release of NHx4 from
GLUx is not considered in the model (discussed later).
3.1.2. Structured central carbon metabolism model
In order to derive conclusive insights into the regulation of the central carbon metabolism
of adherent MDCK cells, this work seeks a simple kinetic description of the enzyme
catalyzed reactions that agrees with the most basic characteristics reported for the cor-
responding enzymes and pathways. Therefore, differential algebraic equations of the
model, which describe enzyme activities in dependence of metabolite concentrations
and allosteric influences, were composed as far as possible using first order rate laws.
In cases where measurements on maximum enzyme activities are available Michaelis-
Menten and Hill kinetics were used. All metabolite levels and flux rates are related to
the cell-specific volume, which is preferred by many scientists [94, 195, 281], as it allows
an adequate comparison of metabolite pools under varying cell sizes but assumes an
even distribution of metabolites within the intracellular space [44]. In the following we
also assume that the cell population reflects the metabolite pool dynamics of a single
cell.
Glycolysis
The kinetics for glycolysis consider the metabolic conversion of GLC to PYR as well as
the closely related metabolism of PPP and glycogenesis:
d[GLCx]
dt
= −rGLUT V
C
s Xtot
V M
(3.1.23)
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d[GLC]
dt
= rGLUT − rHK − µf [GLC] (3.1.24)
d[G6P ]
dt
= rHK − rGPI − rG6PDH − rUT − µf [G6P ] (3.1.25)
d[F6P ]
dt
= rGPI + rTATKF6P − rPFK − µf [F6P ] (3.1.26)
d[F16BP ]
dt
= rPFK − rALD − µf [F16BP ] (3.1.27)
d[3PG]
dt
= 2rALD + rTATK3PG − rENO − µf [3PG] (3.1.28)
d[PEP ]
dt
= rENO − rPK − µf [PEP ] (3.1.29)
The term µf [M ] expresses the dilution of intracellular metabolite M by the approximate
cell volume growth (µ is here used in 1/min). The dilution by cell volume growth
only occurs during the cell cultivation experiments and not during the perturbation
experiments. The enzyme kinetics for the metabolic conversion rates r are defined as
follows:
Glucose transporter (GLUT): The GLUT diffuses within the cell membrane and
transports glucose between the cytosol and the extracellular medium depending on the
glucose gradient. For yeast cells, a complex kinetic description was developed to reflect
this process mechanistically [282], while the corresponding data is equally well repre-
sented by a simple Michaelis-Menten kinetic that considers G6P inhibition (simulation
not shown). As intracellular GLC could not be detected experimentally (see HK), the
transport across the membrane seems rate limiting and is, according to simulations, in-
sensitive against changes in G6P (simulations not shown). Therefore, and in agreement
to findings for pancreatic β-cells by Luni et al. [116], a simple Michaelis-Menten kinetic
was used and complemented with a variable capacity for the substrate uptake (γGLNT ,
explained in section 3.1.3) for an uni-directional glucose transport rGLUT :
rGLUT = K
max
GLUTγGLUT
[GLCx]
kmGLUT + [GLC
x]
(3.1.30)
KmaxGLUT is the maximum cell-volume-specific activity of the GLUT with affinity k
m
GLUT
for GLCx. Because of the multiplication of KmaxGLUT with γGLUT , structural identifi-
ability problems occurred and a unique estimation of the cell-specific maximum ac-
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tivity of the GLUT (vmaxGLUT ) is not possible. Therefore, v
max
GLUT was chosen to be
1.60× 10−11 mmol/cell/min according to findings for other mammalian cells [104, 107].
Hexokinase, (HK, EC number: 2.7.1.1): GLC could not be detected experimentally
in MDCK cells, which was similarly reported for other cell lines [91, 95, 283]. Therefore,
a possible influence by ATP, as measured by Fromm and Zewe [10] for yeast cells, may
reduce the HK activity but presumably not to a degree sufficient to limit the glycolytic
activity. Due to the lack of appropriate data for GLC and the lack of any indication
regarding a possible regulation by ATP we chose a simple Michaelis-Menten kinetic that
considers the maximum in vitro enzyme activity measured by Janke et al. [22] for MDCK
cells and an affinity constant for glucose of kmHK = 0.02 mmol/L [86], which together yield
a highly active HK and low GLC levels.
rHK = K
max
HK
[GLC]
kmHK + [GLC]
(3.1.31)
KmaxHK is the maximum cell-volume-specific activity of the HK with affinity k
m
HK for GLC.
Glucosephosphate isomerase (GPI, EC number: 5.3.1.9): A reversible kinetic
of Michaelis-Menten type was used to describe the isomerization of G6P and F6P, as
suggested by Richter et al. [241] for yeast cells and with the maximum in vitro activity
measured by Janke et al. [22].
rGPI = K
max
GPI
(
[G6P ]− F6P
keqGPI
kmGPI + [G6P ] +
F6P
keqGPI
)
(3.1.32)
KmaxGPI is the maximum cell-volume-specific activity of the GPI with affinity k
m
GPI for G6P
and equilibrium constant keqGPI .
Glucose 6-phosphate dehydrogenase (G6PDH, lumped reaction): The conver-
sion of G6P to R5P involves G6PDH and other enzymes with an accompanying produc-
tion of two NADPH molecules. For cancer cells, a negative regulation of the reaction
sequence by 3PG is reported [140]. Our data, however, does not support a negative
correlation between 3PG and R5P, which indicates that this mechanisms may not have
a significant influence in adherent MDCK cells. Assuming that G6PDH is rate limiting
within the reaction sequence allows the model to use a Michaelis-Menten kinetic with
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the maximum in vitro activity measured by Janke et al. [22]:
rG6PDH = K
max
G6PDH
[G6P ]
kmG6PDH + [G6P ]
(3.1.33)
KmaxG6PDH is the maximum cell-volume-specific activity of the G6PDH with affinity k
m
G6PDH
for G6P.
Uridyl transferase (UT, lumped reaction): In glycogenesis, UT is involved in the
generation of UGLC from G6P. A Michaelis-Menten kinetic close to saturation was
necessary to describe the experimental data of this work:
rUT = K
max
UT
[G6P ]
kmUT + [G6P ]
(3.1.34)
KmaxUT is the maximum cell-volume-specific activity of the UT with affinity k
m
UT for G6P.
Phosphofructo kinase (PFK, EC number: 2.7.1.11): The PFK is a highly regu-
lated enzyme in glycolysis and often assumed to be best represented by kinetics that
consider a certain cooperativity. According to measurements of Otto et al. [228] for ery-
throcytes and a review by Boiteux and Hess [284], a cooperativity of four seems to suit
the PFK and is analogously used in this work. A very potent regulator of the PFK is
fructose 2,6-bisphosphate [135], which is synthesized from F6P by phosphofructokinase-
2. For simplicity, it is assumed that F6P and fructose 2,6-bisphosphate are lin-
early positively correlated in their dynamics through a fast and reversible working
phosphofructokinase-2, which allows us to implement the PFK as a Hill kinetic with
sole activation by F6P. During development of the model, other less efficient regulators
such as ATP, ADP, AMP or CIT [135, 228] were tested, and finally withdrawn as the
model fit was not improved.
rPFK = K
max
PFK
[F6P ]4
kmPFK
4 + [F6P ]4
(3.1.35)
KmaxPFK is the maximum cell-volume-specific activity of PFK with affinity k
m
PFK for F6P.
Transaldolase and transketolase (TATK, EC number: 2.2.1.2 / 2.2.1.1): Both en-
zymes are responsible for the reversible conversion of metabolites of the PPP such as
F6P, R5P and GAP. Because of the unknown flux distribution and unknown concen-
trations of many PPP metabolites, we decided to use individual reversible first order
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rate laws for F6P and GAP formation and degradation (see ”Pentose Phosphate Path-
way” for further constraints). As GAP is not explicitly incorporated in the model, we
assumed a strong correlation to 3PG (see ”Aldolase”) and, hence, coupled the activity
of the TATK to 3PG. The equilibrium between consumption and production depends
on the level of F6P (or 3PG) as well as a threshold defined by the equilibrium constants
keqTATKF6P (or k
eq
TATK3PG) assuming a constant pool size of pentose phosphate metabolites
of about 1 mmol/L:
rTATKF6P = KTATKF6P
(
1− [F6P ]
keqTATKF6P
)
(3.1.36)
rTATK3PG = KTATK3PG
(
1− [3PG]
keqTATK3PG
)
(3.1.37)
KTATK3PG and KTATKF6P are the cell-volume-specific activities of the TATK for F6P
and 3PG conversion.
Aldolase (ALD, lumped reaction): Since DAP, GAP and 13DGP could not be quan-
tified for MDCK cells by Ritter [23], we assume that the enzymes, which are involved in
the generation of 3PG, highly correlate in their activity with ALD. High in vitro enzyme
activities of the TPI and GAPDH were indeed reported by Janke et al. [22] and support
the idea of a diminishing flux control. Furthermore, all reactions are reversible and ex-
pected to have a minor flux control over glycolysis in tumor cells [108]. Therefore, we
chose a Michaelis-Menten kinetic that represents the net flux from F16BP to 3PG using
the in vitro enzyme activity measured by Janke et al. [22]. A larger model that explicitly
integrates additional reaction steps requires seven additional parameters, while showing
only a minor improvement in fitting the data of this work.
rALD = K
max
ALD
[F16BP ]
kmALD + [F16BP ]
(3.1.38)
KmaxALD is the maximum cell-volume-specific activity of ALD with affinity k
m
ALD for F16BP.
Enolase (ENO, lumped reaction): In yeast, reversible Michaelis-Menten kinetics are
used to describe the ENO activity [241]. Under the assumption that the isomerization of
3PG to 2PG is usually a very fast and reversible step, the model describes the generation
of PEP from 3PG using a single reversible kinetic for ENO. A first order rate law
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sufficiently describes the data of this work:
rENO = KENO
(
[3PG]− [PEP ]
keqENO
)
(3.1.39)
KENO is the cell-volume-specific activity of ENO with equilibrium constant k
eq
ENO.
Pyruvate kinase (PK, EC number: 2.7.1.40): The PK is another strongly regulated
enzyme in tumor cell glycolysis with four subunits and high affinity for PEP [126].
The most prominent control over the PK activity is exerted by a feedforward activation
through F16BP [69]. Since the cofactors ATP and ADP as well as a higher cooperativity
(e.g. four) could not improve the model fit (simulation not shown), we only considered
a Michaelis-Menten kinetic with an activation by F16BP that considers the in vitro
enzyme activity measured by Janke et al. [22]:
rPK = K
max
PK
[PEP ]
kmPK + [PEP ] +
kaPK
F16BP
(3.1.40)
KmaxPK is the maximum cell-volume-specific activity of PK with affinity k
m
PK for PEP and
activation constant kaPK for F16BP.
Pentose phosphate pathway
The link of glycolysis with the PPP through the G6PDH reaction eventually yields R5P,
which is degraded by TATK or used for biosynthesis, and changes with
d[R5P ]
dt
= rG6PDH − rRDPK − µf [R5P ]. (3.1.41)
Corresponding biosynthetic needs for PPP intermediates (rX/PPP ) are indirectly given
with:
rX/PPP = rG6PDH − rTATKF6P − 0.5rTATK3PG. (3.1.42)
Furthermore, the metabolite exchange between glycolysis and PPP is constrained to be
in a typical biologically feasible range of 0 % to 40 % of the glycolytic activity (here
hexokinase activity, [150–152]):
0 <
rX/PPP
rHK
< 0.4 (3.1.43)
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During glucose limitation, the PPP can fuel glycolysis but presumably at a very low
rate. Therefore, the activity of the pyruvate kinase should be as low as possible (at
6 min) but high enough to satisfy the experimental data (see section 3.3.2).
Ribose 1,5-bisphosphate phosphokinase (RDPK, EC number: 2.7.4.23): The
degradation of R5P by ribose 1,5-bisphosphate phosphokinase (RDPK) is implemented
as first order rate law and is representative for all possible conversion reactions.
rRDPK = KRDPK [R5P ] (3.1.44)
KRDPK is the cell-volume-specific activity of RDPK.
Glycogenesis
The generation of glycogen from UGLC, which is mainly derived from G6P by a UT-
mediated reaction (see Eq. (3.1.34)), is mediated by the glycogen synthase (GLYS):
d[UGLC]
dt
= rUT − rGLY S − µf [UGLC] (3.1.45)
Glycogen synthase (GLYS, EC number: 2.4.1.11): The degradation of UGLC by
GLYS is implemented as first order rate law and is representative for all possible con-
version reactions,
rGLY S = KGLY S[UGLC], (3.1.46)
with the cell-volume-specific activity KGLY S.
Glutaminolysis
The supply of the citric acid cycle relies upon anaplerotic reactions that use amino
acids such as GLN, GLU or PYR as substrate. The conversion of GLN to GLU and
subsequently to αKG are initial reaction steps of glutaminolysis and produce intracellular
ammonium (NH4). A fraction of NH4 remains in the cell, either bound to amino acids
or as O-GlcNAcylation [85], while the other fraction is secreted into the medium, which
the model already covers with Eq. 3.1.18. The uptake of GLUx and GLNx and the
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generation of GLU is described in the model with:
d[GLUx]
dt
= −rGLT V
C
s Xtot
V M
(3.1.47)
d[GLNx]
dt
= −rGLNT V
C
s Xtot
V M
(3.1.48)
d[GLU ]
dt
= rGLT + rGLNT − rATA − µf [GLU ] (3.1.49)
rGLT is described in section 3.1.1 (Eq. 3.1.13), while rGLNT and rATA are defined as
follows:
Glutamine transporter (GLNT): The GLNT is not only important for the nutrient
supply of mammalian cells but also crucial for the survival of tumor cells which over-
express the ASCT2 transporter family [117]. Studies with hepatoma cells suggest a
Michaelis-Menten kinetic [285], which we extend, similarly to GLUT, by a variable ca-
pacity for the substrate uptake (γGLNT , see section 3.1.3):
rGLNT = K
max
GLNTγGLNT
[GLNx]
kmGLNT + [GLN
x]
(3.1.50)
KmaxGLNT is the maximum cell-volume-specific activity of GLNT with affinity k
m
GLNT for
GLNx.
Aspartate/Alanine transaminase (ATA, EC number: 2.6.1.1/2.6.1.2): The conver-
sion of GLU to αKG can be exerted by a few enzymes which either release or transfer
an amino group. Modeling the NHx4 dynamics, however, suggests that mainly transami-
nases are used. As data on GLU and NH4 release is not available, a first order rate law
seems sufficient for this reaction:
rATA = KATA[GLU ] (3.1.51)
KATA is the cell-volume-specific activity of ATA.
Citric acid cycle
The rate equations for the lower citric acid cycle were taken from Wetzel [280], extended
such that they include the upper citric acid cycle and slightly simplified, while yielding
the same (or better) data fits. In principle, both parts of the cycle are fueled by GLU
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(through a reversed ICDH activity) and, thus, show independent activities [286]. For
our data, the citric acid cycle seems to be sufficiently represented by:
d[αKG]
dt
= rATA + rAAex + rICDH − rKDH − µf [αKG] (3.1.52)
d[SUC]
dt
= rKDH − rSDH − µf [SUC] (3.1.53)
d[FUM ]
dt
= rSDH − rFMA − µf [FUM ] (3.1.54)
d[MAL]
dt
= rFMA − rMDH − µf [MAL] (3.1.55)
d[ICIT ]
dt
= rACO2 − rICDH − rCL − µf [ICIT ] (3.1.56)
d[CAC]
dt
= +rACO − rACO2 − µf [CAC] (3.1.57)
d[CIT ]
dt
= rPDH − rACO − µf [CIT ] (3.1.58)
The enzyme kinetics underlaying the various reaction rates r are suggested to depend
on many different ions, cofactors, inhibitors and activators [248]. In agreement with a
mathematical analysis of the system by Nazaret et al. [251] and the conceptual direction
of this work, we chose simple kinetic descriptions that suit our data but may fail to cope
with observations made for other cells or isolated mitochondria. Several of the reaction
rates that are introduced on the following pages use the cofactors NAD and NADH, which
are important energy carrier of the mitochondria and link oxidative phosphorylation with
the citric acid cycle. To account for the influence of both carrier on the citric acid cycle,
we assume that NAD levels correlate positively with the relative biosynthesis activity of
the cell bsyn, which is introduced in section 3.1.3 with Eq. (3.1.94). In contrast to bsyn,
NAD levels are not supposed to deplete or to drop below a basal level (NADbasal). So
the virtual, relative NAD level (bNAD) is represented with:
bNAD =
bsyn +NADbasal
1 +NADbasal
. (3.1.59)
In case of very large values for NADbasal, the citric acid cycle is not affected by NAD.
Amino acid exchange (AAex, lumped reaction): Intermediates of the citric acid
cycle are linked to many other amino acids (AA) that are involved in protein synthesis
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and degradation. For MDCK cells, Wahl et al. [15] observed relatively high uptake rates
for the branched chain amino acids leucine, iso-leucine and valine, which are converted
to GLU and αKG [6]. To account for this supply route, we implemented an exchange
between AA (constant pool size: 1 mmol/L) and αKG
rAAex = KAAex
(
1− [αKG]
keqAAex
)
(3.1.60)
KAAex is the cell-volume-specific activity of AAex with equilibrium constant k
eq
AAex.
α-ketoglutarate dehydrogenase (KDH, EC number: 1.2.4.23): The oxidative car-
boxylation of αKG is performed by KDH, a main regulatory enzyme in the citric acid
cycle [248]. But neither activation by ADP nor inhibition by ATP [179] improved the
model fits. So attributed to its dependence on NAD, we chose a first order rate law with
the cell-volume-specific activity KKDH and with an influence by bNAD:
rKDH = KKDH [αKG]bNAD (3.1.61)
KKDH is the cell-volume-specific activity of KDH.
Isocitrate dehydrogenase (ICDH, EC number: 1.1.1.41 / 1.1.1.42 ): According to
Filipp et al. [174], the ICDH is significantly changed in its characteristics in melanoma
and fast proliferating cells compared to all other citric acid cycle enzymes [175]. The
ICDH or another yet unknown enzyme [68] possibly mediate a reductive metabolism
of αKG, which leads to a reversed TCA flux under normoxic conditions and produces
ICIT. Its purpose lies in an enhanced lipid synthesis. Using a reversible Michaelis-
Menten kinetic (used also by Chen and Plaut [287] for bovine heart cells) that depends
on NAD in the forward direction (bNAD) as well as on NADH (1 − bNAD) in the back
reaction suits our data and supports observations about a reversed flux. The kinetic
also takes into account the in vitro activity measured by Janke et al. [22]. Neither an
inhibition by ATP nor an activation by ADP, which is reported by Plaut et al. [288],
improved the fit to a significant degree:
rICDH = K
max
ICDH
[ICIT ]bNAD − [αKG](1−bNAD)keqICDH
kmICDH + [ICIT ] +
[αKG]
keqICDH
(3.1.62)
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KmaxICDH is the maximum cell-volume-specific activity of ICDH with affinity k
m
ICDH for
αKG and with equilibrium constant keqICDH .
Succinate dehydrogenase (SDH, EC number: 1.3.5.1): The conversion of SUC to
FUM is performed by the SDH and yields FADH2, which can be converted to ATP
during oxidative phosphorylation. The enzyme’s activity is reversible with dependence
on the FUM and SUC levels [248]. We used a reversible first order rate law for the SDH:
rSDH = KSDH
(
[SUC]− [FUM ]
keqSDH
)
(3.1.63)
KSDH is the cell-volume-specific activity of SDH with equilibrium constant k
eq
SDH .
Fumarase (FMA, EC number: 4.2.1.2): For isolated cardiac mitochondria, a re-
versible Michaelis-Menten kinetic is proposed for the FMA [167] and here taken for
MDCK cells using the in vitro measured enzyme activity of Janke et al. [22]:
rFMA = K
max
FMA
[FUM ]− [MAL]
keqFMA
kmFMA + [FUM ] +
[Mal]
keqFMA
(3.1.64)
KmaxFMA is the maximum cell-volume-specific activity of FMA with affinity k
m
FMA for SUC
and with equilibrium constant keqFMA.
Malate dehydrogenase (MDH, lumped reaction): According to Sidorenko et al.
[16], main routes of MAL conversion are either via the MDH to OAA, which yields
NADH from NAD, or via the malic enzyme (ME) to PYR, which yields NADPH from
NADP. Furthermore, PYR and OAA are linked via the pyruvate carboxylase (PC). Since
data is missing for the intermediates and fluxes, the actual flux distribution cannot be
identified based on the model and both routes are equally likely. To achieve high LACx
secretion rates with a YLACx/GLCx > 2, we assume a net reaction that is influenced by the
abundance of NAD and eventually yields PYR. Therefore, we chose a Michaelis-Menten
kinetic that considers the in vitro measured enzyme activity by Janke et al. [22] and a
dependence on NAD (bNAD):
rMDH = K
max
MDH
[MAL]
kmMDH + [MAL]
bNAD (3.1.65)
KmaxMDH is the maximum cell-volume-specific activity of MDH with affinity k
m
MDH
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Pyruvate dehydrogenase (PDH, lumped reaction): The PDH and the CS fuel the
citric acid cycle by converting PYR to ACCoA and afterwards to CIT using OAA. A
Michaelis-Menten kinetic and the in vitro measured enzyme activity from Janke et al.
[22] for the PDH were used to account for the transfer of PYR into the citric acid cycle.
Additionally, we consider that the reaction converts NAD to NADH and, thus, multiply
the reaction with bNAD. Inhibition by several compounds such as CIT, ATP, ADP and
AMP, which are described for cardiac mitochondria [167], could not improve the model
fit.
rPDH = K
max
PDH
[PY R]
kmPDH + [PY R]
bNAD (3.1.66)
KmaxPDH is the maximum cell-volume-specific activity of PDH with affinity k
m
PDH for PYR.
Aconitase (ACO, EC number: 2.7.1.40): The ACO converts CIT to ICIT in a re-
versible fashion with CAC as intermediate and is suggested to be best represented by
a reversible Michaelis-Menten kinetic [248]. As measurements for the enzyme’s activity
are missing for MDCK cells, we used a reversible first order rate law and assumed that
CAC dissociates from ACO after the release of a water molecule and poses a substrate
for the second reaction that is mediated by the same enzyme:
rACO = KACO
(
[CIT ]− [CAC]
keqACO
)
(3.1.67)
rACO2 = KACO
(
[CAC]− [ICIT ]
keqACO2
)
(3.1.68)
KACO is the cell-volume-specific activity of ACO with equilibrium constants k
eq
ACO and
keqACO2 between CIT and CAC and between CAC and ICIT, respectively.
Citrate lyase (CL, lumped): In tumor cells, cytosolic CL reversibly converts CIT to
ACCoA and OAA to meet the high demand for lipids [80]. OAA is then either converted
to PEP or converted to PYR with the accompanying production of NADPH from NADP
and of NAD from NADH (see ”Malate dehydrogenase”). Also in MDCK cells the upper
citric acid cycle is proposed to mainly yield cytosolic CIT [16], which may be attributed
to the large demand in cytosolic ACCoA and NADPH. In agreement with findings by
Metallo et al. [175] for tumor cells, we consider the conversion to PYR as main route
and use a simple Michaelis-Menten kinetic that takes into account the enzyme activity
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measured in vitro by Janke et al. [22] and a dependence on NADH (1− bNAD):
rCL = K
max
CL
[ICIT ]
kmCL + [ICIT ]
(1− bNAD) (3.1.69)
KmaxCL is the maximum cell-volume-specific activity of CL with affinity k
m
CL for ICIT.
Pyruvate metabolism
The glycolytic activity (rPK) generates large amounts of pyruvate, which is mainly
converted to lactate (rLDH) and various amino acids (rdPY R). A smaller portion can
enter the upper part of the citric acid cycle (rPDH) and consumes OAA, which can also
be converted from PYR. Furthermore, PYR is produced by MDH and CL (see above
descriptions) and, thus, connects glycolysis and the citric acid cycle:
d[PY R]
dt
= rPK + rMDH + rCL − rLDH − 2rPDH − rdPY R − µf [PY R] (3.1.70)
with: rdPY R = kdPY R[PY R]. (3.1.71)
Here, kdPY R is the specific PYR degradation rate. The macroscopic description of the
lactate release of Eq. 3.1.17 can now alternatively be described with:
d[LACx]
dt
= rLDH
V Cs Xtot
V M
+
Fevap[LAC
x]
V M
(3.1.72)
Lactate dehydrogenase (LDH, EC number: 1.1.1.27): The LDH converts PYR to
LAC and it is generally accepted that its high activity is essential for fast proliferating
cells to maintain a certain redox balance (recouping of NAD). The accumulation of
intracellular LAC was not quantified by Ritter [23] and the largest fraction is presumably
secreted to the medium. Without measurements for LAC, the model is not extended
by the cytosolic influence of NADH. Taken together, the model considers a Michaelis-
Menten kinetic and the maximum activity measured in vitro by Janke et al. [22], which
shows very high activities.
rLDH = K
max
LDH
[PY R]
kmLDH + [PY R] +
kaLDH
F16BP
(3.1.73)
KmaxLDH is the maximum cell-volume-specific activity with affinity k
m
LDH for PYR and
activation constant kaLDH for F16BP.
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Energy metabolism and respiration
For the production and degradation of adenosine-based nucleotides, we used a reaction
network proposed by Verma and colleagues for yeast cells and adopted it such that it suits
our kinetic description for central carbon metabolism [199]. The model considers the
enzyme-mediated interconversion of adenosine-based nucleotides through the adenylate
kinase (rADK), central carbon metabolism (rCCM) and demands by the cells for growth,
maintenance and futile cycles (rdATP ). Furthermore, the synthesis and degradation of
AMP from and to IMP through the purine salvage pathway (rPSP ), which is in detail
explained by Walther et al. [197], is taken into account:
d[ATP ]
dt
= rCCM +
rADK
2
− rdATP (3.1.74)
with: rCCM = rENO + rPK + 2.5rNADH + 2rFADH
− rHK − rPFK , (3.1.75)
rdATP = rX/ATP + rm/ATP + rATPase
= (kX/ATP bsyn + V
C
s kmATP )[ATP ] + rATPase (3.1.76)
d[ADP ]
dt
= −rCCM − rADK + rdATP (3.1.77)
d[AMP ]
dt
=
rADK
2
− rPSP (3.1.78)
d[IMP ]
dt
= +rPSP (3.1.79)
kX/ATP is the specific ATP consumption rate for cell growth, kmATP is the cell-volume-
specific ATP consumption rate for cell maintenance [242]. Here, the production of ATP
by rENO is representative for the PGK mediated reaction, which is not explicitly taken
into account. For convenience, the model assumes that the purine pool is constant (Eq.
(3.1.74) – (3.1.79)) and, thus, also neglects dilution by growth. The remaining enzyme
reaction rates are described below:
Respiration (NADH / FADH, lumped): Parts of the energy that is produced by re-
actions of the central carbon metabolism are indirectly transfered to ATP through the
hydrogen carriers NAD and FAD. The exact stoichiometry of reactions that produce or
consume NADH and FADH is, however, unclear as many of the mitochondrial reaction
paths have alternatives that may not phosphorylate these hydrogen carriers or use it for
purposes other than oxidative phosphorylation. Therefore, we rather calculate a max-
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imum NADH and FADH production rate based on the reactions defined for glycolysis
and the citric acid cycle:
rNADH = rENO + rKDH + rMDH + rPDH + 2rAAex + rICDH
− rLDH − rCL (3.1.80)
rFADH = rSDH + rAAex (3.1.81)
Note that the conversion of NADH to NAD by rCL is representative for an implicitly
considered cytosolic MDH reaction. Furthermore, metabolism of branched chain amino
acids by rAAex allow for the production of 2 NADH molecules from NAD [6]. The
oxidation of NADH yields 2.5 molecules ATP, while the oxidation of FADH yields 2
molecules of ATP ([6], cf. Eq. (3.1.75)). To enable a consistency check with experimental
data, the cell-number-specific oxygen demand is calculated from the production rates of
rNADH and rFADH (unit: fmol/cell/h):
rO2 =
rNADH + rFADH
2
× V Cs × 60× 1012 (3.1.82)
If further data becomes available, it seems reasonable to integrate a simple model for the
oxidative phosphorylation which considers a membrane potential that couples NADH
to the ATP pool (e.g. Nazaret et al. [251]). The model was already tested in this work
but too many parameters were not identifiable and several difficulties with the resulting
regulation pattern remained.
Adenylpyrophosphatase (ATPase, EC number: 3.6.1.3): Although the model al-
ready considers ATP consumption for growth and maintenance, the MDCK cell is ex-
pected to have a large overproduction in ATP that is simply converted to ADP in futile
cycles [15]. To account for this hypothesis, we implemented a degradation rate that is
based on a first order rate law:
rATPase = KATPase[ATP ]. (3.1.83)
KATPase is the cell-volume-specific activity of the ATPase.
Adenylate kinase (ADK, EC number: 2.7.4.3): The ADK reversibly converts ATP
and AMP into two molecules of ADP and maintains a certain ratio between the three
adenosine nucleotides. In most cases, the ADK is realized with simple conversion kinetics
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that enable a fast equilibrium [199, 242]:
rADK = K
max
ADK
ADP − AMP
keqADK
kmADK + ADP +
AMP
keqADK
. (3.1.84)
KmaxADK is the maximum cell-volume-specific activity with affinity k
m
ADK for ADP and with
equilibrium constant keqADK .
Purine salvage pathway (PSP, lumped reactions): In yeast cells, it is observed that
the sum of adenosines drops in response to a glucose pulse [289]. Presumably because of
a conversion of AMP to IMP, which is part of the PSP [197]. As the overall adenosine
pool also drops in MDCK cells in response to a sudden start of cell growth, we assume
a similar mechanism and implemented a first order rate law for the exchange with the
PSP:
rPSP = KPSP
(
AMP − IMP
keqPSP
)
. (3.1.85)
KPSP is the cell-volume-specific activity with equilibrium constant k
eq
PSP between AMP
and IMP.
3.1.3. Coupling of models
For simulation of the cell cultivation experiments, we couple the kinetic description of
the central carbon metabolism with the segregated cell growth model. In particular, we
track the actual growth status and culture condition of the cell population during batch
cultivation and apply the resulting properties of a mean cell to the structured central
carbon metabolism model. What follows is an influence of the cell growth regime7 on
the concentration of extracellular substances, their uptake and release, dilution of intra-
cellular metabolites, consumption of cellular energy and biomass precursors as well as on
the cell-volume-specific enzyme activities (Fig. 3.1). In the following, we describe mod-
ifications and additional definitions necessary for a consistent coupling of both models.
Transport kinetics of the structured model: During a cell cultivation, the uptake
of GLCx and GLNx is solely defined by the macroscopic, growth-dependent functions.
7growth regime: an intracellular signal processing network that decides over cell growth phases
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Glycolysis 
Citric acid cycle 
Population level 
Cellular level 
Segregated cell growth model 
Structured central carbon metabolism model 
Glycolysis 
Citric acid cycle 
Segregated cell growth model 
Structured central carbon metabolism model 
(1) (2) (3) (4) 
Figure 3.1.: Coupling of segregated cell growth and structured central carbon
metabolism model. The segregated cell growth model influences: (1) the cell-specific vol-
ume (V Cs ) and, concomitantly, the cell-volume-specific enzyme activities (K
max
e , Ke); (2) the
dilution of intracellular metabolite pools by cell growth; (3) the change in extracellular sub-
strate levels; (4) the time-dependent uptake rates (rGLUT , rGLNT , rGLT ).
Therefore, the transport rate by GLUT and GLNT needs to fulfill the relation:
rGLUT = (rX/GLCx + rm/GLCx)
V M
V Cs Xtot
(3.1.86)
rGLNT = (rX/GLNx + rm/GLNx)
V M
V Cs Xtot
(3.1.87)
Note that rX/S and rm/S are here used with unit mmol/L/min. Furthermore, this relation
only holds for the cellular uptake of substrates during cell cultivation experiments under
excess of substrates. In scenarios characterized with low substrate concentrations (e.g.
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< 0.2 mmol/L for hybridoma [51] or < 0.4 for BHK cells [290]) the uptake rates may
strongly depend on the substrate affinity of the transporter and can differ significantly
from the macroscopic descriptions given with Eq. 3.1.86 and 3.1.87. To simultaneously
enable the use of a macroscopic description during cell cultivation and a mechanistic
description during the perturbation experiments, we implemented variable capacities
for the substrate transports (γGLUT and γGLNT ), which are defined as follows:
γGLUT =
(rX/GLCx + rm/GLCx)
VM
V Cs Xtot
KmaxGLUT
[GLCx]
kmGLUT+[GLC
x]
(3.1.88)
γGLNT =
(rX/GLNx + rm/GLNx)
VM
V Cs Xtot
KmaxGLNT
[GLNx]
kmGLNT+[GLN
x]
(3.1.89)
Thus, multiplication of the mechanistic uptake rates with γ (Eq. (3.1.30) and (3.1.50))
adjusts their activity to the macroscopic description given by the segregated cell growth
model. From a biological point of view, the GLUT and the GLNT have a variable
transport capacity that is regulated by the cellular growth regime through a change
in the transporter affinity, translocation of transporter to the membrane or molecule-
based activation [97]. When it comes to the limitation experiments, γ remains constant
(the cellular demand is still the same) and the depletion dynamics solely depend on the
transporter kinetics. Therefore, γ is time-dependent for Cult1 – 3 simulations, where
the growth of cells changes, and constant, experiment-specific for Lim1, Lim2 and Pulse
simulations.
Calculation of specific enzyme activities: For a large portion of enzymes e, the cell-
specific maximum activity vmaxe was measured in vitro by Janke et al. [22] for adherent
MDCK cells cultivated in GMEM-Z. The transformation to Kmaxe follows with
Kmaxe =
vmaxe Elevel
V Cs
, (3.1.90)
where Elevel is the experiment-specific, relative enzyme level of the cell population. So,
we take into account that cell cultures, which can already differ in dm and dc, may
also show concerted variations in vmaxe . However, the variation in maximum enzyme
activities is presumably limited. On the basis of the enzyme activity measurements by
Janke et al. [22], we calculated a mean standard deviation for all enzyme activities of
about ± 8 %. Note that the Kmaxe also change with V Cs and are, hence, time-dependent.
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The cell-volume-specific activity Ke similarly results from the cell-specific activity ve:
Ke =
veElevel
V CS
. (3.1.91)
Growth phases and biosynthesis activity of cells: Based on the segregated cell
growth model, theoretical growth phases for a mean cell can be calculated and are
important for the depiction of metabolite pool dynamics. The lag phase of V C and Xtot
is here the time span required by half of the cells to double in cell-specific volume or
number, respectively. Afterwards, the growth phase follows and ends with the onset of
the intermediate growth phase. The intermediate growth-phase for V C is supposed to
be in the time interval where
0.95 > f > 0.05 (3.1.92)
holds. In case of Xtot, we use the relative growth rate of the cell number in the interval
0.95 ·µmax > X5(t)rtrans(t)
Xtot(t)
> 0.05 ·µmax, with: t > 20 h. (3.1.93)
Afterwards, a stationary growth phase forXtot and V
C follows. However, the degradation
of citric acid cycle intermediates and ATP may not directly correlate with the increase
of Xt or V
C but with the propagation of cells through the different classes Xi, which we
define as relative biosynthesis activity (bsyn) that is
bsyn =
X1f +
∑5
i=2Xi
Xtot
. (3.1.94)
The intermediate growth phase for bsyn shall be the time span that satisfies
0.95 > bsyn > 0.05. (3.1.95)
3.2. Model simulation
Apart from the definition of the model structure, ODE-based models require the set-
ting of initial conditions for each experimental scenario. In this work three cultivation
experiments (Cult1 – 3) and three perturbation experiments (Lim1, Lim2, Pulse) are an-
alyzed. For the sake of a clear overview, the initial conditions are divided into cultivation
conditions, growth status and metabolic status.
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3.2.1. Considering the preculture of cells
Cell cultivation experiments rely on the transfer of cells from a preculture into a new well
or at least on changes in cultivation conditions, e.g. addition or removal of substrates.
In both cases, the initial growth status (such as cell diameter, cell number, growth
inhibition etc.) and metabolic status (intracellular metabolite concentrations) of the
cells are pre-defined by the cultivation prior to the actual experiment (see Table C.1 and
C.2). For a consistent simulation of the cellular behavior, the experiments conducted by
Ritter [23] are set into the chronology shown in Figure 3.2. In particular, the simulation
of the cultivation experiment (e.g. Cult1) provides (at individual time points t∗) the
growth and metabolic status for the limitation experiments (Lim1 – 3), which in turn
provide initial conditions and experiment-specific parameters for the pulse experiment.
The corresponding culture conditions are given by Ritter [23] or estimated in the next
section 3.2.2. For the inoculation of the cultivation experiments, however, the initial
conditions were derived from different sources: The growth status and culture condition
were determined with the segregated cell growth model during parameter estimation
Figure 3.2.: Flow of information and link to experimental data. (1) Use of growth
status and cultivation condition of Cult1 at 200 h to determine the metabolic status by steady
state simulation. (2) Transfer of the metabolic steady state to the simulation of the Cult1 – 3
and the Pred. simulation. (3) At individual time points t∗, the metabolic and growth status of
Cult1 is transferred to the respective simulation of the Lim1 – 3 experiments. (4) Simulation of
pulse response with initial conditions determined with the Lim3 simulation. Green background:
Coupling of segregated cell growth model and structured metabolism model; red background:
coupling of adjusted segregated cell growth model, which renders cell growth under limited
GLCx concentrations, to the structured metabolism model.
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and vary due to differences in the preculture device and the precultivation time [23].
The metabolic status was derived from a steady state simulation with the structured
metabolism model using the culture conditions as well as the growth status present
in Cult1 at t = 200 h. This, however, implies the assumption that cells achieve a
reproducible metabolic status in the stationary growth phase of the precultures and
that batch-to-batch variations during this growth phase are small and have a negligible
impact on the metabolite pool levels. Both can be observed in the cultivation data (e.g.
Fig. 4.11).
3.2.2. Substrate limitations through medium dilution
For the limitation experiments, the medium was discarded and replaced by phosphate
buffered saline (PBS) [23]. At that time point of cultivation, e.g. 48 h, the activ-
ity of glycolysis is about 2.7 mmol/L/min which would deplete the G6P pool within
seconds. Inspection of the corresponding G6P dynamics reveals high levels for about
0.3 min and a depletion of G6P after 0.6 min of cultivation (Figure 3.3A). Based on
V C(t = 48 h) = 5.9 µL, about 4.8×10−6 mmol GLCx is required to satisfy the gly-
colytic activity for 0.3 min. Assuming that medium remains on the cellular surface
and the intercelluar space with a GLCx concentration of 25 mmol/L (at 48 h) yields a
V M = 4.8× 10−6/25 = 1.9× 10−7 L. Simulation studies with the structured metabolism
model yield 3 × 10−7 L (simulation not shown). So instead of inducing the limitation
with GLCx(t=0)=0 mmol/L we simply set V M = 3 × 10−7 L, which corresponds to a
PBS 
Cell Cell 
Well surface 
Medium 
0.3 µm 
14.0 µm 
A B 
Figure 3.3.: A priori estimations for the substrate limitation experiments. (A) G6P
time series (◦) during the Lim1 experiment with mean and standard deviation of three wells
(data taken from [23]). Red lines were derived by regression analysis and used to assess the
time span of high G6P levels. Dashed gray line is the limit of quantification. (B) Illustration
of remaining medium in the 6-well plate after medium depletion and addition of PBS.
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height of 0.3 µm in the well for a surface of 10 cm2 (cell layer height ≈ 14.0 µm, Fig.
3.3B). Note that dilution of the medium by PBS is likely and may yield a V M higher
than 3 × 10−7 and a reduced GLCx level, which, however, can be equally well realized
with the model in case more detailed data becomes available.
To keep the simulations as simple as possible, we assume that cells remain constant in
their initial growth status for the duration of the perturbation experiments (Table C.2).
3.2.3. Hierarchy of model parts and sequential model fitting
A reliable parameter estimation and an in-depth analysis of causal relationships is key
to a proper model development but greatly hampered by a high model complexity. As
a direct solution to that problem, we only considered simple enzyme kinetics (section
3.1.2) and used the cell’s cultivation history (section 3.2.1) to both minimize the degree
of freedom and focus on mechanisms that are essential to describe the data. However,
the analysis of the full model (segregated growth + structured metabolism) was still
difficult and we splitted the model into smaller, manageable parts (defined in section
3.1.2) and conducted a piecewise analysis. In particular, the macroscopic segregated
cell growth model is by definition independent from intracellular changes. Glycolysis
and glutaminolysis depend on the segregated cell growth model, while metabolites and
nucleotides of the PPP, glycogenesis, pyruvate metabolism and energy metabolism de-
pend on glycolysis and glutaminolysis but not on each other. The proposed hierarchy is
illustrated in Figure 3.4. Using the hierarchy of model parts enables a sequential model
fitting where only the actual model part is subject to parameter estimation. Model parts
of lower hierarchy are disregarded, while model parts of higher hierarchy are not part
of the parameter estimation as they already possess a final structure and parameteriza-
tion. Note that the estimation of parameter confidence intervals takes into account the
parameter uncertainty of model parts with higher hierarchy except of the segregated cell
growth model. So the uncertainties in the segregated cell growth model and the overall
Segregated 
cell growth  
Glycolysis 
Glutaminolysis and pyruvate 
Pentose Phosphate Pathway 
Glyocogenesis 
Energy metabolism 
Figure 3.4.: Hierarchy of model parts. Blue lines indicate an unidirectional influence of
a model part on another (from left to right).
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kinetic description of central carbon metabolism are separately analyzed.
3.3. Theoretical tools
3.3.1. Algorithms and objective function
For model fitting, estimation of parameter confidence intervals, and visualization of re-
sults MATLABr (Version R2012b, The MathWorks, Inc.) was used. Models and data
were handled with the Systems Biology Toolbox 2 developed by Schmidt and Jirstrand
[291]; integrations of the ordinary differential equations were performed with the CVODE
from SUNDIALS [292]. The algorithm SSm [293] was used for stochastic global opti-
mization of the parameters and experiment settings. All simulations were carried out
on a Linux-based system (partly by using the Linux-Cluster ”Otto” of the Max Planck
Institute for Dynamics of Complex Technical Systems Magdeburg). By using this setup,
a model simulation required less than 0.1 s.
3.3.2. Model analysis
Objective function: The fitness of the model trajectories y˜lmj to the data ylmj was
evaluated based on a weighted sum of squared residuals (FQS), defined with
FQS =
N l∑
l=1
Nml∑
m=1
Njlm∑
j=1
(
ylmj − y˜lmj
σ
)2
, (3.3.1)
comprising the experiments l = 1, ..., N l, the states m = 1, ..., Nml measured in ex-
periment l and the time points j = 1, ..., N jlm for state m in experiment l, while
σ = maxlm([ylm1, ..., ylmNtlm ]) is a weighting to the maximum data point for state m
in experiment l. A violation of the constraint given in Eq. 3.1.43 increases FQS by a
penalty value of 0.5. For low PK activities during the limitation experiments, rPK(6min)
10
of the Lim1 experiment was added to the FQS value.
Parameter confidence intervals: For assessment of the parameter confidence inter-
vals a bootstrap method with at least 2000 runs was used [271, 294]. A total of 2000
runs is presumably sufficient for the parameter optimization problems of this work, espe-
cially when considering a sequential model fitting. Convergence of the parameter bounds
was observed. The bootstrap method in short: 2000 in silico data sets were generated
from the normal distribution of each ylmj (defined by mean and standard deviation of
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the measurement) and fitted with SSm yielding 2000 model parameterizations Φ. From
these parameterizations, each parameter was sorted by value and the 0.025 and 0.975
quantile constitute the bounds of the 95 % confidence interval.
Local sensitivity analysis: According to Gutenkunst et al. [269], the change in model
behavior χ2 in response to a change in the parameter set φ is described with:
χ2(φ) =
1
2
N l∑
l=1
Nml∑
m=1
Njlm∑
j=1
1
Nml N
t
lm
(
y˜lmj(φ)− y˜lmj(φ′)
σ˜
)2
(3.3.2)
where σ˜ = maxlm([y˜lm1(φ), ..., y˜lmNjlm
(φ)]) is a weighting with the maximum simulation
point for state m in experiment l. In this work, a 1 % change in a single parameter
value of φ was used (φ′). Note that only time points at which data points exist were
considered for the sensitivity analysis.
3.3.3. Limit of quantification
The limit of quantification (LOQ) of the assays to determine the concentration of intra-
cellular metabolites M is given in molar units in the Appendix B.1 (Table B.1) and here
denoted as LOQmmolM . As all adherent cells of a 6-well plate are quenched and analyzed,
the LOQ used in the figures is related to V C (taken from Cult1):
LOQM =
LOQmmolM
V C
(3.3.3)
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4.1. Observations for MDCK cell cultivations in different media
Current experimental approaches to the analysis of the MDCK cell metabolism comprise
the quantification of extracellular and intracellular metabolites [23], the inferences of
flux rates from flux balance analysis [15, 16], and the measurement of in vitro enzyme
activities [22]. In this first part, we pre-analyze the data from all four sources to extract a
working hypothesis for the integrated modeling approach of the following sections. Since
a multitude of factors can influence metabolism, we concentrate in the pre-analysis on
cell cultivation experiments where MDCK cells from the same preculture are seeded
into a new well with either the serum-containing medium GMEM-Z or the serum-free
medium EpiSerf to highlight similarities or dissimilarities. In particular, we examine
the growth of the cells together with the uptake and release of metabolites, followed by
the analysis of intracellular metabolite time series in glycolysis, glutaminolysis, and the
closely related pathways as well as the level of purines. Finally, we discuss to which
extent metabolism is influenced by the corresponding medium and the change in cell
growth phase. Note that parts of the following analysis are taken from our original
research article Rehberg et al. [295]. Copyright of these passages lies with the Journal
of Applied Microbiology and Biotechnology (Springer-Verlag GmbH, Heidelberg).
4.1.1. Growth, nutrient supply and byproduct release
Cell number, diameter and volume: The time course of cell numbers of the two cul-
tures (Fig. 4.1A) showed in mean a maximum specific growth rate for GMEM-Z cultures
of 0.040 h−1 in the time interval of 21 – 54 h and for EpiSerf cultures of 0.035 h−1 in the
time interval of 27 – 54 h, based on a logarithmic regression for the three experiments
(∆, 2, ◦, performed by Ritter [23]). The mean diameter of cells was similar for both
media starting with 14 – 17 µm, increased to 17 – 21 µm after one day of cultivation,
and afterwards decreased to its initial level (t = 0 h). However, for EpiSerf cultures
the mean cell diameter was initially lower and the maximum is slightly later achieved
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Figure 4.1.: Growth of adherent MDCK cells in 6-well plates with either GMEM-
Z (black) medium or EpiSerf (red) medium. Time series of cell number (A), mean
cell diameter (B), total cell volume (C, with splines used by Ritter [23] for calculation of
intracellular metabolite concentrations), and extracellular metabolites glucose (D), glutamine
(E), glutamate (F), lactate (G), and ammonium (H) were measured in three independent
experiments by Ritter [23] marked with symbols ∆, 2 and ◦ (mean and standard deviation
of three wells). The energy charge (I) is calculated from intracellular concentrations of ATP,
ADP and AMP (Eq. (2.2.1)). Light gray field between 30 – 58 h illustrates the intermediate
growth phase of the total cell volume (V C in Table 4.2).
(Fig. 4.1B). In contrast to the increase in cell numbers, growth in total cell volume
(Fig. 4.1C) occurred at a similar time interval for both media (6 – 46 h) with nearly
the same maximum specific growth rate (0.040 h−1 in GMEM-Z; 0.039 h−1 in EpiSerf
based on a logarithmic regression performed by Ritter [23]). Note that the time interval
of the regression analysis of Ritter [23] overlaps with the gray fields of Fig. 4.1, which
illustrate the intermediate growth phase and are derived from simulating the GMEM-Z
cultivations with the model of section 4.2. After 58 h of cultivation, the cell volumes
in the EpiSerf cultures reached higher levels of about 10 – 11 µL (GMEM-Z: 7 µL) due
to slightly higher mean cell diameters and apparently higher cell numbers with 4×106 –
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5×106 cells per well (GMEM-Z: 3×106 – 4×106).
Substrate uptake and byproduct release: Both media differ significantly in the
initial concentration of GLCx, GLNx and GLUx (Fig. 4.1D – F). Nevertheless, the total
cell-volume-specific uptakes of GLCx (rGLCx) and GLN
x (rGLNx) are similar (Table 4.1)
and the decrease in GLCx and GLNx correlates with the increase in cell volume until 58 h
of cultivation. Afterwards, the GLCx concentration decreased more or less linearly in
GMEM-Z indicating cell maintenance (stationary growth phase, 58 – 200 h, Fig. 4.1D).
According to Baggetto [50], cancer cells require no or only marginal amounts of GLNx
during stationary growth phase and the linear decrease of GLNx after 58 h fits exactly
to the spontaneous decomposition present in GMEM-Z medium (0.0036 h−1, Fig. 4.1E,
[51, 212]) and loss of water (water evaporation rate constant: 2.75×10−6 L/h, [23]). In
EpiSerf cultures, however, GLCx was depleted after cells reached the stationary growth
phase (72 h, Fig. 4.1D) while the GLNx concentration was constant during stationary
growth phase (Fig. 4.1E). Obviously, spontaneous decomposition of GLNx does not play
a role in EpiSerf medium. The uptake of GLUx (Fig. 4.1F) started shortly after onset
of cell growth inhibition (gray field) and lasted until GLUx was depleted (GMEM-Z:
58 h, EpiSerf: 96 h). The corresponding uptake rate of GLUx (rGLUx) was slightly lower
in EpiSerf cultures compared to GMEM-Z (Table 4.1) and the uptake lasted longer
due to higher initial GLUx levels. The accumulation of LACx correlates with the drop
in GLCx (Fig. 4.1G) and, therefore, ceased after about 58 h of cultivation in EpiSerf
medium while in GMEM-Z a linear increase until the end of the cultivation was observed.
Extracellular ammonia (NHx4) levels showed a linear increase during cultivation, even at
late time points where GLNx and GLUx were not consumed. In GMEM-Z cultures, the
spontaneous decomposition of GLNx may explain this increase in NHx4 after 58 h. In
EpiSerf cultures, however, the increase in NHx4 most likely reflects the consumption of
Table 4.1.: Total cell-volume-specific uptake rate of substrates and release rate of byproducts
in two different media, derived by polynomial regression analysis of three independent cultiva-
tions (units: mmol/L/min). Depicted are mean and standard deviation of the three regression
analyzes.
rGLCx
a rGLNx
a rGLUx
b rLACx
a rNHx4
a
GMEM-Z 3.12± 1.17 0.27± 0.10 0.20± 0.02 6.82± 1.22 0.13± 0.02
EpiSerf 2.78± 0.33 0.12± 0.08 0.13± 0.03 6.42± 0.35 0.20± 0.02
acalculated for the time interval 0 – 48 h
bcalculated for the time interval 35 – 62 hour (GMEM-Z), 61 – 132 hour (EpiSerf)
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other amino acids. The EC showed values above 0.8 over the complete time course of
cultivations (Fig. 4.1I), which is within the typical limits found for mammalian cells
[192].
4.1.2. Response of metabolism to growth and media
Glycolysis and associated pathways: During cultivation in GMEM-Z and EpiS-
erf, the intermediates G6P, F6P and F16BP (Fig. 4.2A – C) of upper glycolysis showed
a strong increase for the first 24 h of cultivations. With the onset of the intermediate
growth phase (gray field) all three intermediates decreased in concentration and remained
in the subsequent stationary growth phase at more or less constant levels. Interestingly,
Sellick et al. [32] similarly observed for CHO cells that levels of glycolytic intermediates
decrease during the transition to the stationary growth phase. With depletion of GLCx
in EpiSerf medium, the measured levels of G6P and F16BP were lower than the limit of
quantification and, thus, slightly different to that of the GMEM-Z culture. In the lower
part of glycolysis, 3PG as well as PEP showed an increase in concentration until 48 h,
which corresponded to the cease of cell volume growth (end of gray field, Fig. 4.2D, E).
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Figure 4.2.: Dynamics of glycolytic intermediates during cultivation of adherently
growing MDCK cells in GMEM-Z and EpiSerf. The upper part of glycolysis with
glucose 6-phosphate (A), fructose 6-phosphate (B), fructose 1,6-bisphosphate (C) and the
lower part of glycolysis with glyceraldehyde 3-phosphate (D), phosphoenolpyruvate (E) and
pyruvate (F) are shown in the color code of Figure 4.1 (data taken from Ritter [23]). The limit
of quantification is shown as dashed black line. Light gray field between 30 – 58 h illustrates
the intermediate growth phase of V C (Table 4.2).
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In the EpiSerf culture, the time courses of PEP seemed to follow the peak behavior of
3PG concentrations. In GMEM-Z, the time series of PEP were rather similar to PYR as
both increased to their maximum concentrations at about 48 h and remained constant
afterwards (Fig. 4.2E, F). Albeit the fact that cells of both cultures originated from the
same pre-culture, intracellular PYR concentrations of the cells in EpiSerf cultures were
initially significantly higher with a fast drop to concentrations lower than in GMEM-Z
cultures. Possible metabolic branches for the glycolytic intermediate G6P are glycogen-
esis or the PPP comprising UGLC and R5P, respectively. Interestingly, R5P and UGLC
seem to correlate with intermediates of upper glycolysis, which is presumably attributed
to the close linkage of these pathways (Fig. 4.3A, B). Both metabolites increased ini-
tially, achieved a maximum at 24 h and decreased with onset of cell growth inhibition
(gray field) to a stationary level. In the EpiSerf culture, the level of UGLC was mostly
below that of the GMEM-Z cultures (similarly to the intracellular metabolites of the
upper glycolytic pathway). UDPGlcNAc and its sterioisomer UDPGalNAc (not shown
since it is identical in its dynamics) are linked to F6P but showed a totally different time
course. It seems that both metabolite pools performed a nearly inverse dynamic with a
maximum for GMEM-Z medium and a minimum for EpiSerf medium at day three (Fig.
4.3C, D). Note that Ryll et al. [85] found the highest level of these hexosamines at the
end of the growth phase for various other cell lines. Their results are, thus, in line with
the GMEM-Z cultivation but not with the EpiSerf cultivation.
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Figure 4.3.: Dynamics of intermediates of glycogenesis, pentose phosphate path-
way and hexosamine biosynthesis pathway during cultivation of adherently grow-
ing MDCK cells in GMEM-Z and EpiSerf. Uridine diphosphate glucose (A), ribose
5-phosphate (B), and uridine diphosphate N-acetylglucosamine (C) are shown in the color
code of Figure 4.1 (data taken from Ritter [23]). The limit of quantification is shown as
dashed black line. Light gray field between 1 – 2.5 days illustrates the intermediate growth
phase of V C (Table 4.2).
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Citric acid cycle: In MDCK cells, PYR is mainly metabolized to lactate and only
minor amounts enter the citric acid cycle, according to the analysis of fluxes [16] and
of enzyme activities [22]. Therefore, it is not surprising to find no correlations between
metabolite pool dynamics of the citric acid cycle and glycolysis. The most prominent
observation is the peak formation of αKG , SUC, FUM and MAL at about 24 h of culti-
vation (Fig. 4.4A – D). It appears that the peak coincides with the cease of cell volume
growth (end of gray bar). Thus, the drop of metabolite pools may be related to the stop
in GLNx and GLUx uptake. At least in case of the EpiSerf culture, the second drop at
96 h can be explained with the depletion of GLUx. Thus, the intracellular concentrations
of metabolites differ between both media after 96 h of cultivation. Unexpectedly, final
levels of αKG in experiment ◦ and ◦ were generally higher compared to the other exper-
iments. These high levels were not found for other metabolites of both experiments (Fig.
4.4A). SUC showed slightly lower levels for cells grown in EpiSerf, which indicates small
differences among both media (Fig. 4.4B). In the upper part of the citric acid cycle, CIT
and ICIT are highly correlated in their dynamics and showed decreasing concentrations
over time (Fig. 4.4E, F). The concentrations in EpiSerf cultures were initially higher
than that of GMEM-Z cultures. However, with increasing cultivation time CIT and
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Figure 4.4.: Dynamics of citric acid cycle intermediates during cultivation of ad-
herently growing MDCK cells in GMEM-Z and EpiSerf. The lower part of the citric
acid cycle with α-ketoglutarate (A), succinate (B), fumarate (C), malate (D) and the upper
part with citrate (E) and isocitrate (F) are shown in the color code of Figure 4.1 (data taken
from Ritter [23]). The limit of quantification is shown as dashed black line. Light gray field
between 1 – 2.5 days illustrates the intermediate growth phase of V C (Table 4.2).
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ICIT of EpiSerf cultures approached the same levels found in GMEM-Z cultures. With
depletion of GLCx in the EpiSerf culture after 72 h, it seems that concentration of both
metabolites dropped again.
Purines: The nucleotides ATP, ADP and AMP showed significant changes in con-
centrations during the time course of cultivations (Fig. 4.5A – C). With the start of
cultivations, concentrations of ATP increased roughly from 2 mmol/L to 4 mmol/L al-
though large experiment-specific differences were observed. Experiment ◦, for example,
showed the highest ATP levels at initial times of cultivation. For the other cultiva-
tions, however, the ATP level was highest when cells approach the stationary growth
phase. In case of EpiSerf cultures, ATP concentrations dropped slightly after about 96 h
while in GMEM-Z cultivations a minor increase towards later time points was measured.
ADP and AMP concentrations were low in general (0.4 mmol/L; 0.1 mmol/L) with time
courses more or less inverted to the ATP dynamics. Interestingly, neither a constant
behavior of ATP nor a constant sum of adenosine-based nucleotides can be observed
(the change in ATP is much larger than in AMP and ADP). In particular, the difference
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Figure 4.5.: Dynamics of purines during cultivation of adherently growing MDCK
cells in GMEM-Z and EpiSerf. The adenosine-based nucleotides with adenosine triphos-
phate (A), adenosine diphosphate (B), and adenosine monophosphate (C) as well as the
guanosine-based nucleotides with guanosine triphosphate (D), guanosine diphosphate (E) and
guanosine monophosphate (F) are shown in the color code of Figure 4.1 (data taken from
Ritter [23]). The limit of quantification is shown as dashed black line. Light gray field between
1 – 2.5 days illustrates the intermediate growth phase of V C (Table 4.2).
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in ATP levels reach up to 2 mmol/L, which cannot be fully explained with variations
in ADP and AMP. The time series of the guanosines (Fig. 4.5D – F) were very similar
to those of the adenosines but with much lower intracellular concentrations. In case of
GMP (Fig. 4.5F), the concentration was mostly below the quantification limit but with
a trend that might be similar to the AMP dynamics. The description of the pyrimidines
is given elsewhere [295].
4.1.3. Discussion
Ritter [23] seeded MDCK cells from identical GMEM-Z precultures into 6-well plates to
grow either in GMEM-Z or in EpiSerf medium. Thus, cells inoculated in EpiSerf medium
grew without preliminary adaptation and faced substantial differences in the abundance
of substrates and amino acids. In particular, the EpiSerf medium is serum-free. There-
fore, the first aspect considered is to which extent the growth of cells cultivated in EpiSerf
differs from cultivations with GMEM-Z. Next, it is discussed to which extent growth and
substrate supply in both media can be linked to changes in the cellular metabolism and
whether a robust regulation regime is present.
Cell growth and substrate uptake in two different media: In accordance to lit-
erature, we expected the cells to show clear differences in their growth behavior
[4, 78, 168, 296], e.g. in lag phase, in specific growth rate or in time point of growth lim-
itation by substrates or inhibitors with largely unknown effects on intracellular metabo-
lite pool dynamics. Interestingly, however, the general growth behavior is very similar
in both media. Minor differences are found in a slightly extended delay in cell num-
ber increase (about 6 h) and in a higher final cell volume of EpiSerf cultures, which
may be attributed to differences in the osmolality (EpiSerf: 375 mOsm/kg; GMEM-Z:
320 mOsm/kg, measured by the group of Y. Genzel, Bioprocess Engineering Group, MPI
Magdeburg, Germany) and missing factors for cell attachment in the serum-free EpiSerf
medium. Also, the uptake of substrates appears to be qualitatively and quantitatively
similar (Table 4.1), at least until GLCx depletion occurs in the EpiSerf medium. In
conclusion, a reduced cellular uptake or a more efficient breakdown of GLCx, which is
reported as Crabtree effect for many other cells [82, 87, 92, 95], is not observed in our
data, although concentrations of substrates are far different. Therefore, the influence
of the medium on cell growth and uptake rates is rather small, as long as substrate
concentrations are not at limiting levels (< 0.2 mmol/L [51, 87]). However, an effect on
intracellular metabolite pools can be expected at later stages of cultivation where either
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GLCx or GLUx drop to very low levels.
Response of glycolysis to growth and media: Major amounts of G6P are con-
verted in glycogenesis, the PPP and glycolysis to UDPGlc, R5P and F6P, respectively.
Whilst these metabolites show fundamental changes in their pool size over time, differ-
ences between GMEM-Z and EpiSerf cultures are surprisingly small. All metabolites
show a strongly correlated dynamic even though the involved enzyme-mediated reac-
tions have different requirements for cofactors. A concerted regulation of these enzymes
through cofactors, such as ATP or NADP, appears therefore unlikely. The peak-like re-
sponse in several metabolites is, thus, rather a result of a reduction in the overall enzyme
level or of rate limiting reactions, such as the HK or the GLUT facilitated transport,
which is suggested for cancer cells by Rodr´ıguez-Enr´ıquez et al. [133]. For example, if
none of the enzymes involved in G6P conversion are saturated or inhibited in their cat-
alytic activity an increase in G6P levels should increase the production rate of UDPGlc,
R5P and F6P. A rate limiting GLUT or HK may then exert flux control over this part of
the network. Comparison of rGLCx (Table 4.1) with in vitro measured enzyme activities
(e.g. of G6PDH and GPI, [22]) indicates a very high remaining capacity for G6P conver-
sion and, thus, enzymes downstream of HK are presumably not rate limiting (and also
not flux controlling). In line with this hypothesis, we recognized slightly lower GLCx
uptake rates in EpiSerf medium (Table 4.1) and found slightly lower metabolite pools
in upper glycolysis and associated pathways, which also points towards a rate limiting
GLUT or HK. Such a correlation between metabolite levels and fluxes, at least in the
upper part of glycolysis, is also described by Munger et al. [297]. Taking into account
that intracellular amounts of GLC were always below the detection limit, similarly de-
scribed for other cell lines by Renner et al. [95] and Schmid and Blanch [91], renders the
HK to be very active and the GLUT as rate limiting step. However, changes in intra-
cellular metabolite levels can also be explained with concerted changes in the enzyme
level. Nonetheless, the medium has only little influence and a rate limiting GLUT may
represent a starting point for modeling. Interestingly, the strong influence of GLUT on
the glycolytic activity was already shown for tumor cells [107, 108, 298]. In yeast cells,
the GLUT transport is identified as a major effector of dynamics in glycolysis [102].
In the lower part of glycolysis, where the hexoses are split into trioses, the general pic-
ture of the metabolite dynamics is not as clear. The first measured component 3PG
shows a broader peak than metabolites of upper glycolysis but is apparently decoupled
from PEP dynamics (especially for GMEM-Z). It is established that F16BP is a po-
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tent allosteric activator of the PK [142, 143]. Therefore, one explanation is that the
decrease in F16BP reduces the PK activity and leads to higher PEP levels, which occurs
in both media. Another explanation for differences in the PEP dynamics may lie in
the linkage to the serine and glycine production, which can be responsible for medium-
specific differences (a peak for PEP can be anticipated in the larger variations found
for the EpiSerf cultures). A more pronounced medium-specific difference was observed
for PYR, which started initially high in the EpiSerf culture and afterwards decreased to
levels of the GMEM-Z culture. Amino acids such as alanine, glycine, serine and threo-
nine are typically involved in the production or degradation of PYR in MDCK cells [15].
The conversion of these amino acids to cytosolic PYR, which results in the production
of NHx4, may take place in the stationary growth phase of EpiSerf cultures when other
substrates such as GLCx and GLUx were already depleted, and GLNx was not taken up.
Furthermore, providing an alternative source for intracellular PYR allows sustaining the
glycolytic intermediates in the EpiSerf cultures under depletion of extracellular GLCx.
Therefore, in these cultures, the flux through glycolysis towards PYR may be compar-
atively low in the stationary growth phase, and even gluconeogenesis seems possible.
Finally, also the hexosamines UDPGlcNAc and UDPGalNAc showed an inverse behav-
ior in EpiSerf medium compared to GMEM-Z. However, almost no correlation was found
with time series of other metabolites especially not to glycolytic intermediates, which
is in agreement with observations of Barnabe´ and Butler [78]. Nonetheless, main parts
of the glycolytic pathway as well as glycogenesis and the PPP show a similar behavior
in both cultures. Differences in the lower glycolysis may be linked to differences in the
amino acid metabolism, which may change with the media. Overall, it seems reasonable
to assume that intracellular metabolite pools are mainly regulated by the GLUT activity
and by an feed-forward activation of the PK by F16BP.
Two different parts of the citric acid cycle: The citric acid cycle is fed by
anaplerotic reactions from the precursors GLN and PYR, which are produced by glu-
taminolysis and glycolysis with about 0.3 mmol/L/min and 3.0 mmol/L/min, respec-
tively (Table 4.1). This large difference in glucose and glutamine conversion is a common
feature of cancer cells [50, 58], hybridoma cells [104], BHK cells [86], and AGE1.HN cells
[168]. Although PYR might be the main precursor for fueling the upper citric acid cycle
in normal cells, the enzyme that is involved in this step (PDH) shows only an activity
of 0.1 mmol/L/min in MDCK cells ([22], assuming a cell-specific volume of 3×10−12 L),
and can limit the transfer speed, which is a phenomenon described by Warburg et al.
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[56]. Moreover, a glucose-specific lactate yield coefficient above two was found, similarly
reported by Genzel et al. [299] for MDCK cells in GMEM-Z, indicating that only low
amounts of PYR are transferred to the citric acid cycle. Accordingly, we assume that
fluxes in both parts of the citric acid cycle are relatively low compared to glycolysis and
mainly fed from GLN, which agrees with the analysis of Sidorenko et al. [16].
In the lower part of the citric acid cycle, we again observed concerted changes in metabo-
lite pools, which on the one hand excludes an influence by the medium and on the other
points towards a robust regulation regime that either controls the transport steps or the
enzyme level. Accordingly, we speculate that the observed peak behavior in αKG, SUC,
FUM and MAL is linked to changes in GLNx and especially in GLUx consumption.
The increase in metabolite pools started with beginning of GLUx uptake (beginning of
gray field), while depletion of GLUx coincided with low intracellular metabolite pools.
Interestingly, the EpiSerf cultures showed a clear drop in FUM and MAL pools with
depletion of GLUx (t > 4 days) that may further support its role as main substrate.
In the stationary growth phase, constant levels of citric acid cycle intermediates were
observed, although GLUx is depleted and GLNx is not taken up by the cell. To maintain
constant levels, the cell may reduce the pathway activity, as the demand for biosynthe-
sis is low, and may engage in the consumption of other substrates to compensate any
cataplerotic effects, which presumably prevents apoptosis induced by depletion of these
intermediates [300]. Either, pyruvate is used to compensate cataplerosis, which seems
counterintuitive considering a lactate yield from glucose above two, or other amino acids
are converted to GLN, which explains the NHx4 release in EpiSerf cultures.
In the upper part, the pools of CIT and ICIT dropped more strongly in the EpiSerf
culture, which might be linked to high PYR levels. However, it is established that ICIT
is also generated from αKG to support lipid synthesis [175, 176]. Being produced from
both pathways, CIT is presumably withdrawn from the mitochondrium such that the
upper and lower part are uncoupled and that the citric acid cycle is truncated, which
explains completely different metabolite dynamics in both parts. In the cytosol, CIT is
transferred into glycolysis and may allow for a glucose-specific lactate yield coefficient
that is above the theoretical maximum of two [121, 150].
The mutual influence of metabolism and purines: For the purines, significant
changes were observed over the time course of cultivation. ATP and GTP, which are
mostly identical in their dynamics, showed a negative correlation to their diphosphatic
and monophosphatic counterparts and a adenosine (or guanosine) conservation seems
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to be a rational explanation. Similar observations where also made for yeast cells after
a GLCx pulse [199, 289, 301]. The dynamics in ATP after inoculating cells in a new
well may represent an interesting analogy to the GLCx pulses in starved yeast cells. In
both cases, the main growth inhibitor is suddenly removed. However, calculations re-
vealed that the increase in ATP concentration is 66 % higher than the decrease in ADP
and AMP. Thus, the total adenosine pool is not constant and apparently influenced by
the purine salvage pathway [197] and by the usage of nucleosides for nucleic acid syn-
thesis [302]. Regarding the dynamics in ATP, this raises the question to what extent
the metabolism is subject to adenylate control [195] or whether energy-rich nucleotides
serve as a mediator that adjusts biosynthesis depending on supply reactions [61, 198],
e.g. glycolysis and oxidative phosphorylation. As an example for the first hypothesis,
the PFK as well as the CL enzyme are both assumed to be controlled by the ATP/AMP
ratio, a regulatory mechanism that is comprehensively described by Atkinson and Wal-
ton [194]. In this scenario, low levels in ATP during the growth phase may stimulate
the PFK, which would yield reduced F6P levels but higher F16BP levels. Inspecting our
data reveals a strong correlation in both metabolite pools with a prominent peak during
the cell growth phase. Hence, adenylate control over the PFK may be superimposed
by the large, GLUT-mediated carbon flux through glycolysis with generally elevated
metabolite levels in upper glycolysis. Furthermore, with the depletion of GLCx and
GLUx in the supernatant of EpiSerf cultures and a negligible GLNx uptake the pools of
ATP and GTP decreased slightly. In particular, dynamics of ATP seemed to correlate
with the drop of citric acid cycle intermediates of the lower branch (> 72 h). However,
the remaining citric acid cycle metabolites were not fully consumed to increase the ATP
level and, hence, adenylate control was also not obvious during GLCx and GLUx de-
pletion. Furthermore, a full control by adenosines implies rather constant ATP levels,
which were not observed during during cell growth. Therefore, it appears reasonable to
assume that the importance of biomass growth as well as a cellular response to substrate
depletions may overcome the necessity to maintain a constant nucleotide pool, at least
on the time scale of days. Perhaps adenosines influence the biosynthesis activity but a
strong influence on dynamics in metabolism seems unlikely for MDCK cells, which is an
important observation for the development of a mathematical model.
4.1.4. Summary
By using two very different cultivation media, we expected cells from the same preculture
to show significant changes in their growth behavior and metabolism. Firstly, because
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cells that are passaged in different media adapt their physiology regarding enzyme ac-
tivities and intracellular metabolite pools [33]. Secondly, because limitation in main
substrates may occur at different time points of cultivation, which inevitably influences
cell growth and metabolism. However, apart from minor differences in growth, which
may be attributed to the osmolality or the lack of factors for cell attachment, and a few
changes in metabolite pools, which indicate a slightly changed amino acid metabolism,
the behavior of the cells is quite the same. Obviously, the media of this study provide
sufficient amounts of main substrates such that limitations only occur at late stages of
cultivation. As medium components have only a minor influence on intracellular metabo-
lites, we, thus, anticipate that the metabolism of MDCK cells is robustly regulated by
pathway properties, transport mechanisms or hierarchical processes that allow for a con-
certed change in metabolite pools. In particular, the growth phase-dependent substrate
uptake rates together with few enzyme metabolite interactions may explain most of the
experimental observations. Interestingly, we could neither observe a nucleotide balance
nor a central role of purines for the regulation of central carbon metabolism. To which
extent these hypotheses can cover the measured metabolite pool dynamics and whether
they fit into a consistent picture of the metabolic regulation is part of the model-based
analyzes in the following sections.
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4.2. A segregated model for cell growth
From the observations made in the last chapter, the analysis of intracellular metabo-
lite pools on the background of the cell’s growth status is a line of investigation worth
pursuing. It, however, calls for a model that precisely captures the growth of cells in
number and volume over different phases of cultivation and that explains the uptake
of substrates. Furthermore, a certain simplicity for fast and stable simulation results is
required to enable the coupling with more complex structured models describing intra-
cellular reaction processes. Since such a model has not yet been addressed for growth
of adherent cells (see also section 2.3.1), we developed in section 3.1.1 a segregated
model that can describe the growth of cultivated MDCK cells in diameter and num-
ber. The model assumes that the cell passes from one diameter class to the next with
the concomitant consumption of substrates and release of byproducts (Fig. 4.6). After
reaching the highest diameter class, the cell divides into two daughter cells of equal size.
Growth inhibition can either occur due to limitation in GLCx or due to the cell-volume
dependent growth inhibition (f). Cells that pass the first transition proceed without
this limitation. Note that parts of the segregated cell growth model are taken from our
original research article Rehberg et al. [216]. Copyright of these passages lies with the
Journal of Biotechnology (Elsevier).
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Figure 4.6.: Scheme of segregated cell growth model. Cells proceed through Nc = 5
classes with increasing diameter until they reach dc and divide into two cells with diameter dm.
The transition from the minimum diameter dm to the second class (X1 → X2) is controlled by
the cell volume-dependent growth inhibition factor f .
4.2.1. Relation between cell number, diameter and volume changes
In the following, experimental results of the GMEM-Z cultivations of section 4.1 were
simulated with the model using the initial conditions of Table C.3 and a single set of
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cell growth parameters of Table C.4. In the model simulation, the cell numbers per
well show a lag phase of about 20 h in which cells attach to the growth surface and
start to proliferate (Fig. 4.7A inset). Interestingly, the attachment of cells was found
to be fast, as 50 % of cells were attached after 3 h and 80 % were attached after 6 h
of cultivation, and, thus, constitutes only a small part of the 20 h delay (half of cells
sedimented at: 2.4 h; mean duration of attachment process: 0.8 h; see Appendix A.1).
Consequently, the remaining 17 h are more or less attributed to the cell size increase
until division. According to the model simulations, exponential growth follows the lag
phase with a maximum specific growth rate of µmax = 0.039 h
−1 (Table C.4) until about
45 h of cultivation (Fig. 4.7A). The cell numbers reach their maximum in average after
82 h in the range of 3 × 106 – 4 × 106 per well. The model can take into account that
cultivations with higher final cell numbers show smaller mean cell diameters towards
the end of cultivation (Fig. 4.7B). Another aspect of cell growth is the increase in cell
volume (calculated with Eq. 3.1.8), which reaches similar levels of about 7 µL in all three
experiments (Fig. 4.7C). Note that the cell volume dynamics in the experiments and
in the model simulations show a very reproducible time course. The maximum specific
growth rate of the cell volume is expected to (largely) correspond to that of the cell
number. However, compared to the cell number the growth phases are different (already
described in section 2.1.2), which will be important for later discussions. The increase in
the cell volume starts immediately in the model simulation (5 h) and was also observed
experimentally to start at 6 h of cultivation or even before, which is much earlier than
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Figure 4.7.: MDCK cell growth in six-well plates with GMEM-Z medium. (A) Cell
numbers (inset: first 20 h). (B) Mean cell diameter. (C) Volume of all cells calculated from
the mean cell diameter and the cell number. Data of three independent experiments (∆, 2,◦) were taken from Ritter [23]. Error bars represent mean and standard deviation of three
wells (in case of V C error bars were calculated according to the error propagation law). Lines
represent the corresponding model simulation (parameters of Table 1-2).
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the increase in cell number. The exact delay between cell volume and cell number varies
with cultivation time. Therefore, a summary of the obtained growth phases for Xtot,
V C and bsyn is given in Table 4.2 (for definitions see section 3.1.3). Taken together,
the developed model is in good agreement with both, the time courses of cell numbers
and of the cell volumes (Fig. 4.7A, 4.7C). In particular, it fits the delayed cell number
increase and different final cell numbers using a single parameterization. Measurements
of the mean cell diameters showed an increase from approximately 14 µm to 21 µm at
30 h of cultivation for all experiments (Fig. 4.7B). With onset of growth inhibition (after
30 h), the measured mean cell diameters decreased to their initial values. Preculturing
in T-flasks (Cult1 (∆), Cult2 (2)) and roller bottles (Cult3 (◦)) as well as different du-
rations of the preculture (Cult1 (∆): 6 days, Cult2 (2): 3 days, Cult3 (◦): 4 days) may
have caused the systematic difference in the experimentally found mean cell diameters.
Thus, the dm and dc of the cells division process vary with experiment and preculture
and require estimation for every experiment (Table C.3). The step-like increase of the
mean cell diameter at the end of experiment Cult3 (◦) resulted presumably from an
error during sample preparation (Fig. 4.7B, t > 132 h). The simulations show some
disagreement to the measured mean cell diameter at the beginning of cultivations. The
trajectories increase faster with a slight overshoot at about 12 h. Extending the model
by cell sedimentation and attachment to the well surface may improve the model fit but
Table 4.2.: Calculated growth phases of cell number (Xtot), cell volume (V
C) and relative
biosynthesis activity (bsyn).
Laga Exponential Intermediateb Stationary
phase growth phase growth phase growth phase
Xtot Cult1 ∆ 0 – 18 h 18 – 45 h 45 – 82 h 82 – 200 h
Cult2 2 0 – 18 h 18 – 43 h 43 – 98 h 98 – 200 h
Cult3 ◦ 0 – 18 h 18 – 47 h 47 – 84 h 84 – 200 h
V C Cult1 ∆ 0 – 5 h 5 – 30 h 30 – 56 h 56 – 200 h
Cult2 2 0 – 5 h 5 – 27 h 27 – 59 h 59 – 200 h
Cult3 ◦ 0 – 5 h 5 – 32 h 32 – 58 h 58 – 200 h
bsyn Cult1 ∆ - 0 – 37 h 37 – 76 h 76 – 200 h
Cult2 2 - 0 – 34 h 34 – 86 h 86 – 200 h
Cult3 ◦ - 0 – 39 h 39 – 78 h 78 – 200 h
athe lag phase is the time required for half of the cells to double in Xtot or V
C
bintermediate phase is defined for V C with Eq. 3.1.92; for Xtot with Eq. 3.1.92; for bsyn
with Eq. 3.1.95
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is not considered in this work as differences are small. Nevertheless, the model captures
the maximum mean cell diameter and the decrease of the mean cell diameter towards
constant values in the stationary growth phase.
4.2.2. Extracellular substrate and byproduct dynamics
The most essential substrates for cell growth are GLCx and GLNx. Until 30 h of culti-
vation, the model suggests a fast decrease in both substrates based on an exponentially
increasing demand by the cells (Fig. 4.8A and 4.8B). Between 30 h and 58 h, the con-
sumption of both substrates reduces, which coincides with the intermediate growth phase
in V C (Fig. 4.7C, Table 4.2). After 58 h the consumption of GLCx reaches constantly
low levels and is the demand for cellular maintenance. In contrast, the reduction in
GLNx is fully explained with water evaporation and spontaneous decomposition, which
renders the maintenance metabolism of adherent MDCK cells to be independent from
GLNx. Final concentrations of 11 mmol/L for GLCx and of 0.5 mmol/L for GLNx were
measured and not growth limiting in the model. Another substrate source for the citric
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Figure 4.8.: Concentrations of extracellular substrates and byproducts. Glucose
(A), glutamine (B), glutamate (C), lactate (D) and ammonia (E) during MDCK cell growth
in six-well plate with cell growth medium (GMEM-Z). Data (∆, 2, ◦) and error bars, which
represent mean and standard deviation of three wells, were taken from Ritter [23]. (F) Cell
volume-dependent growth inhibition (f , line) and relative biosynthesis activity (bsyn, dashed
line) of the cells. Data and corresponding model simulations (based on parameters of Table
C.3 and Table C.4) are shown in the color code of Fig. 4.7. Grey dashed lines are the limit of
quantification (LOQ; data below LOQ marked in gray).
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acid cycle is GLUx. In contrast to GLCx and GLNx, the uptake of GLUx is in the
model dependent on a transporter activity that increases when cells are inhibited by f
(Eq. 3.1.13, analyzed in Wetzel [280]). Therefore, GLUx concentrations even increase
slightly due to water evaporation until 30 h of cultivation and then sharply decrease to
very low levels (below LOQ, Fig.4.8C). The model resembles the GLUx data for the
three cultivations with a single parameter value for the transporter activity (Table C.4).
Simulations for LACx show initially low concentrations and an exponential increase due
to the conversion of GLCx (Fig. 4.8C). Between 30 h and 58 h, the formation of LACx
ceases and reaches a final concentration of 52 mmol/L with a lactate yield from glucose
of YLACx/GLCx = 2.14. Experiment Cult3 (◦) shows a LACx accumulation exceeding the
simulation results. In case of NHx4, levels increase until 30 h of cultivation (Fig. 4.8D)
and depend exclusively on the GLNx consumption with a yield of roughly 0.8 molecules
(cf. Fig. 4.8B, E). An additional contribution from GLUx produces a peak in NHx4
release at 48 h that is not observed experimentally and is, therefore, not implemented
in the model. In the stationary growth phase, NHx4 accumulates linearly until the end
of cultivation due to spontaneous decomposition of GLNx and water evaporation. Final
levels of NHx4 reach 2 mmol/L and are below growth limiting levels of about 2.4 mmol/L
reported for MDCK cells by Butler et al. [54]. Thus, cell volume growth depends in the
model simulations almost completely on the cell volume-dependent growth inhibition
factor f , which is also used to control the GLUx uptake. At the beginning of the culti-
vation, f is one and has thus no effect on cell volume growth (Fig. 4.8F). Surprisingly,
growth inhibition starts early at about 30 h and f drops to zero within a day. The rela-
tive biosynthesis rate bsyn (explained in section 3.1.3) follows f although slightly delayed
in time because cells can divide while the cell volume remains constant (Fig. 4.8F), e.g.
a mother cell divides into two daughter cells that immediately stop proliferating.
Overall, the model reflects the growth and metabolite dynamics of all three experiments
with an intermediate phase that fits experimental observations. Experiment-specific dif-
ferences are explained with variations in the initial conditions and experiment-specific
parameters (Table C.3). Key growth parameters and metabolic parameters for adherent
MDCK cells are within the range reported in literature (Table 4.3).
4.2.3. Substrate uptake rates during cell cultivation
In principle, uptake rates of cell growth models are based on causal relationships that
hold for the entire course of cultivation and are, thus, more consistent and more pre-
cise compared to the polynomial regression analysis of Table 4.1 (section 4.1.1). The
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Table 4.3.: Estimated parameters of adherent MDCK cell growth model compared to values
given in literature
Parameter Our model Literaturea Unit
µmax 0.039 0.029− 0.082 1/h
YX/GLCx
b (1.23− 1.43)× 10−8 (1.11− 2.00)× 10−8 mmol/cell
YX/GLNx
b (0.93− 1.08)× 10−8 (0.61− 1.81)× 10−9 mmol/cell
mGLCx
c (0.69− 1.69)× 10−10 (0.02− 2.18)× 10−10 mmol/cell/h
mGLNx
c ≈ 0 (0.02− 1.13)× 10−10 mmol/cell/h
aGlacken et al. [41], Butler et al. [54], Mo¨hler et al. [211], Bock et al. [212]
binterval results from multiplication of the optimal value with medium volume for all time points
and cultivations
cinterval results from multiplication of the optimal value with cell volume and medium volume and division
by cell number for all time points and cultivations
derived cell-volume-specific uptake rates are main inputs to the structured model of
central carbon metabolism and derived from a model that fits data for growth, interme-
diate and stationary phases. The cell-volume-specific uptake rates of GLCx and GLNx
(rGLUT and rGLNT , respectively) are highest at the beginning of cultivation with ap-
proximately 5.8 mmol/L/min for GLCx and 0.3 mmol/L/min for GLNx (Fig. 4.9A – B).
Afterwards, a two step decrease follows: technically, the first decrease is a result of an
increasing cell-specific volume under a constant substrate uptake (cf. Eq. 3.1.12), which
reaches a plateau at 24 h that represents the actual consumption for growth with about
3.5 mmol/L/min for GLCx and 0.2 mmol/L/min for GLNx; the second decrease results
from the cell volume-dependent growth inhibition f and ends in cellular maintenance,
which requires about 0.7 mmol/L/min of GLCx and no GLNx. In contrast to GLCx and
GLNx, the uptake of GLUx (rGLT ) occurs only when cells are inhibited by f and drops as
soon as the pool is depleted (Fig. 4.9C). In consequence, the corresponding cell-volume-
specific uptake rate of GLUx has a peak-like shape. Its maximum can reach similar
values than the uptake rate for GLNx. Some biotechnological studies use cell-specific
substrate uptake rates to compare cell lines, which are also shown in Fig. 4.9D – F.
Main features of the above described cell-volume-specific uptake rates are also observed
for the cell-number-specific ones, i.e.: high uptake of GLCx and GLNx during growth,
low or zero uptake of GLCx and GLNx during cell maintenance, and a peak-like uptake
of GLUx. Differences to the cell-volume-specific rates are the lack of the first, artificial
decrease and smaller experiment-specific variations.
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Figure 4.9.: Simulated substrate uptake rates during MDCK cell cultivation. Simu-
lated cell-volume-specific uptake rates of glucose (A), glutamine (B) and glutamate (C). Sim-
ulated cell-number-specific uptake of glucose (D), glutamine (E) and glutamate (F). Model
simulations (based on parameters of Table C.3 and Table C.4) are shown in the color code of
Fig. 4.7.
4.2.4. Discussion
Model structure and possible modifications: We developed a model that accounts
for different cell classes with varying cell diameters. The propagation through the classes
depends on the density of cells on the attachment surface and the extracellular glucose
concentration. However, none of the measured substrates or byproducts reached growth-
limiting concentrations. Ammonia, for example, most likely does not inhibit MDCK cell
growth below concentrations of 2.3 mmol/L [54] while GLCx and GLNx are available
in sufficient amounts. The kmGLCx parameter of the Monod kinetic, which describes the
influence of the glucose concentration on the specific growth rate, has a very low relative
local sensitivity (Table C.4). Thus, the cell density is the major effector of growth
under the cultivation conditions considered in this work. The underlying equation for
f (Eq. 3.1.4) is based on an exponential function originally proposed by Frame and
Hu [278] and allows the model to fit the experimental data. It relies on the adjustable
parameter s, which is estimated with a large confidence interval (2.14 < s < 4.15) and
low relative local sensitivity (Table C.4). A linear term for f , as proposed by Mo¨hler
et al. [211], results in a too slow transition from zero to maximum growth inhibition
and was not able to describe our data (simulation not shown). Although the proposed
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model is focused on adherently growing cells, which show a distinct growth inhibition
by cell volume density, an application of the model to other adherent cells (MDBK cells,
tested with data from IDT Biologika GmbH, results not shown) and even suspension
cells seems possible (AGE1.HN cells, tested with data of Rath et al. [283] in Klassen
[303]; MDCK.SUS cells, see appendix A.3). Note that the variable f might alternatively
be, for example, a function of a metabolite, of another resource or of a limiting factor and
can be applied to any of the N c classes. Therefore, the model is a promising candidate
for future applications considering growth dynamics of cultivated cells. Dynamics for
cell attachment were not explicitly incorporated in the model but may be of interest
if cell growth and metabolite uptake during the first hours of cultivation are under
investigation [212]. However, the resulting delay of 3 h due to cell sedimentation and
attachment (see appendix A.1) has only little influence on the simulation results and is
partly covered by the intrinsic delay of 5 h for cell volume growth (see Table 4.2). The
chosen number of classes N c = 5 affects in combination with µ the delay between cell
volume increase and cell number increase (for explanation see mathematical analysis
provided by D. Flockerzi [216]). However, the dimension N c of the model can be used to
generate a set of nested models. All N c > 1 dimensional models capture the qualitative
behavior observed during cell growth. Considering the parameters of Table C.3 and C.4,
the inspection of the model results suggests the use of low numbers for N c. Low numbers
for N c yield a sufficient strong distribution in the growth rate of cells and, therefore,
introduce some heterogeneity. With high values for N c, cell growth becomes more and
more synchronized leading to a step-like increase in cell number, which is not observed
experimentally. Furthermore, N c determines also a fraction of the growth cycle that
is affected by f (Fig. 4.6). This has the following biological implication: Once cells
have passed the first transition the subsequent growth process remains unaffected by
cell volume density. Overall, model fits to the experimental data yielded N c = 5 as best
solution.
Metabolic parameters and uptake rates: the estimated parameters for MDCK cell
growth are within the range published in literature. The cell-growth-specific yield co-
efficients YX/GLCx and YX/GLNx as well as the specific GLC
x uptake for maintenance
mGLCx , for example, mirror values for MDCK cells grown in bioreactor systems (Table
4.3). The specific GLNx uptake for maintenance mGLNx , is very small and therefore
negligible. In particular, the drop in GLNx in the stationary growth phase can be fully
explained with spontaneous decomposition and water evaporation [23, 53]. Results ob-
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tained in bioreactor cultivations show higher mGLNx , which can result from residual cell
growth to compensate cell death by shear forces and other stressful conditions. However,
a very small mGLNx suggests that glutamine is only required during cell growth as it is
typically used for biosynthesis purposes [50, 87]. The YLACx/GLCx is found to be high
with 2.14. This may indicate, as discussed in the previous section 4.1.3, that GLCx is
primarily converted to LACx [16] and that glutaminolysis, which relies on GLNx and
GLUx [58], increases the YLACx/GLCx to values above 2. Overall, taking into account that
simulations are based on a single set of parameters for all three cultivations, the model
is in good agreement with the measured metabolite dynamics and is capable to predict
each of the three cultivation processes if the other two are used for validation (shown in
Rehberg et al. [216]). Furthermore, the applied bootstrap method yields narrow confi-
dence intervals for most of the parameters (Table C.4), which indicates identifiability.
For the uptake of GLUx, we defined a transport kinetic that is activated by f , which
may appear atypical for standard growth models. However, it is also recognized by Gen-
zel et al. [14] that GLUx uptake starts with growth inhibition. Together with the good
fitting of the measured data, a kinetic that is inhibited by cell growth seems justified.
Assuming that the transport is indeed inhibited by growth in turn validates the shape f
with measurements for GLUx. However, the model also takes into account the release of
NHx4 from the conversion of GLN
x. Based on the high transaminase activities in MDCK
cells [22], which is also observed by Gstraunthaler et al. [170], and the accumulation
dynamics of NHx4 a contribution from GLU
x is presumably negligible.
Dynamics in cell growth: The model estimates a doubling time of 17.7 h (µmax =
0.039 h−1), which lies within the interval reported in literature [41, 54, 211, 212]. Note
that differences in the doubling time, e.g. to the 24 h reported by Butler et al. [54], may
result from differences in the cultivation conditions compared to 6-well plates, which have
low shear stress and no risk of cell disruption by bubble bursting. Direct determinations
of µmax by logarithmic transformation for the exponential growth phase showed a similar
average value of 17.3 h (µmax = 0.040 h
−1, section 4.1.1). Based on the model, 80 % of
cells are already inhibited by f within the regression interval chosen for the experimental
determination of µmax by Ritter [23] (20 h to 52 h). Nonetheless, the µmax determined
by regression analysis corresponds to the model-based estimation since the cell number
is delayed and shows growth inhibition later than the cell volume. Before increase in cell
number starts, a lag phase of roughly 20 h was observed, which is similarly described for
MDCK cells in microcarrier cultivations [211], and presumably involves about 2.4 h for
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sedimentation and 0.8 h for cell attachment (see Appendix A.1). Thus, about 17 h of
the 20 h remain left for cell size increase and division, which corresponds to the 17.7 h
estimated above. Nielsen et al. [42] developed a mathematical model that accounts for a
time difference between the start of cell volume and cell number growth by using delay
differential equations. In our data, however, the time shift between the growth phases of
Xtot and V
C is not constant (cf. Table 4.2). The intermediate growth phase starts 15 h
earlier and the stationary growth phase starts 30 h earlier for cell volume growth than
for cell number growth. Thus, differences in growth phases may not be caused by a fixed
delay and the dependencies may be time varying in a more general sense. Although a
delay model, which requires the same number of parameters, yields seemingly similar
fits (akaike information criterion evaluted in [216]: Rehberg model: 6.47× 103; Nielsen
model: 6.59 × 103), we prefer a finite (N c) dimensional model. Another benefit lies in
a much faster computation time (four magnitudes), which not only allows for a reliable
and comprehensive parameter study but also for coupling with more complex structured
models of metabolism. Moreover, it can take into account general class-specific effects,
as shown by the implementation of f . In this regard, the proposed model has a better
transferability and generality to incorporate diameter changes during cell growth.
Diameter changes during cultivation: To simulate the mean cell diameter during
cultivation, we assume that all cells exhibit an identical linear increase from the minimum
(dm) to the critical diameter (dc). Thus, heterogeneity in dm or dc as well as in rtrans is not
considered but is typically observed in mammalian cells [47]. Ramirez and Mutharasan
[45] as well as Boucrot and Kirchhausen [46] found that changes in cell size are correlated
with the propagation through the cell cycle. Furthermore, dm and dc as well as the
intermediate diameters do not change with each generation of cells but rather represent
upper and lower limits. In consequence, the cell-specific volume of class N c is more
than the double of the cell-specific volume of the first class. The model pays indirectly
tribute to a so called cell-sizing effect reported by Tzur et al. [48]. These discrepancies
easily explain differences between model simulation and experimental data, especially
until 12 h of cultivation. Nevertheless, the requirement for simulating mean cell diameter
dynamics with a coarse-grained model is adequately met. It fits the measurements of all
three cultivations and the observations of Rothen-Rutishauser et al. [25] of a decreasing
cell diameter when cells pass into the stationary growth phase. For a more precise and
deeper analysis of cell diameter dynamics, the use of mass distribution population-based
models is an option worth considering [220, 223]. However, the information required
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for such an analysis is currently not available for MDCK cells. Furthermore, to our
knowledge none of the mass distribution population-based models were yet validated for
batch cultivations of adherent cells.
4.2.5. Summary
From analyzing, in a previous section, MDCK cell cultivations in two different media,
we derived the hypothesis of a growth-dependent regulation of intracellular metabolite
pools. To support further investigations in this direction, we developed in this section
a segregated model that describes cell growth in numbers and volume by considering
the mean cell diameter. The model takes into account cell volume-dependent growth
inhibition as well as the consumption of GLCx, GLNx and GLUx for the progression
through different diameter classes. The structure of the developed model is slightly
more complex than conventional cell number-based models since additional information
about the mean cell diameter are considered, which are, however, easily obtained from
cell counting devices. For the three independent MDCK cell cultivations in GMEM-Z
medium, the model successfully fits the experimental data using a single set of parame-
ters. It also considers that cells may differ in their maximum and minimum diameter in
dependence of their preculture. Analysis of the extracellular metabolite pool dynamics
unraveled that substrates are not growth limiting under the chosen cultivation conditions
and that cell growth ceases due to the limited availability of free surface for cell attach-
ment. Furthermore, the model possesses a certain power in predicting cell cultivations
and is applicable to other cell lines and cultivation systems. Therefore, it fills the gap
between standard cell growth models and mass distribution population-based models
with a certain generality and applicability that can support both the understanding of
cell growth and the analysis of biotechnological processes. More importantly for this
work, however, dynamics in cell growth can now be coupled to structured metabolic
models, which facilitates studying the regulation of central carbon metabolism during
cell cultivation.
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4.3. Dynamics in central carbon metabolism
Analysis of MDCK cells indicated that many intracellular metabolite pools show the
same dynamics, although cells are grown in two different media (see section 4.1). We
hypothesized that the dynamics in metabolism depend on the uptake of substrates and
on a few mechanisms for enzyme regulation. In the previous section 4.2, we developed
a segregated model that describes adherent MDCK cell growth in volume and number
and explains the uptake of main substrates. We now seek to evaluate whether the
structured model for the central carbon metabolism, established in section 3.1.2, is able
to explain intracellular metabolite pools when coupled to a segregated cell growth model
(see section 3.1.3). To realize a proper balance between a detailed description of results
and a conclusive discussion, the analysis is divided into two parts: first, we evaluate
the simulation results for glycolysis and the closely related metabolic pathways and,
afterwards, analyze to which extent the derived regulatory principles are also capable
to explain metabolite dynamics in glutaminolysis, which includes the citric acid cycle,
and the energy metabolism. In the following, parts of the structured glycolysis model
published in PLoS Computational Biology [304] (open source) and of the structured
glutaminolysis model published in the IFAC proceedings [305] (copyrights are with the
International Federation of Automation and Control) are used.
4.3.1. Glycolysis
Due to its highly active and robust nature, glycolysis is an ideal candidate pathway to
start evaluating general principles of metabolic regulation. The scenarios considered in
the following sections cover a broad range of operation conditions including cell culti-
vation, substrate limitation and substrate pulse experiments. Afterwards, we estimate
the capacity of the glycolytic pathway to unravel potential targets for the design of
bioprocesses, e.g. higher growth rates or more efficient substrate use, and evaluate the
predictive power of the model based on a cultivation in a second medium. The underly-
ing model focuses on intermediates that were measured experimentally and is composed
of a concise set of enzyme kinetics with few regulatory mechanisms, while taking into
account the link to PPP and glycogenesis. A schematic overview of the considered en-
zyme reactions, metabolite pools and maximum in vitro enzyme activities is given in
Fig. 4.10.
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Figure 4.10.: Scheme of glycolysis model with calculated fluxes. Green boxes repre-
sent metabolite pools that were quantified experimentally, while white ones were not quanti-
fied. Enzymes are shown as ellipses with blue background if the maximum enzyme activity
was measured in vitro and with white background otherwise. Reactions and their directions
are shown as arrows. Dashed arrows represent allosteric regulation of enzymes by metabo-
lites. Colored bars are attached to each reaction and express the relative flux compared
to the largest flux in glycolysis (see legend, blue: cell growth at 24 h of Cult1; green: cell
maintenance at 100 h of Cult1; orange: limitation after 6 min). Absolute flux rates (unit:
mmol/L/min) are given next to the bars. Abbreviations are: GLCx extracellular glucose; GLC
glucose; G6P glucose 6-phosphate; UGLC uridyl diphosphate glucose; R5P ribose 5-phosphate;
PPP pentose phosphate pathway; F6P fructose 6-phosphate; F16BP fructose 1,6-bisphosphate;
3PG 3-phosphoglyceric acid; PEP phosphoenol pyruvate; HK hexokinase; UT UTP-glucose-1-
phosphate uridylyltransferase; G6PDH glucose 6-phosphate dehydrogenase; GPI glucose phos-
phate isomerase; ALD aldolase; ENO enolase; PK pyruvate kinase.
Metabolite pool dynamics and fluxes during cell cultivation: In three indepen-
dent experiments, adherent MDCK cells were grown in 6-well plates with the serum-
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containing medium GMEM-Z. The cells used for inoculation of Cult1 (∆), Cult2 (2)
and Cult3 (◦) originate from a preculture that has reached the stationary growth phase.
According to the findings of previous section 4.2, the medium provides sufficient amounts
of extracellular substrates over the chosen cultivation time and inhibition of cell growth
is mainly induced by the cell density on the surface, which ultimately applies to the
preculture. Assuming that the cells robustly achieve a certain metabolic status in the
stationary growth phase of the preculture allows us to infer the metabolic starting con-
ditions for the cultivation experiments by simulating the conditions at that time point
of preculture (see also section 3.2.1). This simulation of starting conditions allows us
to limit model fitting to 19 unknown parameters (as discussed later). The resulting
metabolic status of the preculture is depicted in the time interval from −20 h to 0 h
(Figure 4.11, Table C.1).
With the onset of cell growth, the simulation of the three experiments exhibits a peak-
like behavior for G6P, F6P and F16BP concentrations that agrees well with the data
for each cultivation (Fig. 4.11A – I). The maximum is reached at around 24 h and fol-
lowed by a decrease during the intermediate biosynthesis phase where the growth rate
of cells reduces, which is indicated by a gray bar (based on bsyn, Eq. (3.1.94), Table
4.2). In the model, the peak results from high cell-volume-specific glucose uptake rates
and low maximum cell-volume-specific enzyme activities. The peak and the subsequent
decrease of the metabolite pools is slightly different among the cultivations, although
all three metabolites drop to the same final level that mostly corresponds to the initial
level at 0 h (Fig. 4.11A – I). Due to the tight coupling of cell growth to glycolysis, the
model considers experiment-specific differences, such as Xtot(t=0) used for inoculation
as well as dm and dc, which have a considerable influence on time point and height of
the peak. Also, small differences in the relative enzyme level (Elevel; Table C.2) affect
the maximum catalytic activity of every enzyme in the model (Eq. 3.1.90 and 3.1.91)
and required estimation during data fitting for every cultivation. The Elevel vary by
±8 % for the three cultivations, which corresponds to the mean standard deviation for
all enzyme activities based on the assay of Janke et al. [22]. Interestingly, cells with the
lowest diameter also had the lowest enzyme level (Table C.2). Besides variations due
to assay noise, the experiment-specific differences in Xtot, d and Elevel explain batch-to-
batch variations such as the lower peak height for Cult1 (∆), a medium peak height for
Cult2 (2) and an increased peak height for Cult3 (◦), which is most prominent for F6P.
An exemplary intracellular flux from glycolysis into associated pathways is shown for
Cult1 in Fig. 4.10. During cell growth the activity of HK (3.28 mmol/L/min) is roughly
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Figure 4.11.: Metabolite pools of glycolysis during adherent MDCK cell cultiva-
tion. Glucose 6-phosphate (A – C), fructose 6-phosphate (D – F), fructose 1,6-bisphosphate
(G – I), 3-phosphoglyceric acid (J – L) and phosphoenolpyruvate (M – O) concentrations in
three independent MDCK cell cultivations (∆, 2, ◦) in 6-well plates and GMEM-Z. Data and
error bars represent mean and standard deviation of three wells and were taken from Ritter
[23]. Dashed lines are the limit of quantification (LOQ; data below LOQ marked in gray).
Lines represent the respective simulation result based on the experiment-specific parameters
in Table C.2 and parameters in Table C.5. The intermediate biosynthesis phase of the cells is
indicated as gray bar for the respective cultivation (bsyn in Table 4.2).
five times higher than during stationary growth (0.7 mmol/L/min). The metabolite flux
into the PPP is primarily mediated by the G6PDH route, which enables a net supply
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Figure 4.12.: Estimated fluxes into pentose phosphate pathway and glycogenesis
during adherent MDCK cell cultivation. (A) Net flux into pentose phosphate pathway
(PPP) relative to glucose transport activity and (B) net flux into glycogenesis relative to
glucose transport activity are simulated for the three cultivations (Cult1 – 3) and shown in the
color code of Fig. 4.11
(rX/PPP ) that reaches 13 – 16 % of the glycolytic flux during cell growth and 0 – 3 % of
the glycolytic flux during cell maintenance (Fig. 4.12A) and fulfills the constraint to
be in the range of 0 % to 40 % (section 3.1.2). During cell growth, the TATK reactions
transfer only a minor portion of PPP metabolites back to glycolysis. However, during
the stationary growth phase the flux through the G6PDH route is completely compen-
sated by the TATK reactions, which transfer all metabolites generated by this route
back to glycolysis. It may indicate that the demand of biosynthesis for PPP metabolites
is low and that GLC is completely converted to PYR. In comparison to the PPP, the
relative net flux branched off from glycolysis for glycogenesis is low and reaches less than
0.1 % during cell growth with an increase to 0.4 % during cell maintenance (Fig. 4.12B).
In the lower part of glycolysis, the level of 3PG follows the peak-like behavior of upper
glycolysis albeit with a two-fold increase in concentration only, which is quite simi-
lar among the three cultivations (Fig. 4.11J – L). The data of Cult1 (∆) have larger
standard deviations and a peak-like behavior is not as obvious as for the other two
cultivations (Cult2 (2), Cult3 (◦)). Assuming that the peak is also present in Cult1
(∆) renders the model to be in general agreement with the 3PG dynamics for all three
cultivations. The data for PEP are below the limit of quantification (LOQ) until 48 h of
cultivation (indicated by gray symbols) but still support the hypothesis of a fast drop at
the beginning of cultivation with a slow but steady increase until the stationary growth
phase begins (Fig. 4.11M – O, 50 – 200 h). Under consideration of these data points,
the model similarly suggests a decrease and increase in PEP levels due to an allosteric
feed-forward activation of PK by F16BP. If data points below the LOQ are neglected,
a straight line would be sufficient to describe the data. In the stationary growth phase,
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the simulation result is slightly above the data points as higher levels of PEP in the
cultivation simulations facilitates a more precise fitting of the perturbation experiments
(see next section). In the model, the lower part of glycolysis shows a four-fold higher
activity during cell growth (5.7 mmol/L/min) compared to the stationary growth phase
(1.39 mmol/L/min).
Response of glycolysis to substrate limitations and a substrate pulse: At dis-
tinct time points of cultivation the medium was replaced by PBS, which removes sub-
strates and byproducts. The model assumes that 3×10−7 L medium (0.008 % of original
medium volume) remain on the cell’s surface and the intercellular space (see section
3.2.2). If no medium remains, an activity of 3.28 mmol/L/min in glycolysis (Fig. 4.10)
would, for example, deplete the G6P pool of 0.06 mmol/L within a second, which is not
the case (Fig. 4.13A).
The intracellular metabolite pools of upper glycolysis, i.e. G6P, F6P and F16BP, show
different starting concentrations in the first (Lim1; Fig. 4.13A, D, G) and the second
limitation experiment (Lim2; Fig. 4.13B, E, H). The model, however, can readily explain
the observed differences in the initial values for Lim1 and Lim2 by assuming that the
cells originate from different time points (t*) of Cult1 (Lim1: 48 h, Lim2: 60 h, see Table
C.2, for explanation see section 3.2.1). Choosing Cult2 or Cult3 as a starting point for
simulation of Lim1 and Lim2 would yield similar results (simulation not shown). Within
one minute, the corresponding metabolite pools drop below the limit of quantification.
Interestingly, traces of F6P and G6P are still detected by the assay, while the pool of
F16BP seems to be empty. According to the model, a flux from PPP to F6P of about
0.013 mmol/L/min is sufficient to maintain the F6P and G6P pool under a reversed
activity of the GPI (Fig. 4.10). However, G6PDH transfers metabolites back to the
PPP and a cycle of metabolite exchange is created that is also described by Sengupta
et al. [62]. The conversion of F6P by PFK is reduced due to a lack of an F6P-mediated
activation and the remaining activity slowly generates 3PG (Fig. 4.10). Overall, we
conclude that the model is in good agreement with experimental data for cells under
glucose limitation, especially for the data above the limit of quantification.
In the lower part of glycolysis, 3PG and PEP remain comparatively constant or even
increase in concentration until reaching a steady state after 3 min (Fig. 4.13J, K, M, N).
In the model, the increase in PEP results from a reduction in the PK activity due to
decreasing F16BP levels (Fig. 4.10). The initial concentration of PEP measured in both
limitation experiments is higher than in the model simulations but also higher than the
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Figure 4.13.: Response of glycolytic metabolite pools to substrate limitations and
a substrate pulse. Glucose 6-phosphate (A – C), fructose 6-phosphate (D – F), fructose 1,6-
bisphosphate (G – I), 3-phosphoglyceric acid (J – L) and phosphoenolpyruvate (M – O) con-
centrations of three independent perturbation experiments with MDCK cells in 6-well plates.
Cells, originating from a cultivation experiment (see Table C.2), were deprived of extracellu-
lar nutrients by removal of medium and addition of phosphate buffered saline (PBS), shown
in the first (Lim1) and second column (Lim2). In a similar experiment, cells were exposed
to a 2 h limitation and afterwards PBS was exchanged by fresh medium, shown in the third
column (Pulse). Data (◦) and error bars represent mean and standard deviation of three
wells and were taken from Ritter [23]. Dashed lines are the limit of quantification (LOQ; data
below LOQ marked in gray). Lines represent the respective simulation result based on the
experiment-specific parameters in Table C.2 and parameters in Table C.5.
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levels found in the cultivation experiment (Fig. 4.11M – O). To improve the fitting of
the Lim1 and Lim2 experiments, the model realized slightly higher final PEP levels in
the cultivation experiments than measured experimentally, which is a common problem
in multi-experiment fitting that may indicate data inconsistencies. The simulation of
3PG showed a negative peak at 1 min of glucose limitation, which may also be present
in the data although to a lesser extent.
The pulse experiment followed a limitation experiment conducted at 32 h of Cult1 (not
shown). After two hours of limitation PBS was replaced with fresh medium, which pro-
vided the cells with glucose and other substrates. The model suggests that glycolysis
almost immediately starts with the conversion of GLC to PYR (1.4 s until PK activ-
ity is 5 % of full operation) and returns to the cell status of Cult1 at 32 h. After one
to two minutes, the metabolite pools reach the corresponding metabolic steady state
(Fig. 4.13C, F, I, L, O). Such a fast increase in several glycolytic intermediates was
also observed for tumor ascites [94]. As a result, the dynamic is mirroring the limita-
tion experiment with increasing metabolite levels in upper glycolysis (Fig. 4.13C, F, I)
and a decreasing PEP pool (Fig. 4.13O) due to the feed-forward activation of PK by
F16BP. However, the slight, continuous increase measured for G6P and F6P pools is not
reflected by the model and also the simulated dynamics in 3PG, which remains more
or less constant in the simulation with a small drop at 0.5 min, is somewhat different
compared to the experimental data (Fig. 4.13L). However, the model simulation simply
returns to the metabolic status that was present in Cult1 at 32 h of cultivation, which
fits most of the data of the pulse experiment.
In silico modulation of GLUT activity: Up to this point, our model suggests that
the GLUT controls the glycolytic activity during cell cultivation in GMEM-Z, which we
exploit to assess the capacity of glycolysis. Modulation of the GLUT is not only recog-
nized as a target for the improvement of production cell lines but also as an approach
for cancer treatment with the intention to interfere with the high metabolic activity of
cells, and eventually with tumor growth. For the subsequent analysis of glycolysis by
in silico modulation of the GLUT activity, we chose cells from Cult1 at 24 h of cultiva-
tion. We also consider the impact of the parameter uncertainty by using the 2000 model
parameterizations derived from the bootstrap method8 (section 3.3.2). All parameter-
izations are eligible to describe the data. The modulation of the GLUT activity in all
these model parameterizations was chosen to range from 0 – 10 mmol/L/min, which ex-
8excluding the upper and lower 2.5 % of the results leaves a total of 1900 simulations for analysis
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ceeds the typical uptake rates determined for Cult1 (0.7 – 3 mmol/L/min, Fig. 4.9A).
The resulting steady state production rates of ATP and PPP metabolites were sorted in
increasing ATP production rates and are shown in Fig. 4.14. Interestingly, an increase
in GLUT activity until about 4 mmol/L/min enhances the production of ATP and PPP
metabolites, depending on the model parameterization. A further increase in GLUT ac-
tivity to 6 mmol/L/min saturates the PFK (for cells of Cult1 at 24 h). In consequence,
the metabolic flux is directed into the PPP, which further increases the synthesis of
metabolites but impairs the glycolytic ATP production. Note that the increase in PPP
metabolite production results exclusively from an enhanced G6PDH activity, which, in
cooperation with other enzymes, also yields NADPH. As a result, the PPP-based pro-
duction of NAPDH correlates linearly with the PPP metabolite production, which are
both essential for biosynthesis. However, for a GLUT activity above 6 mmol/L/min, the
HK becomes saturated as well and a further increase in GLUT activity is suggested to
yield an accumulation of GLC.
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Figure 4.14.: Impact of in silico GLUT activity changes on energy and precursor
production rates. ATP (A) and pentose phosphate pathway (PPP) metabolite production
rates (B) in 1900 model parameterizations for the status of cells in Cult1 at 24 h. The model
parameterizations were derived from the optimal result of each bootstrap run, which were
also used to infer the parameter confidence intervals of Table C.5. The results were arranged
from minimum to maximum ATP production rates (0.025-quantile to 0.975-quantile) and the
colored bars on the right hand show the respective production rate, respectively; the vertical
black line represents the original GLUT activity of cells of Cult1 at 24 h.
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Predictions for DMEM cultivation: Validating the above made estimations for higher
ATP or PPP metabolite production rates involves a considerable experimental effort,
for instance by overexpression of GLUT or HIF-1 [97, 306] in combination with the
measurement of ATP, NADPH and PPP metabolite production rates. To still evaluate
the predictive power of the developed model, we simulate a cultivation with a second
medium that has low initial GLCx concentrations. This implies that neither initial con-
ditions nor kinetic parameter of the structured glycolysis model were changed. Only the
cell growth model was adjusted to reflect growth of cells in a GLCx-limited culture (fur-
ther information is given in the appendix A.2). Although initial conditions and kinetic
parameter of the structured glycolysis model were not changed, the model resembles the
shortened peaks in the metabolite pools and a transient shift into a limitation scenario
(Fig. 4.15). In particular, the increase in metabolite pools and the time point of the
maximum is correctly predicted. The subsequent decrease in metabolite levels cannot be
attributed to the intermediate growth phase (gray bar) but to the limitation in GLCx.
However, the maximum peak height measured for F6P and F16BP exceeds that of the
model prediction (Fig. 4.15B, C). Both peaks are also higher than those of the Cult1 – 3
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Figure 4.15.: Prediction for glycolytic metabolite pools during cultivation of adher-
ent MDCK cells in DMEM with reduced glucose supplementation (2.5 mmol/L).
Data on glucose 6-phosphate (A), fructose 6-phosphate (B), fructose 1,6-bisphosphate (C),
3-phosphoglyceric acid (D) and phosphoenolpyruvate (E) concentrations (3) are depicted as
mean and standard deviation of three wells and were taken from Ritter [23]. Dashed lines
are the limit of quantification (LOQ; data below LOQ marked in gray). Lines represent the
model prediction based on the modifications of the cell growth model described in the appendix
(section A.2) and the parameters in Table C.2 and Table C.5. The intermediate biosynthesis
phase of the cells is indicated as gray bar for the respective cultivation (bsyn).
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cultivations and may point towards a reduction in the PFK activity. At later times of
cultivation, the levels of G6P, F6P and F16BP are very low, which is similarly predicted
by the model. Interestingly, the model prediction also supports the negative peak of
3PG at 48 h as well as the relatively high final level of PEP (Fig. 4.15D, E).
4.3.2. Pentose phosphate pathway
Apart from glycolysis, G6P can also be converted by G6PDH and enter the PPP such
that it eventually fuels the R5P pool. The use of an additional model parameter for the
RDPK-mediated degradation reaction (Eq. 3.1.44), which represents only one possible
route in the PPP, enables the model to reflect the dynamics of R5P during cell cultivation
(Fig. 4.16A – C). R5P mainly follows the peak-like behavior of G6P (cf. Fig. 4.11A –
C) with similar experiment-specific variations. During the limitation experiments, the
decrease of R5P is delayed in time (Fig. 4.16D, E) but still similar in its shape to G6P (cf.
Fig. 4.13A, B). Although the model cannot render this delay, the shape of the decrease
is reflected. After addition of fresh medium in the pulse experiment (Fig. 4.16F), the
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Figure 4.16.: Ribose 5-phosphate levels during adherent MDCK cell cultivation,
substrate limitations and a substrate pulse. Each single plot illustrates an independent
experiment. (A – C) Cultivation of MDCK cells in 6-well plates and GMEM-Z. (D, E) Sub-
strate limitation. (F) Substrate pulse. Data (∆, 2, ◦, ◦), which are depicted as mean and
standard deviation of three wells, were taken from Ritter [23]. Dashed lines are the limit of
quantification (LOQ; data below LOQ marked in gray). Lines represent the model simulation
based on the parameters in Table C.1, Table C.2 and Table C.5. The intermediate biosynthesis
rate of the cells in (A – C) is indicated as gray bar for the respective cultivation (bsyn in Table
4.2).
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measured level of R5P increases rapidly to values above the LOQ but remains lower than
suggested by the model. In all three cases, the differences between data and simulation
results might by due to specific properties of the PPP, which were not considered by the
model so far (for instance, the high number of reversible reactions, and the linkage of
its intermediates to the biosynthesis machinery).
4.3.3. Glycogenesis
Another route for G6P is its transfer into glycogenesis through UT. Similar to the PPP,
the use of an additional model parameter for a GLYS-mediated degradation reaction
(Eq. 3.1.46), which lumps all possible degradation routes, enables the model to reflect
the dynamics of UGLC during cell cultivation (Fig. 4.17A – C). Note that in contrast
to other intracellular metabolites, UGLC is diluted by cell growth to a visible extent,
which reduces the typical peak-like behavior compared to other metabolites. In other
words, the synthesis and degradation rate for UGLC is such low that cell volume growth
has an influence on its abundance. During substrate limitation and substrate pulse, the
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Figure 4.17.: UDP-glucose levels during adherent cell cultivation, substrate lim-
itations and a substrate pulse. Each single plot illustrates an independent experiment.
(A – C) Cultivation of MDCK cells in 6-well plates and GMEM-Z. (D, E) Substrate limitation.
(F) Substrate pulse. Data (∆, 2, ◦, ◦) are depicted as mean and standard deviation of three
wells and were taken from Ritter [23]. Dashed lines are the limit of quantification (LOQ; data
below LOQ marked in gray). Lines represent the model simulation based on the parameters in
Table C.1, Table C.2 and Table C.5. The intermediate biosynthesis rate of the cells in (A – C)
is indicated as gray bar for the respective cultivation (bsyn in Table 4.2).
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data for UGLC show only a minor decrease and a minor increase, respectively, which is
sufficiently described by the model (Fig. 4.17D – F) and attributed to the low pathway
activity (Fig. 4.10).
4.3.4. Sensitivity analysis for glycolysis
To assess how the model behavior depends on the different model parameters and initial
conditions, we performed a relative local sensitivity analysis by perturbing each param-
eter by 1 %. In particular, we analyzed parameters of the structured model of glycolysis
(Table C.5), parameters of the segregated cell growth model (Table C.4) and initial
conditions regarding culture condition, the growth status, and the metabolic status (Ta-
ble C.2, Fig. 4.18A). The subsequent interpretation of the sensitivity analysis is based
on the height of values relative to each other and not on absolute numbers. For the
cultivation experiments, the model simulations are sensitive to growth and metabolic
parameters but mostly insensitive to the initial metabolic status or initial culture con-
ditions (for perturbations of 1 %). Also, the initial growth status has a certain influence
on the simulation trajectories. The surprisingly low influence of the initial metabolic
status on the metabolite pool dynamics can be explained with a high glycolytic activity
and low metabolite pool sizes. Thus, any initial metabolic status is easily adjusted by
the high flux rates. The reason for a low sensitivity regarding initial culture conditions
is that a perturbation of 1 % is insuifficient for obtaining substrate levels that limit cell
growth or metabolism (see section 4.1). However, when it comes to the simulation of
substrate perturbation experiments, the model behavior becomes sensitive to perturba-
tions in the initial metabolic and growth status of the cells. Therefore, the preculture
of cells affects the Lim1 and Lim2 experiment (Fig. 4.13). The growth parameters
have, by definition, no influence on the model behavior. In contrast, parameters of the
metabolic network rearrange the flux distribution towards a new steady state and, thus,
also have a larger influence. Taken together, the sensitivity analysis illustrates that the
sensitivity of glycolysis shifts with the experimental scenario. An in-depth analysis of
glycolysis parameters reveals that the PFK has the largest influence on metabolite pool
degradation (Fig. 4.18B). However, a certain sensitivity is also given for the remaining
parameters, while parameter correlations are in general low (Fig. A.6), which together
indicates parameter identifiability. The few exeptions of HK, TATK and GLUT are
discussed in section 3.1.2.
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Figure 4.18.: Parameter sensitivity analysis of the structured model of glycolysis.
(A) Relative local sensitivity of model simulations (for cultivation and perturbation experi-
ments) to a 1 % perturbation in glycolysis parameters (Table C.5), parameters of the segregated
cell growth model (Table C.4), culture conditions, growth status and metabolic status (Table
C.2). (B) Relative local sensitivity of model simulations (for cultivation and perturbation
experiments) to a 1 % perturbation of single glycolysis parameter.
4.3.5. Discussion part I
Glycolysis model structure: In this work, a kinetic description of glycolysis is devel-
oped that, coupled to a segregated cell growth model, enables describing and analyzing
roughly 600 intracellular metabolite pool data points of Ritter [23] by using a single
set of parameters for the enzyme kinetics. The description of dynamics in metabolite
conversion can, however, rely on many different types of enzyme kinetics with arbitrary
complexity [257, 260]. As a starting point and for simplicity, the model considers basic
kinetics which only take into account basic regulatory mechanisms of glycolytic enzymes
to reflect the dynamics of metabolite pools found during cultivation and perturbation
experiments. In particular, the kinetics for TATK as well as for ENO represent lumped
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reactions and were realized with reversible mass-action kinetics instead of using more
complex kinetics (e.g. Monod-Wyman-Changeaux models [262]). The enzymes HK,
GPI, G6PDH, UT, and ALD as well as the GLUT were defined as Michaelis-Menten
kinetics, as they provide an upper activity bound that was measured in vitro by Janke
et al. [22] (except for GLUT), and appear either as reversible or irreversible reaction.
In analogy to mass action kinetics, only one or two parameters of the Michaelis-Menten
kinetics required estimation. Only the PFK and PK, which are known to be strongly
regulated enzymes, were considered to be influenced by allosteric effectors. For the
PFK, a Hill-Kinetic with four subunits [234, 284], which takes a direct activation by
F6P [12] and an indirect activation via F26BP into account [58, 135], was sufficient to
fit all data. For the PK, the well-known F16BP-mediated activation [69, 143] was used.
However, the chosen simplifications in enzyme kinetics render the used parameters to be
more abstract, such that, for example, the affinity of an enzyme for its substrate rather
represents a time invariant sum of influences than an explicit dependence on cofactors,
ions or the degree of phosphorylation [65]. The benefit lies in obtaining a comparatively
simple model that describes the experimental data with enzyme kinetics comprising only
19 unmeasured parameters (Table C.5). Thus, the resulting model features the identi-
fication of mechanisms that are involved in certain dynamics through an efficient and
reliable estimation of parameters and a comprehensive model analysis. Furthermore,
extension by additional reaction mechanisms is relatively easy in case further experi-
mental data is available or other cellular functions are of interest, e.g. the response of
primary metabolism to osmotic stress [160], and hypoxia [307] or its influence on the gly-
cosylation of proteins [308]. Note that other models of glycolysis that take into account
further, unmeasured metabolites or more complex enzyme reactions than used here may
equally well describe the dynamics of the intracellular metabolite pools of this study.
Model coupling and simulation: The derived kinetic description of glycolysis con-
siders data of three independent cell cultivation experiments, two limitation experiments
and one pulse experiment and, therefore, required coupling to a model that takes explic-
itly into account the process of cell growth. Because of the many different experimental
settings (6 experiments), simulations would normally require a large set of initial con-
ditions about the cell status, which comprises the metabolic status (6×8 degrees of
freedom) and growth status (6×7 degrees of freedom), and culture conditions (6×7 de-
grees of freedom) as listed in Table C.1 and Table C.2. Considering that the perturbation
experiments were performed at a certain time point of cultivation and that cultivations
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in turn were inoculated with cells from a defined preculture introduces a dependency of
the cell status on the cultivation history. Accordingly, we transfer the required informa-
tion from one simulation to another (Fig. 3.2 of section 3.2.1). First, the intracellular
metabolite levels of the preculture were derived from a steady state simulation and, thus,
depend only on the intrinsic pathway properties and the growth status. Second, the cul-
tivations Cult1 – 3 provide the cell status for the limitation experiments, which in turn
deliver the cell status for the pulse experiments. This modeling scheme not only reduced
the number of kinetic parameters but also the total number of initial conditions that
require estimation. Thus, modeling only involves a total of 21 degrees of freedom (not
considering the parameters used in the segregated cell growth model and the structured
model of glutaminolysis). In addition, using a certain cell cultivation history not only
eliminates the search for adequate initial conditions but also supports consistent data
simulation and can be used to evaluate biological variations [309]. However, inconsistent
data sets or an unknown cell status (e.g. cell status different to those of Cult1 – 3) may
pose a serious challenge for model fitting. For such scenarios, the individual selection
or fitting of initial conditions might be a better option. In this work, however, the
estimation of two experiment-specific parameters, which are the Elevel for the respec-
tive cultivation and t∗ as starting point for the perturbation experiments, as well as a
consistent consideration of all data sets outweighed a perfect data fitting and greatly
supported our systems-level analysis of glycolysis.
Enzymes control glycolysis during substrate limitation: The simulation of the
limitation experiments was started with a growth status and a metabolic status that
corresponded to a time point t∗ of the Cult1 experiment. The selection of different time
points t∗ readily explains variations in the initial concentration of intracellular metabo-
lite pools that were found between the Lim1 and Lim2 experiment. The actual limitation
was induced in the simulations by reducing the medium volume to 3× 10−7 L, which is
estimated as liquid volume that remains on the cellular surface or in the intercellular
space. In comparison, the volume of all cells is roughly 6 × 10−6 L. In principle, a
dilution of the remaining medium with PBS can be realized by choosing lower GLCx
concentrations and a higher medium volume (V M). The affinity of GLUT for GLCx
(kmGLUT ) was found to have a large confidence interval (Table C.5) and, hence, lower
concentrations of GLCx under a higher V M are likewise possible.
The consideration of preculture conditions and of a remaining medium volume enables
the model to reflect the data measured for the limitation experiments. It suggests that
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with the limitation of glycolysis in substrates, the feed-forward regulations of PFK and
PK stop the metabolite pool degradation, while the TATK reactions partially reverse
and fuel glycolysis with 0.03 mmol/L/min, which leads to a new steady state within
minutes. Thus, the control of the glycolytic activity shifts from the growth regime that
regulates the GLUT activity (see next part of discussion) towards an inherent regula-
tion of enzymes by substrates and products in the glycolytic pathway, which is further
supported by the sensitivity analysis. Without the implementations for the TATK reac-
tions, the remaining glycolytic activity eventually depletes the metabolite pools unless
fueled from sources other than GLC. As the limitation applies to all possible extracellular
substrates, the use of intracellular carbon sources from PPP, glycogenolysis or gluconeo-
genesis seems likely. The PPP shares already three metabolites with glycolysis (G6P,
F6P, and GAP) which are most likely not depleted during the limitation experiments
and may pose the most promising and simplest option among the aforementioned intra-
cellular carbon sources. Also, the late decrease in R5P during the limitation experiment
and its lower level during the pulse experiment may support a scenario in which the
PPP fuels glycolysis under substrate limitation and, thus, can have a large influence on
glycolytic intermediates, which is similarly found for hepatoma cells [73]. In turn, after
addition of fresh medium, the PPP metabolite pools may be replenished by glycolysis
and we hypothesize a certain buffering capacity of the PPP as it is composed of many
reversible reactions and intermediates that participate in the biosynthesis machinery.
In the model, the implemented reversible mass action kinetics allow for such a switch
from metabolite consumption to metabolite production by the PPP under the lack of
alternative sources for glycolysis. However, the flux rates as well as the parameters of
the PPP cannot be uniquely identified on the basis of our experimental data (Table
C.5). Therefore, we have used the additional constrain that the flux from the PPP into
glycolysis is low (section 3.1.2). Although the implemented mechanisms may not defi-
nitely be attributed to the PPP, all parameterizations of Table C.5 support the finding
that metabolite pools can be maintained (or increased) under limited substrate avail-
ability. To this end, the model suggests that the allosteric regulation of PFK and PK as
well as the reversibility of GPI and TATK modulate the glycolytic activity in scenarios
characterized by limited substrate availability. This is consistent with findings that flux
control in glycolysis can rely on a combination of many enzymatic steps [73] and can
vary depending on experimental conditions [60]. Counter-intuitively, adenosine-based
nucleotides, which are also considered to control the metabolic activity in general [194],
are constant during our limitation and pulse experiments (appendix Fig. B.1). Similar
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observations were made for yeast and HeLa cells [12, 82]. Therefore, regulation of gly-
colytic enzymes of MDCK cells by adenosine-based nucleotides seems unlikely under the
conditions investigated, which is similarly suggested for rat hepatoma cells by Renner
et al. [95]. Furthermore, an activation of glycolysis by a possibly decreasing ATP/ADP
ratio stands in contrast to the metabolite pool preservation and renders its influence
to be limited (see also discussion section 4.3.11). However, the general purpose of an
enzyme-mediated control of the glycolytic activity through PFK, PK, TATK and GPI
might lie in the prevention of unnecessary dissipation of valuable biomass precursors
and may also guarantee a metabolic status that enables a fast reactivation of glycoly-
sis and other cellular functions when new substrates become available after starvation
conditions (Fig. 4.13C, F, I, L, O).
GLUT controls glycolysis during cell cultivation: Over the full course of culti-
vation cells pass through several growth-phases with varying cell-specific volumes and
glucose uptake rates that strongly influence the metabolite pool dynamics. In addition,
abundance of enzymes, their covalent modifications as well as the level of allosteric reg-
ulators may change over time which can additionally affect metabolite fluxes and pools
[65, 310]. However, to our surprise most of the experimental observations were captured
by the model under a parameterization that simultaneously explained the perturba-
tion experiments. Obviously, other hierarchical control mechanisms besides the growth
regime, for example on the genomic or proteomic level, were not essential for describ-
ing the observed metabolite pool dynamics, which is similarly expected by Schaub and
Reuss [77]. It seems that the used cultivation conditions and media composition are
already tailored to MDCK cells such that an adaptation of the cellular physiology or
an influence of other hierarchical control mechanisms is not necessary. Nevertheless, the
consideration of other levels of hierarchical control, in addition to the growth regime of
this work, may contribute to aspects of the observed dynamics and a greater compli-
ance of the model with the data. However, the enzyme kinetics and the influence by
the growth regime through GLUT are in the following considered as the sole source of
regulatory principles that control glycolysis during MDCK cell cultivation.
First, the peak in the metabolite pools can be explained with a high GLUT-mediated
flux rate in combination with lowered cell-volume-specific enzyme activities, which is
caused by an increase in the mean cell-specific volume. Section 4.1.3 already suggested
a reduction in enzyme activity to be an explanation for the peak in metabolite pools.
However, this effect can only account for smaller metabolite pool changes and, thus,
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the GLUT-mediated flux determines the metabolite pool dynamics to a large extent.
The purpose of high metabolite pools during growth is, presumably, to induce higher
net fluxes into the PPP and other biosynthetic pathways, which is similarly described
by Wu et al. [138] for bovine venular endothelial cells after addition of CIT in order
to inhibit the PFK activity. In another study, activation of GLUT in rat thymus lym-
phocytes with concanavalin A resulted in higher fluxes in glycolysis and into the PPP
[114]. Eventually, higher fluxes into the PPP enable an enhanced nucleotide, macro-
molecule, and lipid synthesis [311], as reviewed by Mazurek et al. [312]. According to
our simulations, the maximum net flux is between 13 % and 15 % of the glycolytic flux,
which is in the range reported for continuously growing mammalian cells in the expo-
nential growth phase [82, 151]. However, a much lower contribution, e.g. 5.8 % and
3.6 %, can be found in the late intermediate growth phase, which corresponds to find-
ings for other transformed mammalian cells [15, 67, 150]. The lower part of glycolysis
is controlled by a feed-forward activation of the PK by F16BP and yields a negative
correlation between PEP and upper glycolysis, similarly observed by Schaub and Reuss
[77]. Therefore, the regulation of enzymes by substrates, products and allosteric effectors
can change concentrations of intracellular metabolite pools, and reorganize the pathway
fluxes, especially under limiting conditions (see previous part of the discussion). How-
ever, during MDCK cell cultivation the control over the glycolytic activity is exerted
by the growth regime through modulation of the GLUT activity. For many mammalian
cells, the GLUT is described as the rate limiting step that can control the glycolytic flux
[95, 102, 108, 313, 314]. Adenosine-based nucleotides are another source of regulation
and reported to play a major role in the control of the glycolytic activity (e.g. HK or
PFK) in rat liver cells [194] or E. coli [59]. According to our observation of MDCK cell
growth in two different media, we already anticipated that the influence of adenosine-
based nucleotides on glycolysis is, however, rather low. Furthermore, neither during cell
growth nor during substrate perturbation the adenosine-based nucleotides contribute in
their role as cofactors to the simulated dynamics (see section 3.1.2). Therefore, we as-
sumed during model construction that the considered glycolytic enzymes are insensitive
against changes in the adenosine-based nucleotide levels, which is also anticipated by
Soboll et al. [200] for rat liver cells.
Snoep and co-workers hypothesized that GLUT controls cell growth [315]. This, how-
ever, raises the question, whether metabolism regulates cell growth or vice versa [21]. In
case of adherent MDCK cell growth with sufficient substrate supply, the growth status
is changed by internal signaling processes that integrate information on the availability
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of free space on the well surface. Eventually, space becomes limiting and cells reduce
the glycolytic activity although high extracellular glucose concentrations are present.
Therefore, we hypothesize that the growth regime of exponentially growing MDCK cells
controls the GLUT activity to realize a higher metabolic activity yielding in turn higher
metabolite pools that meet the energy and precursor demands of the biosynthesis ma-
chinery. On a lower level of regulation, the properties of the involved enzymes shape
metabolism by influencing flux distributions. Under substrate limitation, however, reg-
ulation of enzymes has full control over the glycolytic activity since no GLCx is available
for the GLUT-mediated uptake (see previous discussion ”Glycolytic activity during cell
cultivation”). Thus, the model considers that the regulation of the glycolytic activity
changes with the status of the cell [21] and sheds light on the regulatory principles that
are essential to simultaneously explain various experimental scenarios. Although regu-
lation of glycolysis can change with the microorganism [59] and the culture condition
[103], we are convinced that the derived principles can be applied to other mammalian
cell lines relevant for production of biologicals, e.g. the AGE1.HN.AAT (see [283, 303]).
Tuning the ATP and biomass precursors generation: Within a GLUT activity
of 0 – 4 mmol/L/min, the model for glycolysis is validated with cultivation, limitation
and pulse experiments. It already shows a good predictive power for an experiment
were MDCK cells were grown in DMEM medium with low GLCx levels, which further
strengthens the confidence in the model structure and its parameterization. Although
the model prediction for the DMEM cultivation would benefit from a lower enzyme
level (Elevel) to describe all maximum peak-heights, it still confirms the close linkage of
GLUT activity and intracellular metabolite dynamics. Based on the finding that the
GLUT modulates the glycolytic activity during cell cultivation (under sufficient substrate
availability) it seemed desirable to explore the maximum capacity of glycolysis and
the corresponding ATP and PPP metabolite production. However, such a maximum
capacity clearly depends on the Elevel and the cell-specific volume (V
C
S ). Therefore,
we exemplary analyzed cells from the Cult1 experiment at 24 h of cultivation with an
actual uptake of 3.3 mmol/L. For these cells, in silico modulation of the GLUT activity
revealed that an uptake of up to 3.8 mmol/L/min can be realized until the glycolytic flux
saturates the PFK capacity, which slightly enhances the ATP production on average to
105 %, and the PPP metabolite and NADPH production to surprising 153 % for cells
of Cult1 at 24 h. According to the model, a further increase in ATP production would
require the simultaneous overexpression of the PFK, which illustrates the difficulty in
100
4.3. Dynamics in central carbon metabolism
fast up-regulation of metabolic activity while keeping a certain balance between ATP
and PPP metabolite production. Note that Janke et al. [22] measured higher maximum
in vitro PFK activities than estimated in this study such that glycolysis of MDCK
cells may have higher capacities than suggested by the model. However, an increased
biomass precursor and ATP production can support higher growth rates as shown for
tumor and yeast cells with up-regulation of the GLUT activity [57, 113]. Furthermore,
Schmidt et al. [198] described a correlation between the growth of tumor cells and the
ATP production rate. Potentially, an increase in the ATP production to 105 % may
not or only slightly support higher growth rates for MDCK cells, especially as they are
described to have a large overproduction in ATP [15, 16]. But due to the importance
of PPP metabolites to pyrimidine production [120, 312] or purine production [302] and
NAPDH to lipid synthesis, we believe that an increase to 153 % positively affects the
growth of cells. A glycolytic activity above 5 mmol/L/min drastically enhances the
production of PPP metabolites (433 %) at the expense of the ATP production (77 %) and
seems to be an interesting scenario for future experiments. However, also the reduction
in the glucose uptake, as done by Liebl et al. [106], poses an interesting strategy to
design a more economic breakdown of glucose [87]. For instance, reducing the GLUT
activity with a concomitant reduction in PFK may yield lower glycolytic activities but
similar biomass precursor production rates. Currently, the reduction of the glucose
uptake by interference with the GLUT is also studied as a potential target for cancer
treatment [57, 112] and may benefit from the use of mathematical models to evaluate
corresponding dynamics in metabolism. Taken together, the model can greatly support
the development of strategies that aim either at a faster or a more efficient cell growth,
and is also an aid in the design of new experiments.
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4.3.6. Glutaminolysis
For glycolysis, we found in the last section that metabolite pool dynamics are to a
large degree determined by the facilitated substrate transmembrane transport into the
cytoplasm and a few key mechanisms for enzyme regulation. The citric acid cycle of glu-
taminolysis is, however, located in the mitochondria, which is a separate compartment,
is much more complex in its network structure and is influenced by the respiratory chain,
ion fluxes and amino acid metabolism. Models for in vitro mitochondria are therefore
enormously complex and cannot yet be validated with in vivo data. The emerging ques-
tion is whether a straight forward realization of regulation mechanisms discovered for
glycolysis is also capable to explain salient features observed for the citric acid cycle or
whether additional aspects need to be considered. As before, modeling covers cell culti-
vation, substrate limitation and substrate pulse experiments and analyzes the predictive
power by simulating a cultivation in a second medium (DMEM). The model structure
(described in section 3.1.2) focuses on intermediates that were measured experimen-
tally and is composed of a concise set of enzyme kinetics with only few, key regulatory
mechanisms. It is coupled to the segregated cell growth model, links glycolysis with
the citric acid cycle through modeling of the pyruvate metabolism, and also takes into
account the conversion of branched chain amino acids. A schematic overview of the
considered enzyme reactions, metabolite pools and maximum in vitro enzyme activities
of glutaminolysis is given in Fig. 4.19.
Metabolite pool dynamics and fluxes during cell cultivation: For the simulation
of the cell cultivation experiments, we already explained that the cells used for inocu-
lation of a new well originate from a preculture that has reached the stationary growth
phase (see section 3.2.1 and section 4.3.1). In consequence, we expect the metabolite
pools at the beginning and at the end of the cultivation experiment to be identical.
However, inspecting the data reveals that metabolite levels of the lower citric acid cycle
are already higher or lower in the first measurement time point (t = 6 h) compared to
the stationary growth phase (t > 76 h, Fig. 4.20). Obviously, a change in the citric
acid cycle activity took place between inoculation and 6 h of cultivation, which can be
attributed to the onset of cell growth. The model suggests a fast drop in αKG and
MAL as well as a fast increase in SUC and FUM short after inoculation (around 0 h,
Fig. 4.20). The reason for the fast change in metabolite pools lies in the GLNx uptake,
which is not existent in the stationary growth phase (Fig. 4.9E) and, therefore, also
not in the preculture. A drop in half of the metabolite pools and a decrease in the
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Figure 4.19.: Scheme of glutaminolysis model with calculated fluxes. Green boxes
represent metabolite pools that were quantified experimentally, while white ones were not
quantified. Enzymes are shown as ellipses with blue background if the maximum enzyme
activity was measured in vitro and with white background otherwise. Reactions and their
directions are shown as arrows. Dashed arrows represent allosteric regulation of enzymes by
metabolites. Colored bars are attached to each reaction and express the relative flux compared
to the largest flux in glutaminolysis (see legend, blue: cell growth at 24 h of Cult1; green: cell
maintenance at 100 h of Cult1; orange: limitation after 6 min). Absolute flux rates (unit:
mmol/L/min) are given next to the bars. Fluxes for LDH: 6.03/1.59/0.06 mmol/L/min. Ab-
breviations are: GLNx extracellular glutamine; GLUx extracellular glutamate; GLU glutamate;
AA other amino acids; αKG α-ketoglutarate; SUC succinate; FUM fumarate; MAL malate;
PYR pyruvate; F16BP fructose 1,6-bisphosphate; LAC lactate; LACx extracellular lactate;
CIT citrate; CAC cis-aconitate; ICIT isocitrate; ATA asparatate/alanine transaminase; AAex
exchange with other amino acids; KDH α-ketoglutarate dehydrogenase; SDH succinate dehy-
drogenase; FMA fumarase; MDH malate dehydrogenase; LDH lactate dehydrogenase; PDH
pyruvate dehydrogenase; CL citrate lyase; ACO aconitase; ICDH isocitrate dehydrogenase.
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Figure 4.20.: Metabolite pools of lower citric acid cycle during adherent MDCK
cell cultivation. α-Ketoglutarate (A – C), succinate (D – F), fumarate (G – I) and malate
(J – L) concentrations in three independent MDCK cell cultivations (∆, 2, ◦) in 6-well plates
and GMEM-Z. Data and error bars represent mean and standard deviation of three wells and
were taken from Ritter [23]. Dashed lines are the limit of quantification (LOQ; data below LOQ
marked in gray). Lines represent the respective simulation result based on the experiment-
specific parameters of Table C.1 and parameters of Table C.6. The intermediate growth phase
of the cells is indicated as gray bar for the respective cultivation (bsyn in Table 4.2). Cells, orig-
inating from a cultivation experiment (see Table C.2) were deprived of extracellular nutrients
by removal of medium and addition of phosphate buffered saline, shown in the first column
(Lim1) and second column (Lim2).
remaining ones indicates two groups of differentially regulated enzymes. However, after
one day of cultivation, all four metabolite pools exhibited a peak-like behavior during
cell cultivation with a maximum around 48 h of cultivation, which is roughly one day
later compared to the peak of glycolytic intermediates. The model suggests the peak to
result from the onset of cell growth inhibition and the accompanying uptake of GLUx
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until depletion. The peak in metabolites is, thus, strongly correlated to the uptake rates
shown in Fig. 4.9F. Differences in peak height and peak width can be observed among
Cult1 – 3 experiments and are largely captured by the model (except for αKG). In the
stationary growth phase, all four metabolite pools are constant although the uptake of
GLNx and GLUx ceases. In the model, degradation of metabolite pools is reduced by
inhibition (or lack of activation) of the enzyme group that converts αKG and MAL,
which are KDH and MDH. The remaining cataplerotic activity in the lower citric acid
cycle is compensated by the consumption of AA, which is representative for any other
amino acid such as the branched chain amino acids leucine, isoleucine and valine.
For the upper part of the citric acid cycle, Fig. 4.21 shows measured concentration
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Figure 4.21.: Metabolite pools of upper citric acid cycle during adherent MDCK
cell cultivation. Citrate (A – C), cis-aconitate (D – F) and isocitrate (G – I) concentrations
in three independent MDCK cell cultivations (∆, 2, ◦) in 6-well plates and GMEM-Z. Data
and error bars represent mean and standard deviation of three wells and were taken from
Ritter [23].Cells, originating from a cultivation experiment (see Table C.2) were deprived of
extracellular nutrients by removal of medium and addition of phosphate buffered saline, shown
in the first column (Lim1) and second column (Lim2). Dashed lines are the limit of quantifica-
tion (LOQ; data below LOQ marked in gray). Lines represent the respective simulation result
based on the experiment-specific parameters of Table C.1 and parameters of Table C.6. The
intermediate growth phase of the cells is indicated as gray bar for the respective cultivation
(bsyn in Table 4.2).
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time courses of CIT, CAC and ICIT that are initially high and increase until 24 h of
cultivation (Fig. 4.21). The model suggests an increase in metabolite pools of the upper
citric acid cycle until 24 h that largely fits the data. Thus, the upper and lower part
of the citric acid cycle show different metabolite dynamics. Afterwards CIT, CAC and
ICIT decrease and reach, in the stationary growth phase, the levels that were presum-
ably present at the beginning of cultivation. Among the three cultivations, substantial
experiment-specific differences can be observed (especially for experiment Cult2 (2)).
The model suggests that the increase in metabolite levels results from a reversed ICDH
activity, which is described as an essential feature of fast proliferating cells to support
cytosolic lipid synthesis [174] (Fig. 4.22). Interestingly, only model variants that incor-
porate a regulation of PDH, CL and ICDH by NAD or NADH were capable to reproduce
the observed dynamics. The fact that neither PYR nor αKG, which are the two main
substrates for the upper citric acid cycle, show dynamics that correspond to CIT or
ICIT further strengthens the idea that the this part of the cycle is influenced by other
metabolites or cofactors, for example NAD and NADH.
Analysis of the simulated flux rates reveals an activity in the lower citric acid cycle during
cell growth of about 0.37 mmol/L/min and in the upper part of 1.10×10−3 mmol/L/min
(at 48 h, Fig. 4.19). At this stage of cultivation αKG, generated from glutaminolysis
(rATA) and AA (rAAex, Fig. 4.22A), takes mainly the lower citric acid cycle route (Fig.
4.22B). The upper citric acid cycle is, thus, solely fueled by small amounts of PYR (Fig.
4.22C) and its endproduct, CIT, is transfered to the cytosole. With onset of the cell
growth inhibition the substrate supply of the citric acid cycle changes. Due to a lacking
activation by NAD, the activity of the lower part reduces to 0.06 mmol/L/min and αKG
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Figure 4.22.: Estimated supply and fluxes of the citric acid cycle during adherent
MDCK cell cultivation. (A) Relative supply of citric acid cycle by GLNx and GLUx (rATA)
and by other amino acids (rAAex). (B) Relative use of αKG by ICDH and KDH. (C) Relative
supply of upper citric acid cycle by ICDH and PDH. Lines are shown in the color code of Fig.
4.21.
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generated from AA is transferred to the upper citric acid cycle under a reversed ICDH
activity (0.21 mmol/L/min, 4.22B, C). The increasing contribution of αKG (rICDH)
to the upper citric acid cycle exceeds the contribution of PYR (rPDH) very early dur-
ing cultivation (Fig. 4.22C). Taken together, the model suggests a flexible supply of
the citric acid cycle depending on the growth phase and the availability of substrates.
Furthermore, its operation is truncated as both parts are mostly independent of each
other.
Response of citric acid cycle to substrate limitations and a substrate pulse:
The removal of medium and addition of PBS, which was realized in the model by set-
ting the medium volume to 3× 10−7 L (section 3.2.2), also limits the cell in GLNx and
GLUx supply, which affects intermediates of glutaminolysis. We expected the corre-
sponding metabolite pools to decrease over time but in a slower fashion compared to
glycolysis. Inspecting the metabolite pool dynamics of the Lim1 experiment indeed
shows a moderate overall decrease in metabolite pools but also unravels a peak shortly
after the limitation in αKG, FUM and MAL that appears at different time of cultivation
(Fig. 4.23A, G, J). In the Lim2 experiment, the peak is not observed and αKG, FUM
and MAL simply decrease but more slowly than in the Lim1 experiment (Fig. 4.23B,
H, K). The time series of SUC, however, differs from the other three metabolites as its
level decreases until 2 min followed by an increase that is only observed for the Lim1
experiment (Fig. 4.23D – E). Furthermore, we again observe differences in the initial
metabolite levels for the Lim1 and Lim2 experiment. The experimental data are, thus,
to a certain degree unexpected, different between metabolites and specific for the actual
experiments. Nonetheless, by considering that cells are taken from a certain time point
t∗ of cultivation explains most initial conditions. In addition, the model renders the
experiment-specific decrease in metabolite pools, which is similarly affected by t∗ (see
Table C.2) and underlines the importance of considering the preculture of cells for anal-
ysis of metabolism. In the model, the supply of the lower citric acid cycle relies during
substrate limitation upon the consumption of AA (0.15 mmol/L/min) and the degrada-
tion of remaining citric acid cycle intermediates (Fig. 4.19). In the pulse experiments,
many data points are below the LOQ but a slow and steady increase in concentrations
might be present and is also suggested by the model (Fig. 4.23C, F, I, L). In sum, the
derived model may not appropriately resemble all features of the experimental data,
especially for Lim1, but describes the main response of the lower citric acid cycle to
substrate perturbations adequately, especially with respect to Lim2. The upper part of
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Figure 4.23.: Response of metabolite pools of lower citric acid cycle to substrate
limitations and a substrate pulse. α-Ketoglutarate (A – C), succinate (D – F), fumarate
(G – I) and malate (J – L) concentrations of three independent perturbation experiments with
MDCK cells in 6-well plates. Cells, originating from a cultivation experiment (see Table C.2)
were deprived of extracellular nutrients by removal of medium and addition of phosphate
buffered saline, shown in the first column (Lim1) and second column (Lim2). In a similar
experiment, cells were exposed to a 2 h limitation and afterwards PBS was exchanged by fresh
medium, shown in the third column (Pulse). Data (◦) and error bars represent mean and
standard deviation of three wells and were taken from Ritter [23]. Dashed lines are the limit
of quantification (LOQ; data below LOQ marked in gray). Lines represent the respective
simulation result based on the experiment-specific parameters in Table C.2 and parameters in
Table C.6.
the citric acid cycle is not directly dependent on the supply from extracellular substrates
and shows a low activity in CL of about 0.06 mmol/L/min at 6 min after onset of the
limitation (Fig. 4.19). It is, therefore, not surprising to find the simulation result of
the corresponding metabolite pools to be less sensitive against a substrate depletion or
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pulse (Fig. 4.24). After 3 min of substrate limitation, the concentrations for CIT, CAC
and ICIT of the Lim1 experiment decrease, which is not captured by the model. In the
Lim2 experiment, however, this decrease is less obvious and may equally well support a
constant behavior if considering the error bars of the data and the LOQ (Fig. 4.24A, B,
D, E, G, H). In contrast, a substrate pulse yields a significant increase in intracellular
metabolite pools (Fig. 4.24C, F, I), which is also not captured by the model, to levels
that are measured during cell cultivation. Taken together, the dynamics of the citric acid
cycle are only partly resolved by the model when it comes either to a substrate limitation
or a substrate pulse. Under both experimental conditions, the closely related metabolic
pathways for conversion of amino acids may have a pronounced influence on the citric
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Figure 4.24.: Response of intracellular metabolite pools of upper citric acid cycle to
substrate limitations and a substrate pulse. Citrate (A – C), cis-aconitate (D – F) and
isocitrate (G – I) concentrations of three independent perturbation experiments with MDCK
cells in 6-well plates. Cells, originating from a cultivation experiment (see Table C.2) were
deprived of extracellular nutrients by removal of medium and addition of phosphate buffered
saline, shown in the first column (Lim1) and second column (Lim2). After a 2 h limitation,
PBS was exchanged by fresh medium, shown in the third column (Pulse). Data (◦) and error
bars represent mean and standard deviation of three wells and were taken from Ritter [23].
Dashed lines are the limit of quantification (LOQ; data below LOQ marked in gray). Red
lines represent the respective simulation result based on the experiment-specific parameters in
Table C.2 and parameters in Table C.6.
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acid cycle. Especially the fast increase during the pulse experiment is unexpected.
Prediction for DMEM cultivation: For the prediction of a cultivation in DMEM
medium with low initial GLCx levels, we expected larger discrepancies between model
simulation and data as the citric acid cycle is influenced by many source that are not con-
sidered by the model, especially, when it comes to a substrate limitation. After adjusting
the segregated cell growth model (section A.2), the model prediction suggests generally
higher metabolite pools than measured experimentally (Fig 4.25) and, thus, shows a
certain error in quantitative aspects. However, the qualitative behavior is surprisingly
consistent with the data (except of αKG). It seems that the simulated metabolite pool
levels of SUC, FUM and MAL are simply by a factor of two higher than the measure-
ments and than previous simulations for Cult1 – 3. The reason is that cells cultivated in
the DMEM medium exhibited a doubled GLNx consumption compared to the GMEM-Z
medium (YX/GLNx = 5.92 × 10−7, section A.2), while the intracellular metabolite pools
are similar to Cult1 – 3. Either, the cells respond to the growth on GLUx with a con-
certed increase in enzyme levels (e.g. Elevel = 2) or the GLU
x decrease was measured
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Figure 4.25.: Prediction for metabolite pools of the citric acid cycle during culti-
vation of adherent MDCK cells in DMEM with 2.5 mmol/L extracellular glucose.
Data on α-ketoglutarate (A), succinate (B), fumarate (C), malate (D), citrate (E) and cis-
aconitate (F) concentrations (3) is depicted as mean and standard deviation of three wells and
were taken from Ritter [23]. Dashed gray line is the limit of quantification (LOQ; data below
LOQ marked in gray). Solid lines represent the model prediction based on the modifications
of the cell growth model described in the appendix (section A.2) and the parameters in Table
C.1 and Table C.6. The intermediate growth phase of the cells is indicated as gray bar for the
respective cultivation (bsyn).
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incorrectly (data inconsistencies). Both adjustments would allow the model to also pre-
dict the metabolite pools of the citric acid cycle quantitatively (simulation not shown).
CIT and ICIT are predicted to show a two step decrease that partially fits the data
although with a broader peak and higher levels during the stationary growth phase.
4.3.7. Pyruvate metabolism
The endproduct of glycolysis and glutaminolysis is PYR. It can also fuel the citric
acid cycle and is linked to the amino acid metabolism. Thus, PYR connects these
two main metabolic pathways. In the model, however, PYR is mainly degraded by an
LDH-mediated reaction and only minor amounts enter the citric acid cycle. The flux
through the LDH is activated by F16BP, which is a similar mechanisms as for the PK.
Therefore, the substrates of both enzymes PYR and PEP show strong similarities in
their dynamics during cell cultivation (Fig. 4.26A – C). During the substrate limita-
tion, however, the measured dynamics in PYR levels decrease and are, thus, different
to dynamics in PEP levels although the same regulatory principles are assumed for the
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Figure 4.26.: Pyruvate levels during cell cultivation, substrate limitation and sub-
strate pulse. Each single plot illustrates an independent experiment. (A – C) Cultivation of
MDCK cells in 6-well plates and GMEM-Z. (D, E) Substrate limitation. (F) Substrate pulse.
Data (∆, 2, ◦, ◦), which are depicted as mean and standard deviation of three wells, were
taken from Ritter [23]. Dashed lines are the limit of quantification (LOQ; data below LOQ
marked in gray). Lines represent the model simulation based on the parameters in Table C.1,
Table C.2, and Table C.6. The intermediate growth phase of the cells in (A – C) is indicated
as gray bar for the respective cultivation (bsyn in Table 4.2).
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model. Thus, the model cannot explain the PYR dynamics during the substrate limi-
tation experiments. During the pulse experiment, the levels of PYR remain below the
limit of quantification, which is also different compared to PEP and not captured by the
model. It may indicate that PYR is also part of other metabolic pathways that are not
considered by the model, for example the amino acid metabolism for which data is not
yet available. Nonetheless, the flux through the LDH satisfies the measured LACx ac-
cumulation (Fig. 4.27A) indicating a basic agreement of the model with the actual flux
rate from PYR to LAC. The accumulation fits the data and is also similar to the release
inferred from the segregated cell growth model (Fig. 4.8D). Thus, the LDH is the main
PYR degrading enzyme. Furthermore, metabolic fluxes from glycolysis into the PPP
and glycogenesis are compensated by the production of PYR from glutaminolysis via a
truncated citric acid cycle. The resulting, time-dependent YLACx/GLCx is close to the the-
oretical maximum of 2.0 during the growth phase and increases to surprising 2.4 for the
stationary growth phase (Fig. 4.27B). Note that YLACx/GLCx is only slightly influenced
by changes in the PDH activity (Fig. 4.27C). Thus, the time-dependent YLACx/GLCx
is rather shaped by a flexible use of amino acids in the citric acid cycle and of sugar
metabolites in the PPP than by the PDH activity. In consequence, the YLACx/GLCx may
not be an adequate measure for cellular ”efficiency” in converting GLC to ATP, although
widely used in literature.
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Figure 4.27.: Use of pyruvate during MDCK cell cultivation. (A) Accumulation
of extracellular lactate during MDCK cell growth in 6-well plates with cell growth medium
(GMEM-Z). Data (∆, 2, ◦) and error bars, which represent mean and standard deviation of
three wells, were taken from Fig. 4.8. Grey dashed line is the limit of quantification (LOQ;
data below LOQ marked in gray). (B) Dynamic glucose-specific lactate yield based on the
structured central carbon metabolism model. (C) Relative pyruvate dehydrogenase activity.
Model simulations (based on parameters of Table C.1, Table C.5 and Table C.6) are shown in
the color code of Figure 4.26.
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4.3.8. Sensitivity analysis for glutaminolysis
In analogy to glycolysis, we also evaluated the impact of model parameters (Table C.6,
C.4) and initial conditions, which take into account culture condition, the growth sta-
tus, and the metabolic status (Table C.2), on the model behavior. The relative local
sensitivity analysis, shown in Fig. 4.28, has many similarities to Fig. 4.18 and its in-
terpretation is, as before, based on the height of values relative to each other and not
on absolute numbers. Again, the model behavior during the cultivation experiments is
mainly determined by the parameters for growth and metabolism and to a certain extent
by the initial growth status of the cells used for inoculation. However, when it comes
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Figure 4.28.: Parameter sensitivity analysis of the structured model of glutaminol-
ysis. (A) Relative local sensitivity of model simulations (for cultivation and perturbation
experiments) to a 1 % perturbation in glutaminolysis parameters (Table C.6), parameters of
the segregated cell growth model (Table C.4), culture conditions, growth status and metabolic
status (Table C.2). (B) Relative local sensitivity of model simulations (for cultivation and
perturbation experiments) to a 1 % perturbation of single glutaminolysis parameter.
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to a limitation in substrates the behavior of the model strongly depends on the actual
metabolic status and growth status that was present at time of perturbation. The first
implication is that the preculture of cells has a large impact on intracellular metabolite
pool dynamics. The second is that the sensitivity of glutaminolysis shifts, similarly to
glycolysis, with the experimental scenario. Analysis of glutaminolysis parameters reveals
that, apart from the GLNT, all enzyme kinetics have a certain influence on the overall
network activity. The GLNT is unidentifiable due to multiplication with γGLNT (Eq.
(3.1.89)).
4.3.9. Energy metabolism
Several reaction steps of the central carbon metabolism fulfill the essential function to
provide the cell with energy, which is stored as ATP. To our surprise, none of these
reactions in the model needed an influence by ADP or ATP. We consequently assumed
that the energy state of the cell is rather a result than a regulator of the metabolic
activity, at least for the scenarios analyzed in this work. Thus, our modeling implies that
biosynthetic processes control the level of ATP, similarly to enzymes that control the level
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Figure 4.29.: Scheme of energy metabolism model with calculated fluxes. Green
boxes represent metabolite pools that were quantified experimentally, while white ones were
not measured. Enzymes are shown as ellipses. Reactions and their directions are shown as
arrows. Colored bars are attached to each reaction and express the relative flux compared to
the largest activity in the energy metabolism (see legend, blue: cell growth at 24 h of Cult1;
green: cell maintenance at 100 h of Cult1; orange: limitation after 6 min). Absolute flux
rates (unit: mmol/L/min) are given next to the bars. ATP adenosine triphosphate; ADP
adenosine diphosphate; AMP adenosine monophosphate; IMP inosine monophosphate; rdATP
degradation of ATP by growth and maintenance; rCCM generation of ATP by glycolysis and
citric acid cycle; ADK adenylate kinase; PSP purine salvage pathway.
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of their substrates [131]. To test whether this hypothesis explains the measured dynamics
in adenosine-based nucleotides, we combined the central carbon metabolism model with
a macroscopic biosynthetic process that consumes ATP. In the following, we evaluate
whether the dynamics of adenosine-based nucleotides can be reproduced during batch
cultivation and afterwards conclude on the energy production of the cell. The model also
considers the interconversion of the adenosine-based nucleotides as well as the exchange
of AMP with the PSP [197]. A schematic overview of considered enzyme reactions,
metabolite pools and maximum in vitro enzyme activities of the energy metabolism is
given in Fig. 4.29.
Nucleotide pool dynamics and fluxes during cell cultivation: As already ob-
served at the beginning of this work (section 4.1), the ATP levels show a negative peak
during cell growth and remains constantly high during the stationary growth phase,
which is similarly described by the model (Fig. 4.30A – C). In experiment Cult3 (◦), a
slight overshoot in the intermediate growth phase is observed and also rendered by the
model. The pool dynamics of ADP and AMP are negatively correlated to ATP, while
the overall decrease in ATP levels exceeds the increase in ADP and AMP levels (the
energy charge is depicted in Fig. 4.1I). The model is capable to explain these dynamics
by considering that AMP is converted to IMP, which is part of the PSP. For ADP, we
observe a rather noisy time course compared to ATP and not all data points are covered
by the model (Fig. 4.30D – F). In case of AMP the model shows a reduced peak height
compared to the data (Fig. 4.30G – I). The corresponding production rates for ATP by
glycolysis and the citric acid cycle are shown in Figure 4.31A. The model suggests, that
MDCK cells generate 7 – 10 mmol/L/min ATP during the growth phase with a signif-
icantly larger contribution by glycolysis compared to the citric acid cycle. Note that
the time course of the ATP generation mainly follows the uptake rate of GLCx in case
of glycolytic ATP production, and of GLNx and GLUx in case of mitochondrial ATP
production (cf. Fig. 4.9). In the intermediate growth phase, the ATP generation by
glycolysis decreases while the generation by the mitochondrium peaks such that both
reach an almost equal contribution. In the stationary growth phase, the central car-
bon metabolism delivers a total ATP production rate of 2 mmol/L/min where glycolysis
is again the main source. The consumption of ATP is not separately shown but the
model suggests that ATP is mainly consumed by the macroscopic biosynthetic process
(rX/ATP ) and by futile cycles (rATPase), which is in line with the analysis of Wahl et al.
[15]. The generation of ATP from ADP by oxidative phosphorylation is driven by a
115
4. Results and discussion
0
1
2
3
4
[A
TP
] (m
mo
l/L
) CBA
0
0.2
0.4
0.6
[A
DP
] (m
mo
l/L
) FED
0 48 96 144 192
0
0.05
0.1
0.15
0.2
[A
MP
] (m
mo
l/L
)
time (h)
0 48 96 144 192
time (h)
0 48 96 144 192
time (h)
IHG
Figure 4.30.: Adenosine-based nucleotide pools during adherent MDCK cell cul-
tivation. ATP (A – C), ADP (D – F) and AMP (G – I) concentrations in three independent
MDCK cell cultivations (Cult1 ∆, Cult2 2, Cult3 ◦) in 6-well plates and GMEM-Z. Data and
error bars represent mean and standard deviation of three wells and were taken from Ritter
[23]. Dashed lines are the limit of quantification (LOQ; data below LOQ marked in gray).
Lines represent the respective simulation result based on the experiment-specific parameters
in Table C.2 and parameters in Table C.6. The intermediate growth phase of the cells is
indicated as gray bar for the respective cultivation (bsyn in Table 4.2).
proton gradient, which is established by oxidation of NADH with O2. The resulting
mitochondrial consumption of O2 varies with time (Fig. 4.31B) and follows the time
course of the mitochondrial ATP production rate shown in Fig. 4.31A (dashed line).
The cell-number-specific consumption of 22 – 168 fmol/cell/h covers the values reported
by Wahl et al. [15] (48 fmol/cell/h) and by Bock [316] (70 fmol/cell/h).
4.3.10. Model performance
In the former sections, we comprehensively analyzed simulated and measured metabolite
pool dynamics and inferred regulation principles for the central carbon metabolism. Al-
though a systems-level analysis provides valuable insights into the interplay of biological
mechanisms, the resulting complexity in data fits may not reveal the actual model per-
formance. Therefore, we analyzed the correlation between simulations and experimental
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Figure 4.31.: Production of ATP and demand for O2 during adherent MDCK
cell cultivation. (A) Theoretical production rates of ATP by glycolysis (solid lines) and by
the citric acid cycle (dashed lines). (B) Theoretical specific oxygen consumption rate (Eq.
(3.1.82)). Lines are shown in the color code of Fig. 4.30.
measurements for all model fits (Fig. 4.32A), which is an accepted way to evaluate a
model performance [252], and determined a linear correlation coefficient of 0.95 for the
glycolysis model and of 0.77 for the glutaminolysis model. For both models, a deviation
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Figure 4.32.: Statistical analysis of structured model performance. (A) Correlation
between simulated and measured metabolite concentrations of this chapter. The glycolysis
model is marked in green, the glutaminolysis model is marked in yellow. Black line represents
ideal correlation and dashed black lines contain 95 % of the dots. (B) Relative distance between
simulation and data. Dashed lines show mean relative error. (C) Overview of fitted (light blue,
simulation within 95 % confidence interval of data), not fitted (light red, simulation outside
95 % confidence interval of data) and omitted data (gray) for cultivation and perturbation
experiments.
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of about 0.5-fold to 2.0-fold from the nominal simulation value covers 95 % of the data
points (dashed lines Fig. 4.32A; glycolysis: 0.4 – 1.9; glutaminolysis: 0.6 – 2.6). The
relative error is homogeneously distributed and in mean ± 21 % between both models
and the data (Fig. 4.32B). Under consideration of the data error, which is exceptionally
small for many measurements, 70 % of the data is covered by the model when consid-
ering two times the standard deviation (Fig. 4.32C). Note that data points below the
LOQ were excluded from the analysis.
4.3.11. Discussion part II
Glutaminolysis model structure: Similarly to glycolysis, we coupled the segregated
model for cell growth to a kinetic description of glutaminolysis to reflect intracellular
metabolite pool dynamics during cell cultivation, medium depletion and medium pulse
involving a total of 600 data points. The simulation of the different experiments consid-
ers the preculture of cells (already discussed for the structured model of glycolysis) and,
thus, initial conditions were not estimated but calculated by the model leading to only
20 unknown parameters (Table C.6). Another feature of the model is the consideration
of the relative biosynthesis rate bsyn, which reflects the demand of the cell for energy
and precursors. In particular, bsyn influences the degradation of citric acid cycle inter-
mediates and ATP. Using such macroscopic functions enables the model to consider the
influence of complex cellular processes on metabolic pathways. In case of the citric acid
cycle, the enzymatic reactions that required regulation by bsyn or (1 − bsyn) use NAD
or NADH as cofactors, respectively. Thus, the model implicitly suggests that oxidative
phosphorylation has substantial control over the citric acid cycle, which is also proposed
by Dalmonte et al. [183] and Rodr´ıguez-Enr´ıquez et al. [182]. However, the coupling
to the segregated cell growth model allowed dealing with many more mechanisms that
are not explicitly considered such as the control of the glutamate transporter by cell
growth inhibition or the NH4 metabolism (see next section). Furthermore, modeling cell
growth and the cell-specific volume V CS introduces the option to calculate the dilution
of metabolites and enzymes, which can influence the conversion rate within the reac-
tion pathways (see section 3.1.3). For the structured model of glutaminolysis, we chose
relatively simple, compartment-unspecific enzyme kinetics to derive a reasonable set of
differential equations that focus on key regulatory mechanisms of that pathway. Simi-
larly to the kinetic description of glycolysis, the model for glutaminolysis features the
identification of mechanisms that are involved in metabolite pool dynamics and provides
a basis for the extension by additional mechanisms, e.g. the oxidative phosphorylation
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[251], the influence of cofactors such as GTP and FAD or the compartmentalization of
the cell [248], in case further data is available. Models that take into account further,
unmeasured metabolites or more complex enzyme reactions than used here may equally
well describe the dynamics of the intracellular metabolite pools of this study.
Ammonia release from glutamine and glutamate: The release of NHx4 was de-
scribed by a maximum stoichiometric production from GLNx and GLUx minus a certain
amount that is bound in molecules and used for biosynthesis. We already highlighted
that the yield of NHx4 from GLN
x is roughly 0.8 and that GLUx does not contribute
to the NHx4 release (section 4.2.2). The metabolic explanation is that GLU is primar-
ily processed via the transamination route without production of free NH4. A high
transaminase activity is indeed found in MDCK cells [22, 170] and supports our hy-
pothesis. Since accumulation of NHx4 in the medium can have a negative impact on
cell growth and product formation [54], cultivation processes with high NHx4 levels may
benefit from medium adaptation [54, 173] or a modulation of the cellular transporters
in favor of GLUx uptake. However, it requires the cell to have a certain glutaminase
activity. For MDCK cells, a sufficient glutaminase activity is indeed present [22] and a
switch to GLNx-free medium was successfully tested as cultivation strategy [14].
Amino acid uptake controls glutaminolysis during cell growth: Since cells from
stationary growth phase were used for inoculation of a new well, we hypothesized that
initial metabolite levels (t = 0) are identical to levels of the stationary growth phase.
With the start of cultivation, the model suggests for SUC and FUM a fast increase in
concentration that is attributed to the uptake of GLNx and AA. For MDCK cells, the
uptake of branched chain amino acids is commonly observed [15] and a contribution of
AA to citric acid cycle intermediates of 40 % (Fig 4.19) is in the range reported for cancer
cells [148]. The uptake of GLNx (perhaps also in AA) yields early (t > 6 min) intracellu-
lar levels of SUC and FUM that are higher than levels during stationary growth phase.
For αKG and MAL the opposite is observed and indicates that the degrading enzymes
KDH and MDH are activated between 0 h and 6 h of cultivation. The model suggests
that the inhibition of both enzymes by bNAD is released with onset of growth, which may
imply a certain influence by NAD. With beginning of the indermediate growth phase,
a peak-like behavior is observed for αKG, SUC, FUM and MAL and is, in the model,
driven by a high GLUx uptake. Thus, metabolite pools of the lower citric acid cycle
are largely controlled by the growth-dependent uptake of GLNx, GLUx, and presumably
119
4. Results and discussion
AA. To illustrate the link the between uptake of extracellular substrates and intracel-
lular metabolite dynamics, which was also found for glycolysis (see section 4.3.5), Fig.
4.33 provides a schematic overview on main central carbon metabolism dynamics, on
their linkage and on uptake of substrates (GLCx, GLNx, GLUx) as well as release of
byproducts (LACx). With onset of the stationary growth phase and a limited supply by
GLNx and GLUx, the control changes towards mechanisms that maintain intracellular
metabolite pools and avoid unnecessary dissipation of biomass precursors. Firstly the
GLNx uptake rate 
Upper citric acid cycle 
Lower citric acid cycle 
Upper glycolysis & 3PG 
GLCx uptake rate 
GLUx uptake rate 
LACx release rate 
PEP & PYR metabolism 
PPP and Glycogenesis 
Membrane 
CELL 
Figure 4.33.: Scheme of central carbon metabolism dynamics during cell cultiva-
tion. Arrows and thickness of arrows indicate the relative flux distribution. Metabolite pool
dynamics in different parts of the metabolic network are depicted by representative, schematic
figures and grouped by color code. Light gray bar illustrates the intermediate growth phase.
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inhibition of key enzymes by bNAD becomes significant and, secondly, the breakdown
of AA seems to compensate for cataplerotic effects. We, therefore, anticipate that the
regulation of enzymes through NAD can reduce the citric acid cycle activity and may
pose an intrinsic mechanism to stabilize intracellular concentrations of metabolic inter-
mediates when specific substrates are depleted to critical levels. It seems that seeding of
cells into a new well with sufficient growth surface and high substrate levels releases this
inhibition to support biosynthesis and cellular energy generation. Yuneva and coworker
[300] found a reduction in citric acid cycle intermediates upon limitation in GLNx, which
indicates its role as main substrate, and, most interestingly, reported on MYC-mediated
apoptosis if citric acid cycle metabolite drop to low levels. The regulation of the citric
acid cycle by NAD is also well documented [182, 183] and an inhibition of the lower citric
acid cycle by low NAD levels at late stages of cultivation seems reasonable since ATP
levels are at maximum (see section 4.3.9). High ATP levels presumably block oxidative
phosphorylation [251] and can yield high intracellular NADH and low NAD levels.
Applying the influence of bNAD consistently to the upper citric acid cycle allowed the
model explaining the measured pool dynamics in CIT, CAC and ICIT. A regulation of
the upper citric acid cycle is also supported by the observation that metabolite levels
differ significantly from PYR and αKG, which are the main substrates for this part of
the cycle. However, the actual dynamics show larger variations between the cultiva-
tions, which, according to the model, are attributed to differences in cell growth in the
presence of low pathway activities. Furthermore, the supply of the upper citric acid
cycle seems to change from PYR to αKG with progression in cultivation time indicat-
ing a certain flexibility in pathway operation. The products of both citric acid cycle
branches eventually fuel the PYR pool under the production of either cytosolic NADPH
or cellular energy and, thus, the model reflects a truncation in the cycle [121, 150]. The
subsequent degradation of PYR by LDH is activated by F16BP, which yields dynamics
that are similar to PEP and that largely suit the cultivation data. We subsequently
analyzed whether the activity of glutaminolysis and glycolysis constitute the measured
LACx production. The simulation is in good agreement for all three cultivations and,
thus, strengthens our confidence in the estimated flux distributions. At this point, we
can infer the dynamic efficiency in glucose conversion that was previously defined as
YLACx/GLCx . In contrast to the segregated cell growth model, YLACx/GLCx now varies
with cultivation time (also found by Dean and Reddy [13]) between 1.8 and 2.4 and is
not a result of a varying contribution of PYR to the citric acid cycle (< 1h) but rather
of glutaminolysis to PYR production, which is an aspect that is frequently overseen in
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the analysis of mammalian cell cultures.
Glutaminolysis during substrate perturbation: At distinct time points t∗ of culti-
vation, the medium was replaced by PBS and decreasing metabolite pools were measured
in the citric acid cycle. For glycolysis, choosing a distinct t∗ for each perturbation ex-
periment explains differences in the initial metabolite levels. Using the same t∗ as for
glycolysis allows the model to also successfully render the starting concentrations of the
citric acid cycle (no adjustments necessary). It seems that considering the preculture of
cells consistently reproduced the initial metabolic status of glycolysis and glutaminolysis
at the beginning of the perturbation experiments.
During the time course of the limitation experiments, however, metabolite pools of the
lower part of the cycle show a peak that emerges at different times of cultivation, which
cannot be explained with a regulation of the connecting enzymes. Rather, each metabo-
lite is influenced by separate metabolic pathways and by the involved amino acid pools.
In line with this hypothesis, the model suggests a significant supply from AA during
the substrate limitation scenario. Taken together, the data and the model indicate that
the associated metabolism exerts a significant influence on the lower citric acid cycle if
its activity is low, which is similarly found for the PPP during the limitation experi-
ments. Nonetheless, the model describes the overall degradation of αKG, SUC, FUM,
and MAL sufficiently well, especially for the Lim2 experiment. Further measurements on
the closely related metabolic pathways may help to also clarify the reason for the mea-
sured peaks. With the addition of fresh medium, a pulse in GLNx and GLUx is applied
that leads in the model to slow but steady reactivation of the lower citric acid cycle. The
data, however, shows very low levels for all four metabolites at all time points. Since
cells are capable of growth after the limitation and pulse experiments, the citric acid
cycle might be activated at later times or in a different mode, which the model cannot
yet explain. Currently, the model simply suggests that the citric acid cycle returns to
the metabolic status that was present before the perturbation experiments.
In the upper part of the cycle, the measured metabolite pools are mainly constant dur-
ing the limitation experiments, perhaps with a slight decrease towards later time points.
The model suggests very low activities and the resulting straight line captures most
of the data. During the pulse experiment, the concentrations for the metabolite pools
increase significantly from these low levels, which is in contrast to the lower part of the
cycle. Obviously, a substrate pulse to the citric acid cycle offers a puzzle that cannot
yet be solved by the developed model. The discrepancy to the data is perhaps linked
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to the difficulties in fitting PYR during the pulse experiments. We defined the LDH to
be the main degrading enzyme for PYR, which is activated by F16BP. Instead of an
increase in concentration due to decreasing F16BP levels, PYR drops fast to low levels,
which the model cannot explain. It may indicate that the closely related metabolic
pathways have a certain influence on PYR under these experimental conditions. Taken
together, during the pulse experiment and especially when the pathway activities are
low, parts of the metabolism, which are not considered in this work, play a pronounced
role, such as metabolism of amino acids, compartmentalization and ion fluxes across the
compartment membrane. When the citric acid cycle is operated with higher flux rates,
the metabolite pools are robustly controlled by a few key mechanisms [122] and can,
thus, be described with a facilitated amino acid uptake and an NAD-based regulation
of enzymes.
Estimations and predictions for the operation of glutaminolysis: Since the func-
tioning of glutaminolysis is only partly understood when it comes to short term responses
upon substrate perturbations, the model-based estimations of this work focus only on
standard cell cultivation conditions. The predictive power of the model for these con-
ditions is appreciable considering that the two-fold higher levels in citric acid cycle
metabolites may result from data inconsistencies or changes in the enzyme level. For
bioprocessing, we anticipate that increasing the GLUx uptake may enhance ATP pro-
duction but, more importantly, may also enhance the lipid-synthesis from MAL-derived
NADPH, which might effect µmax in a positive way. Furthermore, a shift towards higher
lipid synthesis might be important for the production of enveloped viruses [297]. Mea-
surements for the maximum in vitro enzyme activities of FMA and MDH indicate a
significant additional capacity for metabolite conversion [22] such that an enhanced glu-
taminolysis activity is not limited by these enzymes.
The control of the energy metabolism: The kinetic description for the citric acid
cycle uses a combination of enzyme metabolite interactions and growth-dependent func-
tions to describe the degradation of metabolite pools. Such macroscopic functions rep-
resent hierarchical regulation mechanisms and can influence the metabolic activity in-
dependent from the abundance of intracellular metabolites. For modeling the energy
metabolism, we again used growth-dependent functions to account for the use of ATP
in biosynthetic reactions. Together with enzyme metabolite interactions, the model suc-
cessfully describes the pool dynamics in ATP, ADP, and AMP during cell cultivation
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using 10 parameters and 3 initial conditions. Since the model for glutaminolysis strug-
gled with describing all dynamics observed during the perturbation experiments, the
model for the energy metabolism is not fitted to corresponding data and not used for
predictions. Nonetheless, it contributes to the analysis of in vivo nucleotide pool dy-
namics of mammalian cells and offers a fit that is similar or better than for yeast cells
[199]. The estimated flux rates through glycolysis and the citric acid cycle constitute
a maximum production rate of 10 mmol/L/min. The model suggests that glycolysis
provides the majority of ATP in adherent MDCK cells, which fits to our observations
of a partial oxidation of glutamine and high lactate secretion rates, and is also reported
in literature [58, 89, 121, 150]. A higher ATP production by glycolysis compared to
the citric acid cycle is also proposed by Wahl et al. [15] using metabolic flux analysis.
Another question is how metabolism, biosynthesis and the energy level influence each
other. Since the energy producing steps are found in the last sections to be independent
of the actual energy level, hypotheses on a demand-driven energy metabolism [193] or
on the control of enzymes by ATP levels [194, 195] are not supported by the model. The
explanation is that a control of enzymes by ATP on the one hand interrupts concerted
changes in metabolite pools, e.g. upper glycolysis, and on the other yields a constant
time course for ATP, which both is not observed in our data (Fig. 4.34A). In a demand-
driven control, intracellular metabolite pools decrease in response to cell growth and
eventually induce the uptake of substrates. However, decreasing metabolite pools for
the cell growth phase are neither observed for glycolysis nor for the citric acid cycle
(Fig. 4.34B). Also a control by extracellular nutrient levels, which is suggested by Dean
and Reddy [13] and Barnabe´ and Butler [78], is not observed during cell cultivation and
may only occur under substrate limiting conditions. Furthermore, the ATP levels can
sustain a substrate limitation for at least 2 h of medium depletion (see Appendix B.2
Fig. B.1 and [23]). Thus, the only hypothesis remaining and supported by the model is
that metabolism generates ATP irrespective of its actual level, which is also suggested
by Soboll et al. [200], while the level of ATP is shaped by the biosynthesis activity. Note
that continuously proliferating cells may never be limited in the ATP supply, which is
implicitly found for tumor cells by Schmidt et al. [198] and reviewed by Vander Heiden
et al. [61]. Furthermore, the observation of a decreasing ATP level in the presence of
increasing metabolite pools indicates that biosynthesis is rather driven by the precursor
supply, which may initially consume more ATP than provided by metabolism. At later
stages of cultivation, cells are more and more inhibited in cell growth and the overpro-
duction in ATP by metabolism slowly restores the pool. Taken together, our hypothesis
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Figure 4.34.: Role of ATP in the control of the central carbon metabolism and
observations of this study. Light arrows indicate reactions for metabolite M, which may
stand for e.g. M1: F6P and M2:F16BP, large arrows indicate a supply and dashed arrows
indicate regulation.
is that biosynthesis is induced by high precursor levels and, because of the increasing
demand, simultaneously reduces ATP levels (Fig. 4.34C).
Model performance: Current models for yeast and bacteria metabolism that con-
sider in vivo dynamics in metabolite pools focus mainly on glucose pulse experiments
[20, 237, 242, 317]. The model of this work describes data of pulse experiments equally
well (or even better) and captures additional measurements from two independent lim-
itation experiments. Although perturbation experiments are ideal to study pathway
dynamics they depict extreme scenarios in which the substrate levels have a pronounced
influence. The advantage of our model is that it explains metabolite pool dynamics of
several perturbation experiments and, at the same time, for cell cultivation experiments,
while using the same parameterization. Differences between replicate experiments are
reflected by considering the preculture of cells and also circumvents the estimation of
individual initial conditions. Based on the comprehensive validation with data from a
broad operation range of metabolism, the model is capable to predict the metabolism
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for a cultivation in a second medium. In sum, the model describes about 70 % of the
1200 data points from a variety of experiments and time scale (Cult1 – 3, Lim1, Lim2,
Pulse), while beeing relatively simple, biologically relevant and predictive.
4.3.12. Summary
In this part, we coupled the segregated cell growth model to a structured model that
incorporates the two main metabolic pathways, glycolysis and glutaminolysis, as well as
their links to the associated metabolism of PPP, glycogenesis, pyruvate metabolism and
to the energy metabolism. To unravel mechanisms that are involved in the metabolite
pool dynamics, the model structure is composed of relatively simple enzyme kinetics
that focus on a few well-known enzyme metabolite interactions. By using macroscopic
growth functions, the model can realize growth-dependent substrate transports as well
as consumption of metabolites and cellular energy for biosynthesis. Furthermore, the
model considers the preculture of cells as well as different intracellular enzyme levels
and explains most experimental observations for cultivation, limitation and pulse ex-
periments under a single parameterization. Thus, the model not only provides a good
performance in describing the experimental data but also delivers a systems level under-
standing of the metabolic regulation for a variety of experimental conditions and time
scales. In particular, the model suggests that the metabolic activity is regulated by
growth-dependent transports of GLCx, GLNx and GLUx, while the resulting production
rates of biomass precursors and cellular energy are influenced by intrinsic pathway prop-
erties. When limited in substrates, the control over the metabolic activity shifts from
the growth regime towards an inherent one that is shared by several enzyme metabo-
lite interactions. Furthermore, the model suggests that oxidative phosphorylation has a
pronounced control over the activity of the citric acid cycle that prevents the dissipation
of valuable biomass precursors and eventually apoptosis. We also successfully tested the
predictive power of the model for the glycolysis and glutaminolysis pathways by simu-
lating a cultivation in a second medium (DMEM), which strengthened our confidence
in the model structure and its parameterization. Based on the model, we hypothesize
that a faster or a more efficient cell growth can be achieved by tuning the substrate
uptake rates of the cell, which has great relevance to the design of bioprocesses and of
new experiments.
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When this work was conceptually formulated, it was not clear whether the overall dy-
namics in the central carbon metabolism of adherent MDCK cells can be explained
by mathematical models. Existing models for metabolism largely focus on yeast and
E. coli or on isolated mitochondria. Furthermore, these models often focus on rather
special scenarios, such as pulse experiments, than on basic metabolic functions relevant
for cell cultivation and production of biologicals. Fortunately, numerous concepts for
the regulation of the cellular metabolism are available and cover the influence by ex-
tracellular substances, transport mechanisms, hierarchical control and intrinsic pathway
properties. The contribution of this work to the field of metabolic research is, thus, the
reasonable combination of the most promising theories such that a mathematical model
is derived that consistently explains intracellular metabolite pool dynamics found for
adherent MDCK cells under various experimental conditions.
The first challenge was to identify regulatory principles that are likely involved in the
control of the MDCK cell metabolism. Although it is clear that the metabolic activity
correlates with cell growth, studies on the interplay of metabolic regulation mecha-
nisms through analysis of metabolite pools under different growth conditions are barely
available, especially not for a broader systems-level analysis. The first part of this
work, therefore, analyzes growth and metabolism of MDCK cells that were cultivated
in two different media using biological and technical replicate measurements for both
media. Surprisingly, the metabolic behavior is quite the same and fundamental changes
in metabolite pools are highly correlated to changes in the growth behavior. These
observations not only imply that the influence of extracellular substrates is limited but
also unravel a robust regulation of the metabolic activity by simple cellular mechanisms,
such as key enzyme-metabolite interactions and transport reactions.
Based on the recognition of these first principles, we aimed for an analysis of metabolite
pool dynamics that specifically takes into account the growth rate, nutrient uptake and
size change of cells. Conventional cell growth models, however, can often not distin-
guish between cell size and cell number increase, while mass population-based models
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are difficult to calibrate with experimental data. Therefore, we developed a segregated
cell growth model where cells pass through different cell diameter classes, thereby con-
suming substrates and releasing byproducts, until a critical size is reached and the cells
divide. Cell volume-dependent growth inhibition occurs at the first transition and allows
the model to recapitulate the observed mean cell diameter dynamics. When applied to
three independent cultivations, the model shows a convincing performance in capturing
cell growth in numbers and volume while it also precisely explains the cellular uptake of
substrates and the release of byproducts. Furthermore, it possesses a simple structure
and is easy to compute. In comparison to conventional approaches, the model proved
advantageous for the simultaneous description of different cultivations with a single pa-
rameterization and is, thus, particularly suited for coupling with structured models of
metabolism. The successful prediction of cultivation experiments as well as the analysis
of other cell lines and cultivation conditions indicate applicability and generality. Hence,
the model fills the gap between existent approaches and represents a promising alterna-
tive to mammalian cell growth models that are typically used to design and optimize
bioprocesses.
The second challenge in the analysis of metabolism lied in its enormous variability, even
for experiments that were seemingly performed as replicates. It is hypothesized by other
groups that variations in the metabolic state can be a result of the cultivation history of
cells. Changes in the cell size as well as in genomic, transcriptomic or proteomic proper-
ties are typically found. Following this idea, we designed a simulation scheme that links
the initial cell status of the actual experiments with the preculture of cells, which differ
in cell diameters and the intracellular enzyme level. For example, simulating the dynam-
ics during cell cultivation delivered all aspects of cell growth, metabolism and culture
condition for the simulation of substrate limitations and finally pulse experiments. An-
other benefit of this concept is that it enables the model to explain experiment-specific
variations in metabolite pool dynamics with differences in the preculture, which other-
wise introduce large uncertainties to the analysis of metabolism.
With a solution for both challenges, we finally developed a structured model for the cen-
tral carbon metabolism and its associated pathways. To illuminate central regulatory
principles, the model focuses on simple, yet biologically relevant descriptions that fea-
ture the identification of mechanisms that are involved in main intracellular metabolite
dynamics. Interestingly, a few key enzyme-metabolite interactions together with macro-
scopic growth functions already explain metabolite pool changes from a comprehensive
data set that covers a variety of experiments and time scales. The quality and relia-
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bility of the model is further emphasized by the successful prediction of a cultivation
in second medium (DMEM) and allows us to infer with greater confidence how differ-
ent regulatory mechanisms interact to realize a broad range of pathway operations. In
particular, the model suggests that glycolysis and glutaminolysis are both controlled by
a cellular growth regime through modulation of the glucose, glutamine and glutamate
transporter activity. On a lower regulatory layer, enzyme-metabolite interactions influ-
ence the flux distribution to suit the cellular demand for energy and biomass precursors.
In extreme cases, where cells are limited in their substrates, the control shifts from the
transporter through the limiting substrates to a control that is shared by key enzymes.
The frequent expectation, however, that enzyme-metabolite interactions constitute a
demand-driven control that shapes metabolism for various growth conditions fails in
explaining metabolite pool dynamics observed for MDCK cells. Therefore, the shift
in control is an essential property of the cellular metabolism that is unraveled in this
work by the systematic integration of various experimental conditions into a coherent
modeling framework. Furthermore, the substrate transport is an often overseen element
that can exert significant control over metabolism but might not become obvious from
substrate pulse experiments or steady state data. Since the transport is regulated by
macroscopic growth functions, it seems that the growth regime ultimately controls the
generation of biomass precursors and cellular energy with rates that are encoded in the
network architecture. Nonetheless, the influence of extracellular substrate concentra-
tions and intracellular enzyme levels (proteomic level) are a necessary part of the model
and contribute already to the metabolite pool dynamics. Furthermore, other hierarchi-
cal aspects, such as enzyme phosphorylation and transcriptional regulation may improve
the current interpretations and can, thus, not be excluded as sources of regulation. In-
terestingly, the hypothesis of a control by energy charge is neither supported by the
model nor by the experimental data. Although the contribution of all of these addi-
tional mechanisms is not essential for describing the metabolite pool data of this work,
they may play a role in very specific and stressful situations, for example when cells are
adapted to a new medium. For the understanding of the cellular metabolism, however,
it seems intuitive that the driving force of cellular life relies on simple mechanisms, i.e.
ordinary enzyme-metabolite interactions and the rate limiting activity of transporters,
as they facilitate a robust functioning in a changing environment.
Overall, we successfully combined the analysis of cell growth dynamics with relatively
simple enzyme-metabolite interactions to study the capacity and regulation of the mam-
malian cell metabolism. Based on a mathematical model, we inferred principles of
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metabolic regulation and their interplay by describing dynamics in metabolism for a
variety of experiments. The insights into metabolism and the predictions for the cell
significantly contribute to the field of metabolic research and support the design of more
efficient cell cultivations.
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With the successful development of a mathematical model that consistently explains
data of a complex metabolic network, a promising systems biotechnology framework is
created that supports the analysis of further metabolic phenomenons. Within the vision
of an iterative cycle of model development and data generation, we here draw an outlook
on experiments that possess the greatest potential for improvement of the model and
for discoveries in the fields of metabolic research and bioprocessing.
Importance of labeling experiments: For the central carbon metabolism of MDCK
cells, the exchange of metabolites with associated pathways is only partially validated by
substrate uptake and byproduct release rates. Flux data from labeling experiments can
provide insights into the metabolic flux distribution and reduce the degree of freedom in
the current interpretation of the metabolic activity. The citric acid cycle, for example,
showed a peak-like response in metabolite levels when it comes to a substrate limitation.
Application of labeling experiments may address the source of these peaks as well as the
surprising observations of constant ATP levels during these experiments. Currently, the
model suggests that AA are converted by the citric acid cycle under the production of
ATP but cannot explain constant ATP levels or peaks in metabolite pools. Furthermore,
it remains to be elucidated for how long the cell can sustain limiting conditions and how
active the different parts of metabolism are. In principle, labeling experiments are an
important element in the analysis of metabolism, even though the method is time and
cost expensive.
Complement existing data sets: Experiments in which single substrates are re-
moved from the medium represent a reasonable strategy to further validate the exchange
of metabolites among pathways with the convenient side effect that current measure-
ment methods are exploited in an economic fashion. Since the model already showed a
good performance in predicting a cultivation with reduced GLCx levels, additional culti-
vations with limitations in GLNx and GLUx not only complement the set of experiments
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and simulations but can also illuminate the conversion routes in glutaminolysis and the
citric acid cycle. Currently, the model suggests a relatively low supply of the citric
acid cycle with PYR and a substantial contribution from GLN and AA. In addition,
the quantification of extracellular amino acid concentrations may clarify the dynamics
in the substrate supply of the citric acid cycle. Another open question is the role of
NADH in the regulation of the citric acid cycle activity. Methods for the quantification
of intracellular NAD and NADH can be adopted for MDCK cells to prove or reject the
hypothesis that high NADH levels limit the activity of the citric acid cycle.
Enzyme activity and content: For the cultivation experiments, we observed that cells
with different cultivation histories varied in dm and dc and anticipated a concomitant
change in the Elevel. The assumption readily explains experiment-specific variations in
metabolite pool dynamics. However, it remains to be shown whether and, if so, to
which extent the enzyme content changes with the cell size. The use of a proteomic
approach, in addition to enzyme activity measurements, provides independent data on
protein level and specific activity. Corresponding studies may unravel principles for
the link between enzyme content and cell diameter, which can potentially refine the
current model. In a preliminary study, S. Kluge analyzed the adaptation of MDCK
cells to suspension growth and we found a reduction in the glycolytic activity equal to
the reduction in enzyme activity. The use of enzyme activity measurements and relative
protein quantifications indicated that changes in the enzymes activity are correlated with
the reduction in protein content. As suspension cells are much smaller than adherent
cells, this finding may support the idea that the enzyme level correlates in general with
the size of cells.
Perturbation of intrinsic pathway properties: Next to the acquisition of data on
further metabolic components, it seems worth to also perturb cellular components and
track the metabolic response. Based on the model, the modulation of the GLUT has
a certain potential for enhancing or decreasing the biomass precursor production rates.
Also an increase of the NADPH production rate by the PPP seems possible and may
support lipid synthesis, which may have great relevance for the cell-based production of
viruses. Therefore, experiments dealing with the overexpression or inhibition of GLUT
can be used to validate its control over glycolysis and to clarify effects on the biosynthesis
activity. Alternatively, GLUT and many enzymes of the glycolytic pathway can be
perturbed by activation or suppression of HIF-1, which is currently tested as a strategy
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to interfere with the Crabtree effect by a member of the BPT group.
Extension of the model: In its current version, the model neglects any compartmen-
talization of the cell as it is designed to comply with the data. In addition, extending the
model by distinct reactions for mitochondria and cytosol will cause identifiability prob-
lems unless compartment-specific data are taken into account. Methods for gathering
compartment-specific data are currently available but an even distribution of metabolites
within the compartments cannot be expected. It seems that metabolites are converted
in enzyme complexes [318] and resolving these metabolic processes may introduce enor-
mous challenges for both experimental methods and modeling. Nonetheless, metabolism
is linked to most cellular processes and, thus, many more cellular functions can be ad-
dressed by model extensions such as the osmotic stress, hypoxia or glycosylation of
proteins. Also the lipid metabolism, as mentioned above, poses a promising extension
to the model if corresponding data becomes available.
Transfer of model to other cell lines: Preliminary studies by Klassen [303] indicate
that central principles for the regulation of metabolism in adherent MDCK cell also
apply to suspension AGE1.HN.AAT cells. Although some mechanisms may require
adjustments, i.e. influence of growth inhibitors and the kinetics for enzyme-mediated
reactions, a direct comparison to MDCK cells seems interesting and would contribute
to a more general understanding of the mammalian cell metabolism. Also, CHO cells,
which are the best studied mammalian cells and widely used for the production of
recombinant proteins, can be considered as field of application for the presented modeling
approach if data on intracellular metabolites and enzyme activities become available.
Both cell lines can also be used to study the link between glycolytic activity and protein
glycosylation and are, thus, highly attractive research objects with great relevance for
a larger biotechnological community. In the field of virus production, the design of
highly productive cells can be supported by the presented modeling approach through
identification of metabolic bottlenecks and of optimal cultivation strategies.
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AAppendixSupplementary studies
A.1. Sedimentation and attachment of MDCK cells to 6-well plate
surface
The lag phase in cell growth can be decomposed in case of adherent MDCK cells into
sedimentation, attachment and increase in cell size until first division. To further clarify
the first two steps, i.e. speed of sedimentation and attachment, we inoculated cells in
6-well plates with GMEM-Z medium and quantified the cell concentration in suspen-
sion (Fig. A.1A), known as suspension depletion [319], and of cells attached to the well
surface (Fig. A.1B, we thank C. Best from the Max Planck Institute for Dynamics of
Complex Technical Systems Magdeburg for conducting the experiments and for mea-
surement of the cell numbers). Polynomial regression of the supernatant cell number
with exponential functions yielded a cell number decrease of ksett = 0.28± 0.02 h−1 (◦:
0.27 h−1; ∆: 0.27 h−1; 2: 0.31 h−1). Afterwards we used a simple first order kinetic with
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Figure A.1.: Attachment of MDCK cells to the surface of a 6-well plate. (A) Concen-
tration of cells in suspension determined in three technical replicates (◦, ∆, 2). Experiments
∆, 2 were shaken before sampling. Lines represent regression of an exponential function (see
text). (B) Concentration of adherent cells in experiment 2. Line represents prediction for
adherent cell concentration based on a specific attachment rate of 0.28 h−1 and an initial cell
concentration in the supernatant of 2.5 × 105 and was shifted by 0.8 h. Data was taken by
Claudia Best and is shown as mean and standard deviation of three wells.
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an initial suspension cell concentration of 2.5 × 105 cells/mL and compared the time
integral of the sedimentation rate with the increase in adherent cell number (model not
shown, Fig. A.1B). The integral in Fig. A.1B recapitulates the data as long as the onset
of the cell attachment is shifted towards later times by about 0.8 h. Therefore, we antic-
ipate that cells require 0.8 h for the actual attachment process while the sedimentation
requires 2.4 h for half of the cells according to ksett. The sum of both renders the mean
cell to potentially start growing in size as early as 3.2 h after inoculation.
A.2. Adjusting the segregated cell growth model to growth in
DMEM medium
The model for cell growth was comprehensively validated with data from three inde-
pendent cultivations in GMEM-Z medium. The well-surface was identified as the main
limiting factor of growth. However, for MDCK cell growth in DMEM medium, the
model of section 3.1.1 requires modifications such that it reflects cell growth under low
GLCx levels.
Changes to the model structure
By fitting the model to the experimental data, we found that the total cell volume
reached by the cells is lower at the end of cultivation (V C∗ = 5.20 µL) than for GMEM-Z
cultivations. Furthermore, the specific growth rate µ of the cells now depends on the
extracellular glutamine concentration (GLNx) instead of the glucose (GLCx) concentra-
tion, as cells grew for a certain time span under low GLCx levels:
µ =
µmax[GLN
x]
kmGLNx + [GLN
x]
(A.2.1)
with kmGLNx = 0.04 mmol/L as the Monod constant for GLN
x. Under low concentrations
of GLCx, the uptake may also depend on the affinity of the glucose transporter, which
can yield smoother depletion dynamics. To account for such an effect, both uptake rates
for GLCx were extended by a Michaelis-Menten kinetic [320]:
rX/GLCx = µ(X1f +
Nc∑
i=2
Xi)YX/GLCx
[GLCx]
kmGLCx + [GLC
x]
(A.2.2)
rm/GLCx = mGLCxV
C [GLC
x]
kmGLCx + [GLC
x]
(A.2.3)
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where kmGLCx = 0.24 mmol/L is the new affinity constant for glucose. Except of YX/GLNx
which increases to 5.92× 10−7 mmol/L/cell, all other parameter values were taken from
the original model (Table C.4) while initial conditions were derived during model fitting
(Table C.3).
Cell number, diameter and volume dynamics
These minor changes allow capturing the growth dynamics of adherent MDCK cells
in numbers and mean cell diameter (Fig. A.2). Similarly to the growth of MDCK
cells in GMEM-Z, the growth phases were identified based on the relative number of
growing cells (bsyn, Eq. 3.1.94) with: growth phase 0 – 40 h (0 – 5 % growth inhibition),
intermediate growth phase 40 – 75 h (5 – 95 % growth inhibition), and stationary growth
phase 75 – 200 h (95 – 100 % growth inhibition). A total cell number of 2.80 × 106 is
reached towards the end of cultivation, which is lower compared to the GMEM-Z cultures
(Fig. 4.7A). The mean cell diameter starts with 15 µm and reaches a maximum of
19 microm at 24 h of cultivation, which is within the range we described for MDCK cells
for cultivations in GMEM-Z medium (Fig. 4.7).
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Figure A.2.: MDCK cell growth with DMEM (2 mmol/L GLCx) in six-well plates.
(A) cell number. (B) mean cell diameter. (C) the volume of all cells calculated from the mean
cell diameter and the cell number. Data was taken from [23] and indicated as diamond (3).
Error bars represent mean and standard deviation of three wells (in case of V C error bars were
calculated according to the error propagation law). Lines represent the corresponding model
simulation (parameters of Table C.3 and Table C.4 with modifications described in the text).
Extracellular metabolite pool dynamics
The level of GLCx starts at low levels (2.3 mmol/L) and decreases fast due to an ex-
ponentially increasing demand by the cells (Fig. A.3A). The original data for GLCx is
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Figure A.3.: Concentrations of extracellular substrates and by-products during
MDCK cell cultivation in DMEM (2 mmol/L GLCx). Extracellular glucose (A), glu-
tamine (B), glutamate (C), lactate (D) and ammonia (E) concentration. Data (3) and error
bars, which represent mean and standard deviation of three wells, were taken from [23]. The
extracellular glucose concentration was shifted by -1.41 mmol/L to achieve a real depletion and
to properly fit the model. F: cell volume-dependent growth inhibition f and relative biosynthe-
sis activity bsyn of the cells. Data and corresponding model simulations (based on parameters
of Table C.3 and C.4 and modifications described in the text) are shown in the color code of
Figure A.2. Grey dashed lines are the limit of quantification (LOQ; data below LOQ marked
in gray)
.
about 1.41 mmol/L higher (but still below the LOQ) and thus constantly high between
40 – 200 h of cultivation. As this neither fits to the observation that MDCK cells require
GLCx nor that V C still increases after 40 h of cultivation we decided to shift the GLCx
concentration such that it depletes during cultivation. However, in both cases GLCx
levels remain constant after 40 h of cultivation while the total cell volume still increases
(until 58 h of cultivation, Fig. 4.7C). Presumably, the cells use stored internal precursors
and take up more GLNx to meet their demands in biomass precursor. So the reduction
in the final level of V C may thus either be explained with the differences between media
or be attributed to a delayed effect of the glucose limitation. The increased uptake of
GLNx is captured by the model (Fig. A.3B) and also agrees with the NHx4 release (Fig.
A.3E). The uptake of GLUx depends on the growth inhibition of the cells and are similar
to cell growth in GMEM-Z (Fig. A.3C, A.3F).
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Figure A.4.: MDCK suspension cell growth in stirred tank bioreactors with SMIF08 medium.
(A) Cell concentration. (B) Mean cell diameter. (C) Volume concentration of all cells calcu-
lated from the mean cell diameter and the cell number. Data of three independent experiments
are indicated as triangle (∆), rectangle (2) and circle (◦). Error bars represent mean and stan-
dard deviation of three technical replicates (in case of V C error bars were calculated according
to the error propagation law). Lines represent the corresponding model simulation.
.
Figure A.5.: Concentration of extracellular substrates and byproducts. Glucose (A), glu-
tamine (B), glutamate (C), lactate (D) and ammonia (E) during MDCK suspension growth
in stirred tank bioreactors with SMIF08 medium. Data (∆, 2, ◦) and error bars represent
mean and standard deviation of three technical replicates. F: cell volume-dependent growth
inhibition. Data and corresponding model simulations are shown in the color code of Fig. A.4.
Grey dashed lines are the limit of quantification (LOQ; data below LOQ marked in gray).
.
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A.4. Parameter correlation analysis
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Figure A.6.: Pairwise linear correlation coefficient of model parameters for glycolysis that
were estimated in this study (Cult1 – 3, Lim1, Lim2, Pulse). The coefficient coefficient is
determined from 2000 parameter sets (Θ), which were generated by the bootstrap method (see
section 3.3.2), and given as color code.
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Figure A.7.: Pairwise linear correlation coefficient of model parameters for glutaminolysis
that were estimated in this study (Cult1 – 3, Lim1, Lim2, Pulse). The coefficient coefficient
is determined from 2000 parameter sets (Θ), which were generated by the bootstrap method
(see section 3.3.2), and given as color code.
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B.1. Limits of quantification for metabolite measurements
Table B.1.: Limit of quantification for intracellular and extracellular metabolites (Max Planck
Institute for Dynamics of Complex Technical Systems Magdeburg, not published)
Metabolite LOQ Unit Metabolite LOQ Unit
2PG 3.75E-008 mmol GLUx 0.29 mmol/L
3PG 3.75E-008 mmol GMP 3.75E-008 mmol
αKG 1.50E-007 mmol GTP 1.19E-007 mmol
ADP 3.00E-007 mmol ICIT 3.75E-008 mmol
AMP 1.50E-007 mmol LACx 8.4 mmol/L
ATP 6.00E-007 mmol MAL 3.00E-007 mmol
CDP 3.75E-008 mmol NHx4 0.15 mmol/L
CAC 3.75E-008 mmol PEP 3.75E-008 mmol
CIT 5.78E-007 mmol PYR 3.00E-007 mmol
CMP 3.75E-008 mmol R5P 3.75E-008 mmol
CTP 6.00E-008 mmol SUC 3.00E-007 mmol
F16BP 3.42E-007 mmol UDP 3.75E-008 mmol
F6P 5.25E-008 mmol UDP-GalNAc 9.00E-008 mmol
FUM 7.50E-008 mmol UDP-GlcNAc 3.00E-007 mmol
GDP 6.00E-008 mmol UGLC 1.05E-007 mmol
G6P 5.25E-008 mmol UMP 3.75E-008 mmol
GLCx 3.9 mmol/L UTP 3.00E-007 mmol
GLNx 0.25 mmol/L
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Figure B.1.: Adenosine-based nucleotide pools during during substrate limitation
and substrate pulse. ATP (A – C), ADP (D – F) and AMP (G – I) concentrations of three
independent perturbation experiments with MDCK cells in 6-well plates. Cells, originating
from a cultivation experiment (see Table C.2) were deprived of extracellular nutrients by re-
moval of medium and addition of phosphate buffered saline (PBS), shown in the first column
(Lim1) and second column (Lim2). After a 2 h limitation, PBS was exchanged by fresh
medium, shown in the third column (Pulse). Data (◦) and error bars represent mean and
standard deviation of three wells and were taken from Ritter [23]. Dashed lines are the limit
of quantification (LOQ).
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Table C.1.: Initial conditions and experiment-specific parameters for the structured model
comprising the metabolic status, growth status and culture conditions relevant for simulation
of the cultivation experiments (Cult1 – 3, Pred.). The metabolic status is derived by steady
state simulation (see section 3.2).
Cult1 (∆) Cult2 (2) Cult3 (◦) Pred. (3) Unit
Initial metabolic status
[αKG] 3.26× 10−1 mmol/L
[3PG] 5.12× 10−2 mmol/L
[ATP ] 3.48 mmol/L
[ADP ] 2.94× 10−1 mmol/L
[AMP ] 5.09× 10−2 mmol/L
[CAC] 5.54× 10−3 mmol/L
[CIT ] 5.71× 10−1 mmol/L
[F16BP ] 9.88× 10−2 mmol/L
[F6P ] 6.66× 10−3 mmol/L
[FUM ] 5.76× 10−2 mmol/L
[G6P ] 1.46× 10−2 mmol/L
[GLC] 1.18× 10−4 mmol/L
[GLU ] 0 mmol/L
[ICIT ] 1.83× 10−2 mmol/L
[IMP ] 1.81 mmol/L
[MAL] 4.59× 10−1 mmol/L
[PEP ] 1.49× 10−2 mmol/L
[PY R] 5.81× 10−1 mmol/L
[R5P ] 5.74× 10−3 mmol/L
[SUC] 1.53× 10−1 mmol/L
[UGLC] 2.54× 10−1 mmol/L
(continued on next page)
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Initial growth status
γGLNT -
γGLUT -
µa (calculated by 1/min
bsyn segregated cell growth model) -
f -
V CS L/cell
Xtot cells
Initial culture condition
[GLCx] mmol/L
[GLNx] mmol/L
[GLUx] (see Table C.3) mmol/L
[LACx] mmol/L
[NHx4 ] mmol/L
V M L
Elevel -
a note that µ is here used in minutes to be consistent with intracellular reaction rates
Table C.2.: Initial conditions and experiment-specific parameters for the structured model
comprising the metabolic status, growth status and culture conditions relevant for simulation
of the perturbation experiments derived from the cell’s cultivation history.
Lim1 (◦) Lim2 (◦) Pulse (◦) Unit
history: Cult1 at t∗= 52 h Cult1 at t∗= 61 h Cult1 at t∗= 34 ha
Initial metabolic status
[3PG] 7.95× 10−2 6.10× 10−2 9.03× 10−2 mmol/L
[αKG] 5.28× 10−1 3.58× 10−1 1.29× 10−1 mmol/L
[ATP ] 3.15 3.36 7.21× 10−1 mmol/L
[ADP ] 3.32× 10−1 3.01× 10−1 1.13 mmol/L
[AMP ] 5.87× 10−2 5.39× 10−2 1.03× 10−1 mmol/L
[CAC] 5.61× 10−3 5.56× 10−3 9.78× 10−3 mmol/L
[CIT ] 5.79× 10−1 5.73× 10−1 1.01 mmol/L
[F16BP ] 5.91× 10−1 2.66× 10−1 1.54× 10−3 mmol/L
(continued on next page)
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[F6P ] 1.19× 10−2 8.86× 10−3 2.31× 10−3 mmol/L
[FUM ] 1.29× 10−1 7.24× 10−2 3.65× 10−2 mmol/L
[G6P ] 6.02× 10−2 3.24× 10−2 1.15× 10−3 mmol/L
[GLC] 7.96× 10−4 3.30× 10−4 0.00 mmol/L
[GLU ] 4.50× 10−1 1.03× 10−1 0.00 mmol/L
[ICIT ] 1.65× 10−2 1.75× 10−2 2.63× 10−2 mmol/L
[IMP ] 2.09 1.92 3.68 mmol/L
[MAL] 7.46× 10−1 5.06× 10−1 1.81× 10−1 mmol/L
[PEP ] 1.09× 10−2 1.28× 10−2 3.42× 10−2 mmol/L
[PY R] 4.79× 10−1 5.07× 10−1 1.66 mmol/L
[R5P ] 2.35× 10−2 1.27× 10−2 4.53× 10−4 mmol/L
[SUC] 4.23× 10−1 2.15× 10−1 1.29× 10−1 mmol/L
[UGLC] 3.63× 10−1 3.38× 10−1 1.96× 10−1 mmol/L
Initial growth status
γGLNT 3.69× 10−2 1.44× 10−2 6.19× 10−2 -
γGLUT 5.36× 10−1 2.84× 10−1 7.92× 10−1 -
bsyn 6.02× 10−1 2.71× 10−1 9.69× 10−1 -
f 1.62× 10−1 4.37× 10−4 8.82× 10−1 -
Xtot 2.10× 106 2.69× 106 1.11× 106 cells
V CS 3.04× 10−12 2.53× 10−12 3.46× 10−12 L/cell
Initial culture condition
[GLCx] 2.42× 101 2.26× 101 b3.00× 101 mmol/L
[GLNx] 9.53× 10−1 8.43× 10−1 b1.61 mmol/L
[GLUx] 1.45× 10−1 1.85× 10−2 b5.80× 10−1 mmol/L
[LACx] 1.85× 101 2.22× 101 b0.00 mmol/L
[NHx4 ] 1.36 1.46
b0.00 mmol/L
Elevel 1.08 1.08 1.08 -
V M 3.00× 10−7 3.00× 10−7 b4.00× 10−3 L
a followed by 2 h substrate limitation
b manually adjusted
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Table C.3.: Estimated initial conditions and experiment-specific parameters of the segregated
cell growth model and enzyme level (Elevel) for simulation adherent MDCK cell growth in 6-well
plates with GMEM-Z medium.
Local parameter Cult1 ∆ Cult2 2 Cult3 ◦ Pred. 3 Unit
[GLCx](t = 0) 31.04 29.25 31.95 2.31 mmol/L
[GLNx](t = 0) 1.61 1.78 1.82 1.86 mmol/L
[GLUx](t = 0) 0.58a 0.54a 0.48a 0.40 mmol/L
[LACx](t = 0) 3.25 3.74 1.25 3.42 mmol/L
[NHx4 ](t = 0) 0.76
a 0.74a 0.74a 0.00 mmol/L
dc 22.93 24.86 20.98 21.12 µm
dm 15.68 15.31 14.34 15.48 µm
Elevel 1.08 1.04 0.92 1.00 -
V M 0.004b 0.004b 0.004b 0.004b L
X1(t = 0) 0.40× 106 0.41× 106 0.48× 106 0.30× 106 cells
X2,...,Nc(t = 0) 0 0 0 0 cells
Precult. system T-flask T-flask Roller bottle T-flask
Precult. duration 3 days 6 days 4 days -
a taken from Wetzel [280]
b manually adjusted
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Table C.4.: Estimated global parameters of the segregated cell growth model (for adherent
MDCK cells cultivated in 6-well plates with GMEM-Z medium) on the basis of three cultiva-
tion experiments with confidence intervals between 0.025-quantile (Q0.025) and 0.975-quantile
(Q0.975) and respective relative local sensitivities χ
2(φ). Note that parameter values are used
in minute units during simulation
Global param. Value Q0.025 – Q0.975 χ
2(φ) Unit
µmax 0.039 0.036 – 0.051 0.74 1/h
Fevap
a2.75× 10−6 - - L/h
kdGLNx
a3.60× 10−3 - - 1/h
kmGLCx 0.923 0.000
c – 9.974c 0.03 mmol/L
mGLCx 1.06× 10−2 (0.92 – 1.19)× 10−2 0.05 mmol/L/µL/h
mGLNx 5.29× 10−9 (0.00c – 2.83)× 10−6 ≈ 0 mmol/L/µL/h
mNHx4 3.33× 10−12 (0.00c – 1.00c)× 10−10 ≈ 0 mmol/L/µL/h
N c b5 - - -
s 2.752 2.140 – 4.145 0.26 -
vGLT 3.33× 10−10 (2.53 – 3.83)× 10−10) 0.22 L/cell/h
V C∗ 6.804 6.568 – 6.969 0.36 µL
YLACx/GLCx 2.140 2.034 – 2.283 0.08 -
YX/GLCx 3.57× 10−6 (3.18 – 3.96)× 10−6 0.09 mmol/L/cell
YX/GLNx 0.27× 10−6 (0.25 – 0.28)× 10−6 0.10 mmol/L/cell
YX/NHx4 3.5× 10−7 (3.09 – 3.72)× 10−7 0.04 mmol/L/cell
a estimated experimentally (Fevap by Ritter [23], kdGLNx by Bock et al. [212])
b estimated in separate simulation studies
c value at parameter bound
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